,words,labels,sentence_id,full sentence
0,The,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
1,nutritional,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
2,value,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
3,of,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
4,gluten,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
5,-,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
6,free,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
7,products,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
8,is,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
9,the,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
10,subject,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
11,of,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
12,interest,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
13,for,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
14,food,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
15,technologists,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
16,and,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
17,nutritionists,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
18,",",O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
19,as,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
20,the,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
21,only,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
22,effective,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
23,treatment,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
24,for,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
25,celiac,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
26,disease,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
27,is,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
28,a,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
29,lifelong,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
30,gluten,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
31,-,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
32,free,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
33,diet,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
34,.,O,0.0,"The nutritional value of gluten - free products is the subject of interest for food technologists and nutritionists , as the only effective treatment for celiac disease is a lifelong gluten - free diet ."
72,Moreover,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
73,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
74,selenium,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
75,content,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
76,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
77,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
78,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
79,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
80,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
81,gluten,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
82,-,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
83,free,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
84,cereals,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
85,like,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
86,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
87,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
88,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
89,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
90,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
91,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
92,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
93,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
94,relatively,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
95,new,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
96,or,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
97,less,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
98,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
99,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
100,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
101,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
102,oat,B-http://purl.bioontology.org/ontology/SNOMEDCT/418504009,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
103,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
104,amaranth,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
105,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
106,teff,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
107,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
108,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
109,quinoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/227515004,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
110,was,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
111,compared,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
112,.,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
430,In,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
431,many,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
432,cases,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
433,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
434,further,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
435,selection,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
436,goals,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
437,such,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
438,as,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
439,milk,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
440,composition,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
441,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
442,udder,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
443,morphology,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
444,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
445,somatic,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
446,cell,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
447,count,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
448,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
449,and,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
450,scrapie,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
451,resistance,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
452,have,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
453,been,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
454,implemented,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
455,.,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
499,In,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
500,this,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
501,context,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
502,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
503,the,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
504,application,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
505,of,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
506,selection,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
507,schemes,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
508,assisted,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
509,by,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
510,molecular,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
511,information,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
512,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
513,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
514,improve,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
515,either,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
516,traditional,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
517,dairy,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
518,traits,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
519,or,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
520,traits,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
521,costly,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
522,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
523,record,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
524,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
525,seems,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
526,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
527,be,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
528,attractive,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
529,in,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
530,dairy,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
531,sheep,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
532,.,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
533,At,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
534,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
535,moment,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
536,",",O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
537,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
538,most,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
539,effective,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
540,strategy,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
541,seems,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
542,to,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
543,be,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
544,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
545,strengthening,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
546,of,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
547,research,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
548,projects,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
549,aimed,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
550,at,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
551,finding,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
552,causal,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
553,mutations,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
554,along,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
555,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
556,genes,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
557,affecting,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
558,traits,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
559,of,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
560,economic,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
561,importance,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
562,.,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
1464,Amounts,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1465,of,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1466,genistein,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1467,and,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1468,genistin,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1469,in,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1470,soybeans,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1471,",",O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1472,soy,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1473,nuts,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1474,and,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1475,soy,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1476,powder,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1477,were,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1478,in,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1479,the,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1480,range,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1481,of,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1482,4.6,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1483,to,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1484,18.2,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1485,and,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1486,200.6,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1487,to,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1488,968.1,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1489,micrograms,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1490,/,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1491,g,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1492,food,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1493,",",O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1494,respectively,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1495,.,O,45.0,"Amounts of genistein and genistin in soybeans , soy nuts and soy powder were in the range of 4.6 to 18.2 and 200.6 to 968.1 micrograms / g food , respectively ."
1496,The,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1497,values,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1498,for,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1499,soy,B-http://purl.bioontology.org/ontology/SNOMEDCT/226793001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1500,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226793001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1501,and,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1502,tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1503,(,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1504,bean,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1505,curd,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1506,),O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1507,were,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1508,1.9,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1509,to,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1510,13.9,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1511,and,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1512,94.8,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1513,to,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1514,137.7,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1515,micrograms,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1516,/,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1517,g,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1518,food,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1519,",",O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1520,respectively,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1521,.,O,46.0,"The values for soy milk and tofu ( bean curd ) were 1.9 to 13.9 and 94.8 to 137.7 micrograms / g food , respectively ."
1767,We,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1768,investigated,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1769,this,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1770,relation,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1771,in,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1772,"490,802",O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1773,United,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1774,States,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1775,participants,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1776,of,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1777,the,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1778,NIH,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1779,-,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1780,AARP,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1781,Diet,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1782,and,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1783,Health,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1784,cohort,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1785,using,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1786,Cox,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1787,proportional,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1788,hazard,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1789,models,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1790,adjusted,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1791,for,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1792,potential,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1793,confounders,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1794,.,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1996,Results,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1997,from,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1998,this,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1999,large,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2000,prospective,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2001,observational,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2002,study,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2003,are,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2004,consistent,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2005,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2006,previous,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2007,case,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2008,-,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2009,control,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2010,studies,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2011,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2012,support,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2013,the,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2014,hypothesis,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2015,that,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2016,total,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2017,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2018,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2019,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2020,intake,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2021,is,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2022,associated,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2023,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2024,reduced,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2025,risk,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2026,of,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2027,head,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2028,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2029,neck,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2030,cancer,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2031,.,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2079,One,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2080,wonders,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2081,which,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2082,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2083,and,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2084,other,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2085,cocoa,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2086,derivatives,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2087,can,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2088,be,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2089,considered,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2090,as,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2091,biofunctional,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2092,food,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2093,products,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2094,.,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2199,Future,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2200,studies,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2201,and,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2202,systematic,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2203,reviews,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2204,will,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2205,shed,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2206,light,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2207,on,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2208,some,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2209,preventive,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2210,effects,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2211,and,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2212,health,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2213,benefits,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2214,of,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2215,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2216,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2217,.,O,69.0,Future studies and systematic reviews will shed light on some preventive effects and health benefits of cocoa products .
2578,For,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2579,people,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2580,lacking,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2581,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2582,LP,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2583,trait,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2584,",",O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2585,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2586,fermentation,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2587,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2588,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2589,into,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2590,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2591,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2592,related,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2593,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2594,(,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2595,a,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2596,process,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2597,known,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2598,for,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2599,≥8500,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2600,y,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2601,),O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2602,aids,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2603,milk,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2604,digestion,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2605,through,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2606,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2607,breakdown,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2608,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2609,some,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2610,lactose,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2611,and,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2612,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2613,provision,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2614,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2615,β,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2616,-,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2617,galactosidase,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2618,",",O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2619,which,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2620,remains,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2621,active,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2622,in,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2623,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2624,gastrointestinal,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2625,tract,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2626,.,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2998,We,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
2999,assessed,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3000,the,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3001,effects,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3002,of,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3003,consuming,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3004,(,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3005,1,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3006,),O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3007,common,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3008,breakfast,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3009,beverages,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3010,(,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3011,water,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3012,",",O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3013,sugar,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3014,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3015,sweetened,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3016,coffee,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3017,",",O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3018,reduced,B-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3019,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3020,energy,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3021,orange,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3022,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3023,(,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3024,OJ,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3025,),O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3026,",",O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3027,and,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3028,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3029,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3030,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3031,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3032,(,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3033,LFM,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3034,),O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3035,),O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3036,;,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3037,and,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3038,(,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3039,2,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3040,),O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3041,fat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3042,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3043,free,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3044,",",I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3045,low,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3046,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3047,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3048,",",I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3049,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3050,whole,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3051,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3052,with,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3053,breakfast,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3054,on,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3055,postprandial,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3056,plasma,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3057,glucose,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3058,and,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3059,insulin,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3060,responses,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3061,in,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3062,adults,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3063,who,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3064,were,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3065,overweight,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3066,/,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3067,obese,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3068,.,O,94.0,"We assessed the effects of consuming ( 1 ) common breakfast beverages ( water , sugar - sweetened coffee , reduced - energy orange juice ( OJ ) , and low - fat milk ( LFM ) ) ; and ( 2 ) fat - free , low - fat , and whole milk with breakfast on postprandial plasma glucose and insulin responses in adults who were overweight / obese ."
3116,The,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3117,test,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3118,beverages,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3119,(,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3120,except,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3121,water,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3122,),O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3123,each,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3124,contained,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3125,12,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3126,g,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3127,digestible,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3128,carbohydrate,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3129,.,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3445,Intake,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3446,of,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3447,citrus,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3448,fruits,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3449,rather,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3450,than,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3451,total,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3452,fruits,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3453,was,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3454,shown,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3455,to,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3456,have,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3457,a,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3458,protective,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3459,effect,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3460,on,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3461,the,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3462,risk,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3463,of,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3464,GC,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3465,",",O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3466,but,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3467,was,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3468,not,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3469,significant,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3470,.,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
4474,All,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4475,street,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4476,food,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4477,vending,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4478,sites,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4479,(,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4480,single,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4481,point,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4482,of,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4483,sale,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4484,),O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4485,located,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4486,in,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4487,a,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4488,1,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4489,-,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4490,km,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4491,buffer,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4492,centred,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4493,on,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4494,the,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4495,main,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4496,public,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4497,market,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4498,were,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4499,systematically,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4500,selected,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4501,(,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4502,n,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4503,439,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4504,;,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4505,n,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4506,328,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4507,participants,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4508,),O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4509,.,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4510,Data,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4511,on,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4512,vending,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4513,sites,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4514,',O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4515,characteristics,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4516,(,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4517,mobility,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4518,",",O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4519,type,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4520,of,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4521,physical,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4522,set,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4523,-,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4524,up,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4525,and,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4526,access,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4527,to,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4528,electricity,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4529,),O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4530,",",O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4531,operating,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4532,periods,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4533,and,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4534,food,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4535,availability,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4536,were,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4537,collected,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4538,.,O,142.0,"Data on vending sites ' characteristics ( mobility , type of physical set - up and access to electricity ) , operating periods and food availability were collected ."
4539,Samples,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4540,of,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4541,the,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4542,most,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4543,commonly,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4544,available,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4545,foods,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4546,of,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4547,unknown,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4548,composition,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4549,were,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4550,collected,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4551,(,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4552,twenty,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4553,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4554,eight,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4555,home,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4556,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4557,made,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4558,and,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4559,twenty,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4560,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4561,four,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4562,industrial,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4563,),O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4564,.,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4565,Macronutrients,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4566,",",O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4567,Na,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4568,and,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4569,K,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4570,were,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4571,quantified,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4572,through,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4573,chemical,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4574,analysis,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4575,.,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4873,Sixty,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4874,nude,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4875,mice,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4876,received,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4877,MDA,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4878,-,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4879,MB,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4880,231,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4881,human,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4882,breast,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4883,cancer,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4884,cells,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4885,and,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4886,were,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4887,fed,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4888,a,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4889,diet,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4890,containing,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4891,8,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4892,%,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4893,w,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4894,/,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4895,w,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4896,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4897,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4898,until,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4899,the,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4900,mean,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4901,tumor,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4902,volume,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4903,was,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4904,60,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4905,mm3,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4906,.,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
5215,We,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5216,observed,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5217,that,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5218,olive,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5219,oil,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5220,administration,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5221,lowered,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5222,tumor,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5223,incidence,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5224,and,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5225,inhibited,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5226,the,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5227,development,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5228,of,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5229,tumors,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5230,in,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5231,DMH,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5232,-,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5233,treated,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5234,rats,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5235,.,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5469,The,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5470,future,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5471,challenge,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5472,is,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5473,to,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5474,identify,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5475,the,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5476,antihypertensive,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5477,components,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5478,in,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5479,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5480,and,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5481,their,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5482,mechanisms,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5483,of,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5484,action,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5485,and,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5486,thus,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5487,to,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5488,find,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5489,more,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5490,possibilities,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5491,for,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5492,using,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5493,these,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5494,constituents,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5495,and,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5496,products,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5497,as,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5498,a,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5499,dietary,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5500,treatment,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5501,of,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5502,hypertension,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5503,.,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5541,A,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5542,total,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5543,of,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5544,"1,586",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5545,cases,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5546,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5547,their,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5548,age-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5549,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5550,sex-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5551,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5552,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5553,race,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5554,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5555,matched,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5556,neighborhood,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5557,controls,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5558,were,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5559,interviewed,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5560,in,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5561,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5562,person,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5563,from,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5564,1987,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5565,to,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5566,1999,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5567,.,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5806,Patients,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5807,with,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5808,migraine,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5809,who,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5810,believed,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5811,that,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5812,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5813,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5814,but,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5815,not,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5816,alcohol,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5817,in,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5818,general,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5819,had,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5820,a,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5821,headache,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5822,-,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5823,provoking,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5824,effect,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5825,on,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5826,them,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5827,were,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5828,challenged,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5829,either,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5830,with,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5831,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5832,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5833,or,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5834,with,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5835,a,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5836,vodka,B-http://purl.bioontology.org/ontology/SNOMEDCT/226064009,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5837,and,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5838,diluent,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5839,mixture,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5840,of,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5841,equivalent,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5842,alcohol,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5843,content,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5844,",",O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5845,both,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5846,consumed,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5847,cold,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5848,out,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5849,of,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5850,dark,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5851,bottles,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5852,to,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5853,disguise,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5854,colour,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5855,and,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5856,flavour,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5857,.,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
6051,It,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6052,is,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6053,important,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6054,source,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6055,of,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6056,vitamin,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6057,C,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6058,",",O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6059,potassium,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6060,",",O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6061,folic,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6062,acid,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6063,",",O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6064,and,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6065,carotenoids,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6066,",",O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6067,such,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6068,as,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6069,lycopene,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6070,.,O,196.0,"It is important source of vitamin C , potassium , folic acid , and carotenoids , such as lycopene ."
6479,Preliminary,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6480,data,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6481,suggest,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6482,that,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6483,polyphenols,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6484,in,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6485,some,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6486,100,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6487,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6488,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6489,juices,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6490,may,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6491,inhibit,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6492,absorption,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6493,of,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6494,naturally,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6495,occurring,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6496,sugars,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6497,.,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6851,More,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6852,often,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6853,",",O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6854,discordant,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6855,works,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6856,indicate,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6857,no,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6858,effect,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6859,of,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6860,dairy,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6861,consumption,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6862,on,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6863,bone,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6864,safety,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6865,.,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
7373,Patient,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7374,history,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7375,of,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7376,food,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7377,intolerance,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7378,was,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7379,documented,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7380,by,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7381,a,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7382,standardized,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7383,questionnaire,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7384,.,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7495,Thus,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7496,",",O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7497,serologic,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7498,tests,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7499,seem,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7500,to,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7501,be,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7502,of,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7503,low,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7504,significance,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7505,for,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7506,prediction,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7507,o,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7508,food,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7509,allergy,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7510,in,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7511,latex,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7512,-,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7513,allergic,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7514,patients,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7515,.,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7847,We,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7848,developed,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7849,a,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7850,comprehensive,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7851,composition,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7852,database,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7853,of,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7854,629,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7855,cereal,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7856,-,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7857,based,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7858,gluten,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7859,free,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7860,(,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7861,GF,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7862,),O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7863,products,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7864,available,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7865,in,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7866,Spain,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7867,.,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
8008,Macronutrient,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8009,analysis,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8010,revealed,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8011,that,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8012,25.4,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8013,%,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8014,of,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8015,the,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8016,products,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8017,could,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8018,be,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8019,labeled,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8020,as,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8021,a,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8022,source,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8023,of,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8024,fiber,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8025,.,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8803,Hoppers,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8804,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8805,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8806,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8807,pittu,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8808,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8809,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8810,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8811,pittu,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8812,and,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8813,Olu,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8814,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8815,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8816,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8817,(,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8818,seeds,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8819,of,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8820,Nymphaea,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8821,lotus,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8822,),O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8823,were,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8824,categorized,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8825,as,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8826,high,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8827,-,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8828,GI,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8829,foods,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8830,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8831,and,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8832,the,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8833,corresponding,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8834,GI,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8835,(,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8836,+,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8837,/-,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8838,standard,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8839,error,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8840,of,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8841,the,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8842,mean,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8843,),O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8844,values,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8845,were,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8846,120+/-8,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8847,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8848,103+/-7,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8849,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8850,101+/-8,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8851,and,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8852,91+/-8,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8853,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8854,respectively,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8855,.,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8856,The,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8857,GI,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8858,values,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8859,significantly,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8860,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8861,P<0.01,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8862,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8863,and,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8864,negatively,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8865,correlated,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8866,with,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8867,the,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8868,insoluble,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8869,dietary,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8870,fibre,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8871,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8872,rho,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8873,=,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8874,-,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8875,0.780,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8876,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8877,",",O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8878,soluble,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8879,dietary,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8880,fibre,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8881,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8882,rho,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8883,=,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8884,-,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8885,0.712,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8886,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8887,and,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8888,protein,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8889,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8890,rho,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8891,=,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8892,-,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8893,0.738,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8894,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8895,contents,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8896,in,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8897,grams,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8898,per,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8899,100,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8900,g,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8901,digestible,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8902,starch,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8903,containing,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8904,foods,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8905,.,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
9053,Whey,B-http://purl.bioontology.org/ontology/SNOMEDCT/226770007,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9054,",",O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9055,lactalbumin,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9056,and,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9057,lactoferrin,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9058,improved,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9059,glucose,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9060,clearance,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9061,partly,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9062,through,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9063,differential,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9064,upregulation,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9065,of,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9066,glucoregulatory,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9067,transcripts,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9068,in,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9069,the,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9070,liver,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9071,and,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9072,skeletal,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9073,muscle,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9074,.,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9544,However,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9545,",",O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9546,FTs,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9547,role,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9548,in,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9549,soybean,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9550,is,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9551,not,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9552,fully,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9553,resolved,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9554,due,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9555,to,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9556,the,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9557,presence,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9558,of,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9559,multiple,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9560,(,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9561,ten,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9562,),O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9563,homologs,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9564,in,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9565,the,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9566,genome,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9567,.,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9754,Lingonberry,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9755,and,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9756,blueberry,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9757,plants,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9758,were,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9759,found,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9760,to,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9761,be,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9762,rich,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9763,sources,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9764,of,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9765,phenolic,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9766,compounds,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9767,.,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9768,Total,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9769,antioxidant,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9770,capacities,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9771,in,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9772,terms,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9773,of,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9774,radical,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9775,scavenging,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9776,activity,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9777,and,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9778,reducing,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9779,power,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9780,were,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9781,much,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9782,higher,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9783,in,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9784,leaves,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9785,of,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9786,both,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9787,plants,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9788,as,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9789,compared,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9790,to,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9791,their,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9792,fruits,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9793,.,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
10426,For,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10427,tomato,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10428,and,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10429,aubergine,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10430,GAs,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10431,",",O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10432,the,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10433,risk,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10434,to,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10435,human,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10436,health,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10437,could,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10438,not,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10439,be,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10440,characterised,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10441,due,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10442,to,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10443,the,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10444,lack,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10445,of,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10446,occurrence,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10447,data,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10448,and,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10449,the,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10450,limited,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10451,toxicity,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10452,data,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10453,.,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10454,For,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10455,horses,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10456,",",O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10457,farm,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10458,and,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10459,companion,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10460,animals,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10461,",",O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10462,no,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10463,risk,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10464,characterisation,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10465,for,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10466,potato,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10467,GAs,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10468,could,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10469,be,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10470,performed,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10471,due,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10472,to,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10473,insufficient,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10474,data,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10475,on,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10476,occurrence,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10477,in,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10478,feed,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10479,and,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10480,on,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10481,potential,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10482,adverse,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10483,effects,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10484,of,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10485,GAs,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10486,in,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10487,these,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10488,species,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10489,.,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10490,Milk,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10491,beverages,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10492,derived,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10493,from,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10494,plant,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10495,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10496,based,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10497,protein,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10498,have,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10499,attracted,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10500,the,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10501,interest,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10502,of,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10503,consumers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10504,and,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10505,researchers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10506,as,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10507,a,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10508,health,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10509,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10510,promoting,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10511,functional,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10512,food,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10513,.,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10696,Furthermore,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10697,",",O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10698,the,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10699,effect,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10700,of,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10701,processing,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10702,",",O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10703,possible,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10704,comparative,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10705,study,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10706,and,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10707,potential,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10708,applications,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10709,in,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10710,healthcare,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10711,have,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10712,been,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10713,discussed,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10714,.,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
11069,A,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11070,high,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11071,consumption,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11072,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11073,caloric,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11074,beverages,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11075,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11076,such,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11077,as,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11078,alcoholic,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11079,or,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11080,sweetened,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11081,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11082,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11083,may,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11084,particularly,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11085,contribute,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11086,to,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11087,weight,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11088,gain,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11089,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11090,and,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11091,lower,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11092,satiety,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11093,has,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11094,been,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11095,associated,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11096,with,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11097,the,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11098,intake,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11099,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11100,liquid,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11101,instead,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11102,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11103,solid,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11104,calories,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11105,.,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11229,In,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11230,substitution,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11231,models,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11232,",",O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11233,the,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11234,consumption,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11235,of,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11236,water,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11237,instead,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11238,of,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11239,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11240,or,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11241,sugar,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11242,-,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11243,sweetened,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11244,soda,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11245,beverages,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11246,was,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11247,associated,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11248,with,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11249,a,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11250,lower,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11251,obesity,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11252,incidence,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11253,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11254,the,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11255,Odds,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11256,Ratio,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11257,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11258,OR,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11259,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11260,0.80,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11261,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11262,95,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11263,%,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11264,confidence,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11265,interval,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11266,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11267,CI,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11268,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11269,0.68,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11270,to,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11271,0.94,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11272,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11273,and,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11274,OR,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11275,0.85,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11276,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11277,95,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11278,%,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11279,CI,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11280,0.75,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11281,to,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11282,0.97,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11283,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11284,;,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11285,respectively,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11286,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11287,and,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11288,",",O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11289,in,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11290,the,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11291,case,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11292,of,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11293,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11294,",",O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11295,it,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11296,was,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11297,also,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11298,associated,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11299,with,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11300,a,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11301,higher,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11302,average,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11303,weight,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11304,loss,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11305,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11306,weight,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11307,change,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11308,difference,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11309,=,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11310,-328,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11311,g,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11312,;,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11313,(,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11314,95,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11315,%,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11316,CI,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11317,-566,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11318,to,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11319,-89,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11320,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11321,),O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11322,.,O,378.0,"In substitution models , the consumption of water instead of beer or sugar - sweetened soda beverages was associated with a lower obesity incidence ( the Odds Ratio ( OR ) 0.80 ( 95 % confidence interval ( CI ) 0.68 to 0.94 ) and OR 0.85 ( 95 % CI 0.75 to 0.97 ) ; respectively ) and , in the case of beer , it was also associated with a higher average weight loss ( weight change difference = -328 g ; ( 95 % CI -566 to -89 ) ) ."
11593,Intradermal,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11594,skin,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11595,testing,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11596,with,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11597,mixed,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11598,spice,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11599,dust,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11600,allergen,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11601,demonstrated,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11602,positive,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11603,skin,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11604,reactions,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11605,in,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11606,73.3,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11607,%,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11608,of,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11609,exposed,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11610,and,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11611,in,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11612,33.3,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11613,%,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11614,of,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11615,control,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11616,workers,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11617,(,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11618,P,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11619,less,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11620,than,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11621,0.001,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11622,),O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11623,.,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
13172,A,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13173,total,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13174,of,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13175,twenty,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13176,-,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13177,five,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13178,obese,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13179,women,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13180,aged,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13181,38,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13182,-,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13183,68,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13184,years,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13185,consumed,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13186,isoenergetic,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13187,meals,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13188,rich,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13189,in,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13190,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13191,(,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13192,POT,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13193,),O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13194,or,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13195,casein,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13196,(,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13197,CA,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13198,),O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13199,or,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13200,a,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13201,combination,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13202,of,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13203,both,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13204,these,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13205,meals,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13206,(,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13207,POT,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13208, ,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13209,+,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13210, ,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13211,CA,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13212,),O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13213,",",O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13214,in,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13215,random,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13216,order,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13217,in,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13218,a,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13219,cross,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13220,-,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13221,over,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13222,trial,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13223,.,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13224,After,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13225,an,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13226,overnight,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13227,fast,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13228,",",O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13229,blood,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13230,samples,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13231,were,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13232,collected,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13233,before,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13234,and,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13235,at,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13236,1,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13237,and,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13238,4,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13239, ,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13240,h,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13241,after,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13242,the,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13243,meals,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13244,and,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13245,circulating,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13246,concentrations,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13247,of,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13248,IL-6,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13249,",",O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13250,glucose,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13251,",",O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13252,insulin,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13253,and,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13254,NEFA,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13255,were,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13256,measured,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13257,.,O,439.0,"After an overnight fast , blood samples were collected before and at 1 and 4   h after the meals and circulating concentrations of IL-6 , glucose , insulin and NEFA were measured ."
13476,The,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13477,study,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13478,population,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13479,comprised,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13480,a,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13481,random,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13482,sample,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13483,of,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13484,1743,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13485,children,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13486,aged,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13487,6,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13488,-,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13489,36,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13490,months,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13491,",",O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13492,recruited,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13493,from,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13494,the,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13495,National,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13496,Danish,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13497,Civil,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13498,Registry,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13499,.,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13559,Dietary,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13560,intake,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13561,was,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13562,recorded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13563,daily,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13564,for,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13565,seven,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13566,consecutive,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13567,days,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13568,in,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13569,pre,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13570,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13571,coded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13572,food,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13573,records,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13574,supplemented,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13575,with,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13576,open,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13577,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13578,answer,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13579,possibilities,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13580,.,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13654,In,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13655,8,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13656,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13657,10,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13658,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13659,month,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13660,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13661,old,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13662,(,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13663,P,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13664, ,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13665,<,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13666, ,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13667,0·0001,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13668,),O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13669,and,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13670,10,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13671,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13672,12,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13673,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13674,month,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13675,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13676,old,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13677,(,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13678,P,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13679, ,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13680,=,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13681, ,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13682,0·007,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13683,),O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13684,",",O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13685,but,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13686,not,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13687,in,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13688,6,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13689,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13690,8,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13691,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13692,month,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13693,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13694,old,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13695,infants,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13696,(,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13697,P,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13698, ,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13699,=,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13700, ,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13701,0·331,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13702,),O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13703,",",O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13704,non,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13705,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13706,breast,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13707,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13708,fed,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13709,infants,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13710,had,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13711,higher,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13712,total,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13713,gluten,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13714,intake,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13715,than,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13716,partially,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13717,breast,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13718,-,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13719,fed,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13720,infants,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13721,.,O,455.0,"In 8 - 10 - month - old ( P   <   0·0001 ) and 10 - 12 - month - old ( P   =   0·007 ) , but not in 6 - 8 - month - old infants ( P   =   0·331 ) , non - breast - fed infants had higher total gluten intake than partially breast - fed infants ."
13743,Plant,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13744,lipid,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13745,transfer,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13746,proteins,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13747,",",O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13748,a,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13749,widespread,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13750,family,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13751,of,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13752,proteins,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13753,",",O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13754,have,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13755,been,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13756,recently,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13757,identified,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13758,as,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13759,important,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13760,food,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13761,allergens,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13762,.,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13798,This,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13799,has,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13800,been,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13801,demonstrated,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13802,for,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13803,the,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13804,LTP,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13805,allergens,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13806,of,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13807,the,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13808,Prunoideae,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13809,subfamily,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13810,",",O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13811,whose,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13812,similarity,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13813,is,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13814,about,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13815,95,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13816,%,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13817,as,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13818,demonstrated,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13819,for,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13820,the,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13821,purified,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13822,allergens,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13823,of,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13824,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13825,",",O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13826,apricot,B-http://purl.bioontology.org/ontology/SNOMEDCT/735214002,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13827,",",O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13828,plum,B-http://purl.bioontology.org/ontology/SNOMEDCT/735051003,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13829,and,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13830,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13831,.,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13929,Foods,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13930,contain,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13931,a,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13932,wide,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13933,range,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13934,of,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13935,food,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13936,ingredients,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13937,that,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13938,serve,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13939,numerous,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13940,technical,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13941,functions,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13942,.,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
14118,Food,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14119,manufacturers,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14120,should,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14121,declare,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14122,the,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14123,presence,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14124,of,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14125,allergenic,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14126,food,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14127,ingredients,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14128,in,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14129,the,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14130,ingredient,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14131,listings,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14132,on,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14133,product,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14134,labels,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14135,so,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14136,that,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14137,allergic,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14138,consumers,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14139,can,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14140,know,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14141,to,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14142,avoid,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14143,these,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14144,potentially,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14145,hazardous,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14146,products,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14147,.,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14775,Between,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14776,meals,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14777,",",O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14778,it,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14779,provides,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14780,fuel,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14781,to,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14782,the,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14783,body,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14784,by,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14785,releasing,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14786,glucose,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14787,produced,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14788,from,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14789,glucogenic,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14790,precursors,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14791,and,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14792,ketones,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14793,from,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14794,fatty,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14795,acids,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14796,and,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14797,ketogenic,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14798,amino,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14799,acids,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
14800,.,O,491.0,"Between meals , it provides fuel to the body by releasing glucose produced from glucogenic precursors and ketones from fatty acids and ketogenic amino acids ."
15183,Cravings,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15184,are,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15185,frequently,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15186,reported,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15187,for,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15188,specific,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15189,types,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15190,of,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15191,foods,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15192,",",O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15193,including,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15194,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15195,and,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15196,foods,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15197,high,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15198,in,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15199,both,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15200,sugar,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15201,and,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15202,fat,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15203,.,O,505.0,"Cravings are frequently reported for specific types of foods , including chocolate and foods high in both sugar and fat ."
15319,An,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15320,understanding,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15321,of,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15322,food,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15323,cravings,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15324,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15325,aversions,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15326,may,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15327,lead,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15328,to,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15329,improved,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15330,methods,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15331,for,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15332,the,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15333,prevention,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15334,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15335,treatment,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15336,of,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15337,obesity,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15338,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15339,eating,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15340,disorders,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15341,.,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15549,The,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15550,authors,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15551,used,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15552,case,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15553,-,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15554,control,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15555,data,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15556,from,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15557,488,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15558,matched,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15559,pairs,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15560,to,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15561,evaluate,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15562,associations,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15563,of,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15564,vegetables,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15565,",",O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15566,fruits,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15567,",",O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15568,and,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15569,grains,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15570,with,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15571,polyps,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15572,.,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15605,Frequent,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15606,consumption,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15607,of,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15608,vegetables,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15609,",",O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15610,fruits,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15611,",",O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15612,and,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15613,grains,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15614,was,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15615,associated,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15616,with,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15617,decreased,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15618,polyp,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15619,prevalence,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
15620,.,O,523.0,"Frequent consumption of vegetables , fruits , and grains was associated with decreased polyp prevalence ."
16029,We,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16030,identified,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16031,3,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16032,major,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16033,dietary,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16034,patterns,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16035,:,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16036,refined,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16037,foods,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16038,and,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16039,sweets,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16040,(,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16041,RS,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16042,),O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16043,",",O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16044,traditional,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16045,(,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16046,T,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16047,),O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16048,",",O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16049,and,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16050,diverse,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16051,(,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16052,D,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16053,),O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16054,.,O,535.0,"We identified 3 major dietary patterns : refined foods and sweets ( RS ) , traditional ( T ) , and diverse ( D ) ."
16135,The,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16136,D,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16137,pattern,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16138,had,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16139,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16140,lowest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16141,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16142,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16143,maize,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16144,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16145,15.5,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16146,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16147,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16148,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16149,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16150,highest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16151,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16152,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16153,whole,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16154,-,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16155,fat,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16156,dairy,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16157,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16158,8.0,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16159,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16160,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16161,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16162,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16163,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16164,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16165,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16166,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16167,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16168,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16169,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16170,eggs,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16171,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16172,saturated,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16173,fat,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16174,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16175,fruits,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16176,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16177,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16178,vegetables,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16179,.,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16298,Metabolic,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16299,adaptations,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16300,of,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16301,the,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16302,liver,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16303,are,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16304,critical,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16305,for,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16306,successful,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16307,transition,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16308,",",O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16309,yet,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16310,it,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16311,is,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16312,unclear,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16313,how,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16314,heat,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16315,stress,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16316,affects,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16317,metabolic,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16318,pathways,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16319,within,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16320,the,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16321,liver,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16322,at,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16323,the,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16324,proteomic,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16325,level,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16326,.,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16455,In,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16456,the,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16457,most,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16458,comprehensive,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16459,bovine,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16460,liver,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16461,proteomics,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16462,analysis,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16463,completed,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16464,to,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16465,date,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16466,",",O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16467,we,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16468,identified,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16469,"3,270",O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16470,proteins,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16471,",",O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16472,75,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16473,of,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16474,which,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16475,were,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16476,differentially,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16477,expressed,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16478,between,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16479,HT,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16480,and,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16481,CL,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16482,cows,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16483,(,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16484,fold,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16485,change,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16486,±1.2,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16487,),O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16488,.,O,547.0,"In the most comprehensive bovine liver proteomics analysis completed to date , we identified 3,270 proteins , 75 of which were differentially expressed between HT and CL cows ( fold change ±1.2 ) ."
16524,Cooling,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16525,cows,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16526,during,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16527,the,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16528,dry,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16529,period,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16530,likely,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16531,improves,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16532,ATP,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16533,production,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16534,",",O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16535,reduces,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16536,oxidative,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16537,stress,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16538,",",O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16539,and,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16540,prevents,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16541,excessive,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16542,accumulation,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16543,of,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16544,hepatic,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16545,triglycerides,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16546,and,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16547,cholesterol,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16548,",",O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16549,which,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16550,may,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16551,contribute,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16552,to,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16553,greater,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16554,milk,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16555,yield,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16556,and,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16557,lower,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16558,susceptibility,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16559,to,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16560,transition,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16561,-,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16562,related,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16563,diseases,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16564,.,O,549.0,"Cooling cows during the dry period likely improves ATP production , reduces oxidative stress , and prevents excessive accumulation of hepatic triglycerides and cholesterol , which may contribute to greater milk yield and lower susceptibility to transition - related diseases ."
16644,The,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16645,addition,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16646,of,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16647,dairy,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16648,products,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16649,to,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16650,meals,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16651,high,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16652,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16653,carbohydrates,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16654,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16655,fat,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16656,may,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16657,lessen,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16658,these,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16659,risks,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16660,through,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16661,reductions,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16662,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16663,postprandial,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16664,glucose,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16665,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16666,triglyceride,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16667,responses,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16668,.,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16669,Purported,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16670,mechanisms,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16671,include,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16672,dairy,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16673,proteins,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16674,and,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16675,bioactive,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16676,compounds,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16677,",",O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16678,which,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16679,may,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16680,explain,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16681,the,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16682,inverse,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16683,relationship,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16684,between,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16685,dairy,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16686,consumption,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16687,and,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16688,cardiometabolic,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16689,diseases,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
16690,.,O,554.0,"Purported mechanisms include dairy proteins and bioactive compounds , which may explain the inverse relationship between dairy consumption and cardiometabolic diseases ."
17200,Both,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17201,methods,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17202,detected,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17203,the,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17204,target,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17205,DNA,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17206,from,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17207,strawberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227601008,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17208,jam,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227601008,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17209,and,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17210,cookies,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17211,spiked,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17212,with,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17213,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17214,and,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17215,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17216,at,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17217,a,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17218,level,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17219,equivalent,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17220,to,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17221,about,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17222,10,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17223,μg,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17224,of,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17225,total,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17226,soluble,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17227,proteins,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17228,of,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17229,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17230,or,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17231,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17232,per,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17233,gram,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17234,of,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17235,incurred,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17236,food,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17237,.,O,575.0,Both methods detected the target DNA from strawberry jam and cookies spiked with peach and apple at a level equivalent to about 10 μg of total soluble proteins of peach or apple per gram of incurred food .
17640,Excess,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17641,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17642,fat,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17643,intake,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17644,leads,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17645,to,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17646,obesity,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17647,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17648,causes,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17649,a,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17650,variety,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17651,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17652,metabolic,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17653,diseases,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17654,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17655,cancer,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17656,.,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
18206,However,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18207,",",O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18208,nutrient,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18209,content,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18210,is,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18211,affected,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18212,by,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18213,cooking,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18214,method,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18215,;,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18216,boiling,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18217,causes,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18218,leaching,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18219,of,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18220,water,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18221,-,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18222,soluble,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18223,nutrients,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18224,",",O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18225,whereas,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18226,frying,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18227,can,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18228,increase,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18229,the,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18230,resistant,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18231,starch,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18232,content,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18233,of,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18234,the,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18235,cooked,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18236,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18237,.,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18650,Gluten,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18651,-,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18652,free,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18653,beers,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18654,produced,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18655,using,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18656,alternative,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18657,materials,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18658,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18659,such,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18660,as,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18661,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18662,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18663,sorghum,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18664,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18665,maize,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18666,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18667,millet,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18668,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18669,oats,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18670,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18671,and,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18672,pseudocereals,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18673,(,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18674,e.g.,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18675,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18676,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18677,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18678,quinoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/227515004,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18679,and,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18680,Amaranth,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18681,),O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18682,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18683,are,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18684,studied,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18685,in,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18686,this,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18687,review,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18688,that,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18689,examines,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18690,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18691,effects,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18692,of,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18693,specific,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18694,substitutions,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18695,on,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18696,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18697,different,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18698,characteristics,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18699,of,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18700,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18701,final,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18702,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18703,to,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18704,ensure,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18705,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18706,appropriateness,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18707,of,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18708,their,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18709,use,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18710,.,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18943,Male,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18944,Sprague,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18945,-,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18946,Dawley,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18947,rats,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18948,were,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18949,fed,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18950,a,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18951,high,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18952,carbohydrate,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18953,",",O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18954,high,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18955,fat,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18956,(,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18957,HCHF,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18958,),O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18959,diet,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18960,and,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18961,15,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18962,%,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18963,fructose,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18964,in,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18965,drinking,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18966,water,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18967,for,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18968,16,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18969,weeks,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18970,",",O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18971,where,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18972,control,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18973,rats,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18974,were,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18975,fed,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18976,with,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18977,standard,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18978,chow,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18979,diet,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18980,and,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18981,tap,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18982,water,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
18983,.,O,631.0,"Male Sprague - Dawley rats were fed a high carbohydrate , high fat ( HCHF ) diet and 15 % fructose in drinking water for 16 weeks , where control rats were fed with standard chow diet and tap water ."
19461,For,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19462,381,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19463,cases,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19464,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19465,81.9,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19466,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19467,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19468,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19469,and,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19470,371,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19471,controls,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19472,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19473,76.3,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19474,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19475,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19476,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19477,",",O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19478,total,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19479,fluid,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19480,intake,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19481,could,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19482,be,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19483,calculated,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19484,.,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19938,Cardiovascular,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19939,diseases,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19940,(,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19941,CVDs,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19942,),O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19943,are,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19944,leading,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19945,global,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19946,health,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19947,problems,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19948,.,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
20349,We,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20350,conducted,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20351,a,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20352,case,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20353,-,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20354,control,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20355,study,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20356,of,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20357,nasopharyngeal,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20358,carcinoma,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20359,(,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20360,NPC,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20361,),O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20362,in,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20363,Tunisia,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20364,",",O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20365,on,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20366,diet,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20367,",",O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20368,dietary,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20369,patterns,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20370,and,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20371,life,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20372,style,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20373,",",O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20374,the,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20375,characteristics,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20376,of,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20377,which,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20378,had,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20379,been,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20380,defined,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20381,by,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20382,an,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20383,anthropological,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20384,study,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20385,.,O,678.0,"We conducted a case - control study of nasopharyngeal carcinoma ( NPC ) in Tunisia , on diet , dietary patterns and life style , the characteristics of which had been defined by an anthropological study ."
20415,The,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20416,subjects,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20417,were,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20418,asked,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20419,for,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20420,dietary,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20421,data,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20422,referring,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20423,to,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20424,the,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20425,year,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20426,preceding,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20427,the,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20428,diagnosis,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20429,of,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20430,NPC,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20431,and,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20432,",",O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20433,with,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20434,help,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20435,of,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20436,their,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20437,families,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20438,",",O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20439,during,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20440,childhood,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20441,and,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20442,after,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20443,weaning,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20444,.,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20523,Moreover,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20524,",",O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20525,subjects,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20526,who,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20527,had,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20528,been,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20529,directly,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20530,weaned,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20531,from,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20532,mother,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20533,'s,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20534,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20535,on,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20536,to,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20537,an,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20538,adult,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20539,diet,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20540,were,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20541,found,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20542,to,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20543,be,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20544,at,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20545,higher,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20546,risk,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20547,for,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20548,NPC,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20549,.,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20601,From,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20602,this,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20603,reaction,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20604,",",O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20605,the,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20606,necessity,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20607,derived,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20608,to,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20609,appeal,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20610,to,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20611,the,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20612,reasons,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20613,of,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20614,health,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20615,",",O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20616,with,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20617,which,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20618,doctors,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20619,and,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20620,scientists,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20621,committed,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20622,themselves,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20623,to,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20624,explain,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20625,that,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20626,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20627,was,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20628,good,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20629,for,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20630,the,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20631,body,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20632,.,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20970,Our,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20971,findings,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20972,lead,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20973,us,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20974,to,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20975,reconsider,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20976,the,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20977,role,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20978,of,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20979,starchy,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20980,foods,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20981,and,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20982,refined,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20983,sugar,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20984,in,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20985,light,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20986,of,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20987,recent,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20988,knowledge,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20989,on,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20990,the,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20991,digestive,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20992,physiology,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20993,of,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20994,carbohydrates,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20995,and,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20996,the,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20997,insulin,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20998,/,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20999,colon,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21000,cancer,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21001,hypothesis,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21002,.,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21003,The,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21004,beneficial,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21005,role,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21006,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21007,most,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21008,vegetables,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21009,is,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21010,confirmed,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21011,",",O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21012,with,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21013,more,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21014,than,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21015,20,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21016,%,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21017,reduction,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21018,in,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21019,risk,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21020,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21021,colorectal,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21022,cancer,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21023,from,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21024,the,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21025,addition,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21026,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21027,one,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21028,daily,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21029,serving,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21030,.,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21050,This,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21051,research,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21052,uses,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21053,10,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21054,mo,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21055,of,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21056,consecutive,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21057,dairy,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21058,herd,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21059,improvement,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21060,data,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21061,from,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21062,2013,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21063,and,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21064,2014,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21065,to,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21066,estimate,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21067,milk,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21068,yield,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21069,loss,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21070,using,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21071,SCC,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21072,as,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21073,a,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21074,proxy,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21075,for,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21076,clinical,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21077,and,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21078,subclinical,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21079,mastitis,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21080,.,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21269,Cows,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21270,with,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21271,chronic,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21272,mastitis,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21273,",",O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21274,measured,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21275,by,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21276,increased,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21277,consecutive,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21278,test,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21279,days,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21280,with,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21281,SCC,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21282,"≥100,000",O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21283,cells,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21284,/,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21285,mL,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21286,",",O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21287,resulted,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21288,in,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21289,higher,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21290,milk,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21291,losses,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21292,than,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21293,cows,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21294,with,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21295,a,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21296,new,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21297,infection,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21298,.,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21548,Conversely,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21549,",",O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21550,birds,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21551,orally,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21552,dosed,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21553,with,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21554,oil,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21555,experienced,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21556,hypothermia,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21557,and,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21558,consumed,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21559,less,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21560,fish,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21561,compared,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21562,to,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21563,control,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21564,birds,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21565,.,O,716.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
21730,Twenty,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21731,case,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21732,reports,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21733,and,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21734,seven,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21735,case,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21736,series,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21737,",",O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21738,as,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21739,well,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21740,as,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21741,",",O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21742,spontaneous,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21743,reports,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21744,including,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21745,160,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21746,adverse,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21747,events,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21748,were,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21749,also,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21750,included,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21751,.,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21818,Biogenic,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21819,amines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21820,have,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21821,been,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21822,reported,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21823,in,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21824,a,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21825,variety,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21826,of,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21827,foods,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21828,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21829,such,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21830,as,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21831,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21832,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21833,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21834,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21835,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21836,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21837,vegetables,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21838,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21839,and,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21840,wines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21841,.,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21981,Therefore,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21982,",",O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21983,secondary,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21984,control,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21985,measures,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21986,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21987,prevent,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21988,biogenic,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21989,amine,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21990,formation,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21991,in,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21992,foods,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21993,or,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21994,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21995,reduce,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21996,their,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21997,levels,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21998,once,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21999,formed,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22000,need,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22001,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22002,be,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22003,considered,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22004,as,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22005,alternatives,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22006,.,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22077,Biological,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22078,activities,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22079,associated,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22080,with,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22081,mango,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22082,fractions,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22083,were,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22084,assessed,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22085,in,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22086,cell,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22087,-,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22088,based,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22089,assays,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22090,to,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22091,develop,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22092,effective,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22093,extraction,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22094,and,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22095,fractionation,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22096,methodologies,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22097,and,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22098,to,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22099,define,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22100,sources,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22101,of,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22102,variability,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22103,.,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22104,Two,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22105,techniques,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22106,were,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22107,developed,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22108,for,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22109,extraction,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22110,and,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22111,fractionation,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22112,of,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22113,mango,B-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22114,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22115,peel,I-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22116,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22117,flesh,I-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22118,.,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22691,Consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22692,look,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22693,for,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22694,products,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22695,that,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22696,contribute,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22697,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22698,their,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22699,wellness,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22700,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22701,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22702,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22703,however,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22704,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22705,even,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22706,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22707,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22708,conscious,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22709,consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22710,are,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22711,not,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22712,willing,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22713,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22714,sacrifice,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22715,organoleptic,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22716,properties,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22717,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22718,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22719,intense,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22720,full,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22721,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22722,flavor,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22723,snacks,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22724,remain,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22725,an,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22726,important,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22727,trend,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22728,.,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22729,The,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22730,objective,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22731,of,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22732,this,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22733,study,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22734,was,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22735,to,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22736,examine,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22737,most,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22738,important,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22739,quality,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22740,parameters,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22741,of,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22742,vacuum,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22743,(,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22744,1.92,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22745,inHg,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22746,),O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22747,and,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22748,atmospheric,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22749,-,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22750,fried,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22751,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22752,",",O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22753,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22754,",",O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22755,and,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22756,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22757,slices,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22758,to,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22759,determine,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22760,specific,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22761,advantages,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22762,of,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22763,vacuum,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22764,technology,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22765,.,O,761.0,"The objective of this study was to examine most important quality parameters of vacuum ( 1.92 inHg ) and atmospheric - fried carrot , potato , and apple slices to determine specific advantages of vacuum technology ."
22802,This,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22803,resulted,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22804,in,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22805,frying,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22806,temperatures,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22807,of,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22808,160,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22809,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22810,180,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22811,°,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22812,C,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22813,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22814,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22815,98,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22816,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22817,118,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22818,°,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22819,C,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22820,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22821,for,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22822,atmospheric,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22823,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22824,vacuum,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22825,frying,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22826,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22827,respectively,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22828,.,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
23124,LDL,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23125,isolated,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23126,from,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23127,animals,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23128,fed,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23129,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23130,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23131,",",O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23132,lard,B-http://purl.bioontology.org/ontology/SNOMEDCT/226899009,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23133,or,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23134,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23135,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23136,had,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23137,significantly,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23138,greater,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23139,albumin,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23140,transfer,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23141,across,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23142,cultured,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23143,endothelial,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23144,monolayers,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23145,compared,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23146,with,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23147,those,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23148,of,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23149,the,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23150,low,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23151,fat,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23152,diet,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23153,group,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23154,.,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23277,Wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23278,contains,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23279,various,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23280,poliphenolic,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23281,substances,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23282,which,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23283,may,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23284,be,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23285,beneficial,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23286,for,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23287,health,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23288,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23289,in,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23290,particular,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23291,flavonols,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23292,(,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23293,such,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23294,as,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23295,myricetin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23296,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23297,quercetin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23298,),O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23299,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23300,catechin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23301,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23302,epicatechin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23303,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23304,proanthocyanidins,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23305,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23306,anthocyanins,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23307,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23308,various,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23309,phenolic,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23310,acids,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23311,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23312,the,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23313,stilbene,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23314,resveratrol,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23315,.,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23626,The,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23627,intake,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23628,of,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23629,fermented,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23630,dairy,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23631,products,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23632,",",O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23633,especially,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23634,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23635,",",O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23636,has,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23637,been,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23638,inversely,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23639,associated,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23640,with,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23641,variables,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23642,of,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23643,glucose,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23644,metabolism,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23645,.,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23646,Yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23647,may,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23648,have,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23649,probiotic,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23650,effects,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23651,that,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23652,could,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23653,modulate,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23654,glucose,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23655,metabolism,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23656,.,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23837,However,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23838,",",O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23839,degenerative,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23840,diseases,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23841,such,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23842,as,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23843,cancer,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23844,",",O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23845,atherosclerosis,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23846,",",O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23847,bone,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23848,disease,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23849,",",O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23850,arthritis,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23851,",",O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23852,and,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23853,dementia,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23854,will,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23855,continue,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23856,to,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23857,be,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23858,prevalent,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23859,in,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23860,the,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23861,future,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
23862,.,O,799.0,"However , degenerative diseases such as cancer , atherosclerosis , bone disease , arthritis , and dementia will continue to be prevalent in the future ."
24103,Texture,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24104,profile,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24105,analysis,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24106,indicated,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24107,that,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24108,disruption,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24109,followed,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24110,by,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24111,pasteurization,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24112,improved,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24113,hardness,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24114,from,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24115,approximately,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24116,175,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24117, ,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24118,g,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24119,force,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24120,from,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24121,the,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24122,control,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24123,",",O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24124,to,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24125,approximately,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24126,325,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24127, ,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24128,g,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24129,force,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24130,for,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24131,disrupted,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24132,+,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24133,pasteurizated,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24134,samples,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24135,without,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24136,fat,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24137,addition,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24138,.,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24215,Molecular,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24216,weight,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24217,analysis,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24218,showed,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24219,that,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24220,shear,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24221,(,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24222,from,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24223,disruption,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24224,),O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24225,and,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24226,heat,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24227,separately,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24228,degraded,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24229,the,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24230,proteins,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24231,into,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24232,smaller,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24233,polypeptides,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24234,exposing,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24235,hydrophobic,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24236,interiors,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
24237,.,O,815.0,Molecular weight analysis showed that shear ( from disruption ) and heat separately degraded the proteins into smaller polypeptides exposing hydrophobic interiors .
25221,The,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25222,trial,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25223,had,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25224,some,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25225,weaknesses,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25226,",",O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25227,eg,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25228,there,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25229,were,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25230,eight,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25231,different,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25232,diets,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25233,",",O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25234,compliance,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25235,was,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25236,not,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25237,checked,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25238,objectively,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25239,",",O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25240,and,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25241,duration,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25242,was,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25243,for,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25244,only,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25245,2,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25246,y.,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25247,It,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25248,appears,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25249,valid,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25250,to,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25251,make,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25252,health,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25253,claims,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25254,(,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25255,as,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25256,now,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25257,permitted,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25258,by,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25259,the,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25260,US,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25261,FDA,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25262,),O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25263,that,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25264,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25265,grain,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25266,cereal,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25267,foods,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25268,and,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25269,oat,B-http://purl.bioontology.org/ontology/SNOMEDCT/418504009,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25270,meal,I-http://purl.bioontology.org/ontology/SNOMEDCT/418504009,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25271,or,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25272,bran,B-http://purl.bioontology.org/ontology/SNOMEDCT/391858005,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25273,may,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25274,reduce,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25275,the,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25276,risk,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25277,of,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25278,CHD,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25279,.,O,853.0,"The trial had some weaknesses , eg there were eight different diets , compliance was not checked objectively , and duration was for only 2 y. It appears valid to make health claims ( as now permitted by the US FDA ) that whole grain cereal foods and oat meal or bran may reduce the risk of CHD ."
25738,Recovery,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25739,rates,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25740,of,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25741,fresh,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25742,matter,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25743,were,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25744,higher,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25745,than,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25746,100,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25747,%,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25748,",",O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25749,presumably,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25750,due,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25751,to,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25752,salivary,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25753,and,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25754,gastric,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25755,secretions,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25756,.,O,868.0,"Recovery rates of fresh matter were higher than 100 % , presumably due to salivary and gastric secretions ."
25970,Hydroxytyrosol,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25971,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25972,oleuropein,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25973,inhibited,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25974,the,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25975,multiple,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25976,stages,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25977,in,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25978,colon,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25979,carcinogenesis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25980,;,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25981,initiation,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25982,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25983,promotion,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25984,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25985,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25986,metastasis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25987,.,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
26122,However,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26123,",",O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26124,there,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26125,are,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26126,discrepancies,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26127,regarding,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26128,the,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26129,specific,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26130,effects,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26131,of,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26132,different,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26133,types,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26134,of,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26135,beverages,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26136,(,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26137,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26138,",",O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26139,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26140,and,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26141,spirits,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26142,),O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26143,on,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26144,the,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26145,cardiovascular,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26146,system,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26147,and,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26148,cancer,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26149,",",O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26150,and,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26151,also,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26152,whether,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26153,the,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26154,possible,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26155,protective,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26156,effects,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26157,of,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26158,alcoholic,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26159,beverages,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26160,are,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26161,due,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26162,to,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26163,their,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26164,alcoholic,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26165,content,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26166,(,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26167,ethanol,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26168,),O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26169,or,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26170,to,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26171,their,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26172,non,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26173,-,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26174,alcoholic,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26175,components,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26176,(,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26177,mainly,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26178,polyphenols,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26179,),O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26180,.,O,886.0,"However , there are discrepancies regarding the specific effects of different types of beverages ( wine , beer and spirits ) on the cardiovascular system and cancer , and also whether the possible protective effects of alcoholic beverages are due to their alcoholic content ( ethanol ) or to their non - alcoholic components ( mainly polyphenols ) ."
26468,The,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26469,literature,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26470,reviews,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26471,revealed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26472,similar,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26473,aspects,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26474,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26475,the,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26476,challenges,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26477,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26478,smallholder,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26479,crop,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26480,-,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26481,livestock,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26482,mixed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26483,farming,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26484,systems,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26485,in,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26486,both,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26487,countries,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26488,.,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26784,The,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26785,experiment,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26786,was,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26787,conducted,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26788,in,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26789,the,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26790,summer,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26791,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26792,2006,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26793,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26794,involved,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26795,24,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26796,Friesian,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26797,cows,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26798,that,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26799,were,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26800,divided,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26801,into,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26802,3,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26803,groups,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26804,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26805,8,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26806,animals,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26807,according,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26808,to,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26809,different,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26810,type,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26811,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26812,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26813,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26814,:,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26815,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26816,traditional,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26817,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26818,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26819,no,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26820,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26821,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26822,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26823,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26824,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26825,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26826,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26827,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/710178007,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26828,flaxseed,I-http://purl.bioontology.org/ontology/SNOMEDCT/710178007,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26829,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26830,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26831,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26832,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26833,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26834,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26835,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26836,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26837,.,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
27026,This,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27027,study,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27028,investigates,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27029,the,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27030,effect,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27031,of,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27032,lifelong,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27033,intake,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27034,of,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27035,different,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27036,fat,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27037,sources,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27038,rich,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27039,in,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27040,monounsaturated,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27041,(,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27042,virgin,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27043,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27044,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27045,),O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27046,",",O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27047,n6,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27048,polyunsaturated,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27049,(,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27050,sunflower,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27051,oil,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27052,),O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27053,or,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27054,n3,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27055,polyunsaturated,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27056,(,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27057,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27058,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27059,),O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27060,fatty,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27061,acids,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27062,in,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27063,the,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27064,aged,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27065,liver,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27066,.,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27502,The,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27503,objective,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27504,of,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27505,this,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27506,study,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27507,was,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27508,to,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27509,derive,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27510,food,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27511,-,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27512,based,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27513,dietary,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27514,guidelines,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27515,for,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27516,the,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27517,Dutch,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27518,population,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27519,.,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27617,Findings,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27618,were,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27619,categorized,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27620,as,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27621,strong,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27622,or,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27623,weak,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27624,evidence,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27625,",",O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27626,inconsistent,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27627,effects,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27628,",",O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27629,too,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27630,little,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27631,evidence,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27632,or,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27633,effect,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27634,unlikely,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27635,for,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27636,experimental,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27637,and,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27638,observational,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27639,data,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27640,separately,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27641,.,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27889,The,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27890,results,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27891,showed,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27892,that,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27893,the,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27894,average,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27895,concentrations,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27896,of,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27897,five,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27898,metals,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27899,in,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27900,soil,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27901,exceeded,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27902,the,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27903,limiting,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27904,values,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27905,",",O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27906,and,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27907,their,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27908,bioavailable,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27909,concentrations,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27910,were,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27911,significantly,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27912,positively,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27913,correlated,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27914,to,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27915,the,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27916,total,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27917,ones,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
27918,.,O,947.0,"The results showed that the average concentrations of five metals in soil exceeded the limiting values , and their bioavailable concentrations were significantly positively correlated to the total ones ."
28013,A,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28014,high,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28015,proportion,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28016,of,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28017,ethanol,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28018,-,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28019,extractable,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28020,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28021,showed,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28022,that,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28023,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28024,bioactivity,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28025,and,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28026,toxic,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28027,effects,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28028,were,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28029,the,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28030,highest,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28031,.,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28063,Lead,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28064,and,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28065,arsenic,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28066,were,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28067,imposing,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28068,a,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28069,serious,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28070,threat,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28071,on,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28072,the,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28073,local,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28074,residents,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28075,via,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28076,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28077,consumption,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28078,.,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28523,In,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28524,recent,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28525,findings,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28526,on,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28527,food,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28528,science,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28529,research,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28530,gut,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28531,microbiota,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28532,plays,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28533,a,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28534,significant,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28535,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28536,and,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28537,vastly,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28538,studied,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28539,for,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28540,its,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28541,intermediate,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28542,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28543,in,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28544,regulating,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28545,health,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28546,.,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
30089,The,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30090,28,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30091,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30092,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30093,pepper,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30094,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30095,showed,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30096,homology,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30097,to,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30098,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30099,wheat,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30100,germin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30101,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30102,",",O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30103,and,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30104,the,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30105,23,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30106,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30107,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30108,paprika,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30109,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30110,was,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30111,identified,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30112,as,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30113,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30114,homolog,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30115,of,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30116,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30117,osmotin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30118,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30119,like,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30120,or,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30121,pathogenesis,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30122,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30123,related,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30124,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30125,in,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30126,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30127,.,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30935,For,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30936,39,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30937,genes,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30938,",",O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30939,significant,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30940,dose,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30941,-,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30942,dependent,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30943,effects,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30944,were,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30945,found,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30946,",",O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30947,although,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30948,in,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30949,general,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30950,the,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30951,relations,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30952,were,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30953,not,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30954,linear,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
30955,.,O,1045.0,"For 39 genes , significant dose - dependent effects were found , although in general the relations were not linear ."
31182,Epidemiological,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31183,studies,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31184,have,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31185,repeatedly,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31186,shown,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31187,an,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31188,inverse,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31189,association,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31190,between,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31191,the,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31192,risk,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31193,of,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31194,myocardial,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31195,infarction,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31196,and,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31197,the,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31198,consumption,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31199,of,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31200,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31201,and,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31202,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31203,or,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31204,the,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31205,intake,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31206,level,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31207,of,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31208,some,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31209,particular,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31210,flavonoids,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31211,",",O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31212,but,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31213,no,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31214,clear,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31215,associations,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31216,have,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31217,been,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31218,found,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31219,between,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31220,cancer,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31221,risk,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31222,and,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31223,polyphenol,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31224,consumption,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31225,.,O,1055.0,"Epidemiological studies have repeatedly shown an inverse association between the risk of myocardial infarction and the consumption of tea and wine or the intake level of some particular flavonoids , but no clear associations have been found between cancer risk and polyphenol consumption ."
31327,TPL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31328,and,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31329,TNL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31330,of,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31331,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31332,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31333,were,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31334,fractionated,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31335,by,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31336,HPLC,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31337,for,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31338,further,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31339,study,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31340,.,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31479,This,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31480,review,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31481,encompasses,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31482,epidemiologic,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31483,studies,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31484,of,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31485,stomach,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31486,",",O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31487,colon,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31488,",",O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31489,and,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31490,lung,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31491,cancer,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31492,as,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31493,well,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31494,as,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31495,the,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31496,evidence,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31497,of,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31498,a,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31499,relationship,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31500,between,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31501,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31502,drinking,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31503,and,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31504,cancer,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31505,at,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31506,large,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31507,in,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31508,humans,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31509,.,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31714,Incident,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31715,cases,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31716,of,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31717,histologically,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31718,confirmed,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31719,colon,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31720,cancer,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31721,",",O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31722,age,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31723,40,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31724,-,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31725,80,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31726,years,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31727,",",O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31728,(,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31729,n,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31730,=,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31731,613,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31732,),O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31733,and,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31734,matched,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31735,controls,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31736,(,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31737,n,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31738,=,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31739,996,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31740,),O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31741,were,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31742,interviewed,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31743,in,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31744,-,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31745,person,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31746,to,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31747,ascertain,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31748,potential,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31749,colon,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31750,cancer,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31751,risk,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31752,factors,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31753,.,O,1076.0,"Incident cases of histologically confirmed colon cancer , age 40 - 80 years , ( n = 613 ) and matched controls ( n = 996 ) were interviewed in - person to ascertain potential colon cancer risk factors ."
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
32213,It,O,1093.0,It has been grown since at least 1000 BC in China .
32214,has,O,1093.0,It has been grown since at least 1000 BC in China .
32215,been,O,1093.0,It has been grown since at least 1000 BC in China .
32216,grown,O,1093.0,It has been grown since at least 1000 BC in China .
32217,since,O,1093.0,It has been grown since at least 1000 BC in China .
32218,at,O,1093.0,It has been grown since at least 1000 BC in China .
32219,least,O,1093.0,It has been grown since at least 1000 BC in China .
32220,1000,O,1093.0,It has been grown since at least 1000 BC in China .
32221,BC,O,1093.0,It has been grown since at least 1000 BC in China .
32222,in,O,1093.0,It has been grown since at least 1000 BC in China .
32223,China,O,1093.0,It has been grown since at least 1000 BC in China .
32224,.,O,1093.0,It has been grown since at least 1000 BC in China .
32295,Buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32296,has,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32297,been,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32298,used,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32299,and,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32300,will,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32301,be,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32302,better,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32303,used,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32304,as,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32305,an,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32306,important,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32307,raw,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32308,material,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32309,for,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32310,functional,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32311,food,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32312,production,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32313,.,O,1098.0,Buckwheat has been used and will be better used as an important raw material for functional food production .
32466,Some,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32467,possible,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32468,mechanisms,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32469,involved,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32470,in,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32471,these,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32472,effects,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32473,are,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32474,discussed,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32475,in,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32476,this,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32477,review,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32478,.,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32479,Experiments,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32480,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32481,both,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32482,with,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32483,animal,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32484,models,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32485,and,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32486,with,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32487,human,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32488,beings,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32489,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32490,revealed,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32491,that,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32492,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32493,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32494,can,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32495,improve,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32496,diabetes,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32497,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32498,obesity,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32499,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32500,hypertension,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32501,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32502,hypercholesterolemia,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32503,and,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32504,constipation,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32505,.,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
33269,Bamboos,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33270,",",O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33271,a,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33272,group,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33273,of,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33274,large,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33275,woody,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33276,grasses,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33277,belonging,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33278,to,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33279,the,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33280,family,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33281,Poaceae,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33282,and,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33283,subfamily,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33284,Bambusoideae,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33285,",",O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33286,are,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33287,much,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33288,talked,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33289,about,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33290,for,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33291,their,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33292,contribution,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33293,to,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33294,the,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33295,environment,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33296,.,O,1129.0,"Bamboos , a group of large woody grasses belonging to the family Poaceae and subfamily Bambusoideae , are much talked about for their contribution to the environment ."
33297,However,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33298,",",O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33299,the,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33300,food,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33301,potential,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33302,of,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33303,Bamboo,B-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33304,shoot,I-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33305,per,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33306,se,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33307,remains,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33308,unexploited,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33309,.,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33323,This,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33324,paper,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33325,therefore,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33326,provides,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33327,insight,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33328,on,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33329,bamboo,B-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33330,shoot,I-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33331,as,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33332,a,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33333,food,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33334,resource,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33335,.,O,1132.0,This paper therefore provides insight on bamboo shoot as a food resource .
33576,Rats,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33577,were,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33578,decapitated,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33579,",",O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33580,and,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33581,hepatic,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33582,tissue,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33583,was,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33584,used,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33585,for,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33586,phospholipid,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33587,fatty,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33588,acid,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33589,analysis,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33590,and,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33591,for,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33592,the,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33593,preparation,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33594,of,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33595,mitochondria,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33596,.,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33874,By,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33875,expressing,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33876,iron,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33877,bioavailability,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33878,as,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33879,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33880,efficiency,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33881,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33882,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33883,conversion,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33884,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33885,dietary,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33886,iron,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33887,into,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33888,hemoglobin,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33889,",",O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33890,it,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33891,was,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33892,demonstrated,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33893,that,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33894,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33895,amount,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33896,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33897,fat,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33898,in,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33899,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33900,diet,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33901,did,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33902,not,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33903,affect,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33904,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33905,bioavailability,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33906,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33907,iron,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33908,from,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33909,turkey,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33910,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33911,or,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33912,from,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33913,ferrous,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33914,sulfate,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33915,.,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
34168,Stepwise,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34169,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34170,multiple,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34171,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34172,regression,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34173,analysis,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34174,identified,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34175,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34176,+,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34177,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34178,as,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34179,a,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34180,factor,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34181,contributing,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34182,to,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34183,the,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34184,incidence,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34185,of,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34186,prostatic,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34187,cancer,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34188,(,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34189,R,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34190,=,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34191,0.525,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34192,),O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34193,.,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34225,Stepwise,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34226,-,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34227,multiple,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34228,-,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34229,regression,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34230,analysis,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34231,revealed,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34232,that,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34233,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34234,+,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34235,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34236,was,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34237,a,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34238,factor,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34239,contributing,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34240,to,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34241,mortality,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34242,from,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34243,prostatic,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34244,cancer,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34245,(,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34246,R,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34247,=,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34248,0.580,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34249,),O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34250,.,O,1167.0,Stepwise - multiple - regression analysis revealed that milk + cheese was a factor contributing to mortality from prostatic cancer ( R = 0.580 ) .
34275,The,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34276,close,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34277,correlation,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34278,between,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34279,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34280,and,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34281,testicular,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34282,cancer,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34283,and,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34284,between,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34285,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34286,and,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34287,prostatic,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34288,cancer,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34289,suggests,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34290,that,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34291,further,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34292,mechanistic,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34293,studies,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34294,should,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34295,be,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34296,undertaken,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34297,concerning,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34298,the,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34299,development,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34300,of,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34301,male,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34302,genital,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34303,organ,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34304,cancers,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34305,.,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34873,Areas,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34874,within,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34875,the,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34876,contour,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34877,plots,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34878,of,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34879,these,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34880,critical,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34881,sensory,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34882,attributes,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34883,",",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34884,having,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34885,acceptability,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34886,scores,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34887,>,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34888,or,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34889,=,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34890,68,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34891,(,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34892,"""",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34893,moderately,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34894,like,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34895,"""",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34896,on,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34897,the,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34898,100,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34899,-,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34900,mm,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34901,bidirectional,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34902,labeled,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34903,affective,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34904,magnitude,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34905,scale,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34906,),O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34907,were,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34908,chosen,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34909,and,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34910,superimposed,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34911,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34912,obtain,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34913,a,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34914,predicted,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34915,optimum,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34916,formulation,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34917,range,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34918,(,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34919,37,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34920,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34921,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34922,43,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34923,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34924,RBO,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34925,",",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34926,4,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34927,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34928,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34929,7,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34930,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34931,SPC,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34932,",",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34933,and,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34934,52,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34935,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34936,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34937,57,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34938,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34939,water,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34940,),O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34941,.,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
35006,Purchase,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35007,intent,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35008,of,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35009,all,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35010,flavored,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35011,products,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35012,also,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35013,significantly,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35014,increased,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35015,once,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35016,consumers,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35017,had,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35018,been,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35019,given,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35020,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35021,information,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35022,about,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35023,potential,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35024,health,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35025,benefits,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35026,associated,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35027,with,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35028,RBO,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35029,and,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35030,SPC,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35031,in,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35032,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35033,spreads,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35034,.,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35430, ,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35431,Conversely,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35432,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35433,Hong,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35434,Kong,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35435,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35436,Japan,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35437,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35438,Shanghai,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35439,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35440,and,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35441,Singapore,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35442,have,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35443,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35444,ovarian,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35445,cancer,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35446,risk,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35447,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35448,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35449,consumption,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35450,of,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35451,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35452,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35453,and,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35454,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35455,levels,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35456,of,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35457,lactase,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35458,persistence,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35459,.,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35734,A,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35735,recent,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35736,study,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35737,established,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35738,that,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35739,milk,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35740,perchlorate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35741,concentrations,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35742,in,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35743,cattle,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35744,highly,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35745,correlate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35746,with,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35747,perchlorate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35748,intake,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35749,.,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
36076,To,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36077,address,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36078,this,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36079,issue,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36080,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36081,five,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36082,common,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36083,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36084,brans,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36085,(,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36086,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36087,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36088,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36089,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36090,oat,B-http://purl.bioontology.org/ontology/SNOMEDCT/418504009,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36091,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36092,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36093,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36094,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36095,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36096,),O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36097,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36098,five,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36099,vegetable,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36100,fiber,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36101,isolates,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36102,(,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36103,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36104,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36105,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36106,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36107,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36108,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36109,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36110,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36111,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36112,lettuce,B-http://purl.bioontology.org/ontology/SNOMEDCT/735042006,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36113,),O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36114,were,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36115,fermented,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36116,in,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36117,vitro,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36118,with,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36119,human,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36120,fecal,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36121,microbiota,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36122,for,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36123,4,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36124,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36125,8,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36126,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36127,12,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36128,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36129,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36130,24,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36131,hours,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36132,.,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36210,We,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36211,concluded,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36212,that,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36213,vegetable,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36214,fibers,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36215,may,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36216,more,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36217,effectively,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36218,stimulate,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36219,colonic,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36220,fermentation,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36221,than,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36222,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36223,brans,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36224,do,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36225,.,O,1239.0,We concluded that vegetable fibers may more effectively stimulate colonic fermentation than cereal brans do .
36556,Formal,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36557,education,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36558,influenced,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36559,dietary,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36560,changes,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36561,",",O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36562,and,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36563,dietary,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36564,counselling,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36565,should,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36566,therefore,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36567,ideally,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36568,be,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36569,adapted,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36570,to,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36571,education,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36572,level,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36573,.,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36810,Less,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36811,is,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36812,known,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36813,about,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36814,the,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36815,impact,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36816,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36817,nutritional,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36818,interventions,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36819,in,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36820,people,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36821,with,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36822,a,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36823,diagnosis,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36824,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36825,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36826,",",O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36827,but,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36828,nutrition,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36829,including,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36830,adiposity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36831,and,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36832,physical,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36833,activity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36834,predict,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36835,breast,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36836,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36837,outcome,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36838,.,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36917,Approximately,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36918,30,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36919,million,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36920,people,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36921,in,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36922,the,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36923,USA,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36924,and,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36925,29,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36926,million,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36927,people,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36928,in,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36929,the,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36930,European,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36931,Union,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36932,suffer,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36933,from,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36934,chronic,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36935,liver,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36936,disease,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36937,.,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36992,Among,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36993,their,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36994,bioactive,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36995,components,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36996,",",O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36997,flavonoids,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36998,have,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36999,been,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37000,found,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37001,to,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37002,be,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37003,active,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37004,against,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37005,liver,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37006,dysfunction,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37007,and,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37008,damage,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37009,caused,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37010,by,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37011,liver,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37012,diseases,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37013,.,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37186,These,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37187,Reference,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37188,Doses,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37189,would,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37190,guide,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37191,advisory,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37192,labeling,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37193,decisions,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37194,for,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37195,use,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37196,on,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37197,food,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37198,labels,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37199,.,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37996,Results,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37997,suggest,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37998,that,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37999,NOC,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38000,from,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38001,dietary,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38002,bacon,B-http://purl.bioontology.org/ontology/SNOMEDCT/226928005,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38003,would,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38004,not,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38005,enhance,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38006,colon,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38007,carcinogenesis,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38008,in,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38009,rats,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38010,.,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38184,Coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38185,plays,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38186,a,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38187,dominant,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38188,role,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38189,in,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38190,that,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38191,regard,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38192,because,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38193,it,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38194,is,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38195,the,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38196,major,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38197,dietary,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38198,source,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38199,of,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38200,phenolic,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38201,acids,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38202,and,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38203,polyphenols,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38204,in,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38205,the,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38206,developed,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38207,world,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38208,.,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38435,These,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38436,beverages,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38437,were,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38438,also,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38439,modeled,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38440,quadratically,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38441,in,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38442,the,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38443,Cox,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38444,analyses,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38445,",",O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38446,and,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38447,all,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38448,showed,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38449,strong,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38450,U,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38451,-,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38452,shaped,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38453,curves,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38454,for,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38455,both,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38456,nonsmokers,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38457,and,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38458,heavy,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38459,smokers,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38460,.,O,1321.0,"These beverages were also modeled quadratically in the Cox analyses , and all showed strong U - shaped curves for both nonsmokers and heavy smokers ."
38587,Only,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38588,the,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38589,papaya,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38590,extract,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38591,had,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38592,a,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38593,significant,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38594,antiproliferative,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38595,effect,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38596,measured,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38597,with,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38598,the,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38599,methylthiazolydiphenyl,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38600,-,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38601,tetrazolium,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38602,bromide,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38603,assay,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38604,.,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38665,It,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38666,is,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38667,not,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38668,clear,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38669,whether,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38670,alcohol,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38671,consumption,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38672,is,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38673,associated,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38674,with,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38675,lung,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38676,cancer,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38677,risk,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38678,.,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38801,Analyses,O,1335.0,Analyses by histologic sub - type were included .
38802,by,O,1335.0,Analyses by histologic sub - type were included .
38803,histologic,O,1335.0,Analyses by histologic sub - type were included .
38804,sub,O,1335.0,Analyses by histologic sub - type were included .
38805,-,O,1335.0,Analyses by histologic sub - type were included .
38806,type,O,1335.0,Analyses by histologic sub - type were included .
38807,were,O,1335.0,Analyses by histologic sub - type were included .
38808,included,O,1335.0,Analyses by histologic sub - type were included .
38809,.,O,1335.0,Analyses by histologic sub - type were included .
39177,This,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39178,final,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39179,report,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39180,of,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39181,the,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39182,Lancet,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39183,Commission,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39184,into,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39185,liver,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39186,disease,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39187,in,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39188,the,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39189,UK,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39190,stresses,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39191,the,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39192,continuing,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39193,increase,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39194,in,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39195,burden,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39196,of,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39197,liver,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39198,disease,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39199,from,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39200,excess,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39201,alcohol,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39202,consumption,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39203,and,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39204,obesity,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39205,",",O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39206,with,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39207,high,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39208,levels,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39209,of,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39210,hospital,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39211,admissions,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39212,which,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39213,are,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39214,worsening,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39215,in,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39216,deprived,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39217,areas,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39218,.,O,1348.0,"This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity , with high levels of hospital admissions which are worsening in deprived areas ."
39365,We,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39366,propose,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39367,a,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39368,plan,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39369,based,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39370,around,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39371,specialist,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39372,hospital,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39373,centres,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39374,that,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39375,are,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39376,linked,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39377,to,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39378,district,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39379,general,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39380,hospitals,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39381,by,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39382,operational,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39383,delivery,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39384,networks,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39385,.,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39522,The,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39523,Lancet,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39524,Commission,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39525,has,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39526,serious,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39527,doubts,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39528,about,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39529,whether,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39530,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39531,initiatives,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39532,described,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39533,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39534,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39535,Prevention,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39536,Green,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39537,Paper,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39538,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39539,with,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39540,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39541,onus,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39542,placed,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39543,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39544,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39545,individual,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39546,based,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39547,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39548,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39549,use,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39550,of,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39551,information,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39552,technology,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39553,and,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39554,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39555,latest,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39556,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39557,behavioural,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39558,science,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39559,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39560,will,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39561,be,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39562,effective,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39563,.,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39604,Dairy,O,1360.0,Dairy products are important sources of dietary fat in India .
39605,products,O,1360.0,Dairy products are important sources of dietary fat in India .
39606,are,O,1360.0,Dairy products are important sources of dietary fat in India .
39607,important,O,1360.0,Dairy products are important sources of dietary fat in India .
39608,sources,O,1360.0,Dairy products are important sources of dietary fat in India .
39609,of,O,1360.0,Dairy products are important sources of dietary fat in India .
39610,dietary,O,1360.0,Dairy products are important sources of dietary fat in India .
39611,fat,O,1360.0,Dairy products are important sources of dietary fat in India .
39612,in,O,1360.0,Dairy products are important sources of dietary fat in India .
39613,India,O,1360.0,Dairy products are important sources of dietary fat in India .
39614,.,O,1360.0,Dairy products are important sources of dietary fat in India .
39695,The,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39696,serum,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39697,lipid,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39698,profiles,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39699,of,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39700,these,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39701,animals,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39702,showed,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39703,a,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39704,dose,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39705,dependent,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39706,decrease,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39707,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39708,total,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39709,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39710,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39711,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39712,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39713,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39714,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39715,very,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39716,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39717,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39718,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39719,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39720,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39721,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39722,triglyceride,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39723,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39724,when,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39725,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39726,was,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39727,present,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39728,at,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39729,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39730,greater,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39731,than,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39732,2.5,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39733,%,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39734,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39735,the,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39736,diet,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39737,.,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39839,This,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39840,study,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39841,revealed,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39842,that,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39843,the,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39844,consumption,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39845,of,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39846,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39847,up,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39848,to,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39849,a,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39850,10,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39851,%,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39852,level,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39853,in,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39854,the,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39855,diet,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39856,altered,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39857,blood,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39858,lipid,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39859,profiles,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39860,in,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39861,such,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39862,a,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39863,manner,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39864,as,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39865,not,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39866,to,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39867,elevate,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39868,the,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39869,risk,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39870,factors,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39871,for,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39872,cardiovascular,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39873,diseases,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39874,.,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
40379,We,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40380,observed,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40381,a,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40382,significant,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40383,inverse,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40384,association,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40385,between,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40386,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40387,consumption,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40388,and,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40389,overall,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40390,mortality,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40391,(,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40392,HR,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40393,Opinions,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40394,about,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40395,good,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40396,nutrition,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40397,",",O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40398,causes,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40399,of,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40400,obesity,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40401,and,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40402,its,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40403,prevention,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40404,",",O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40405,as,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40406,well,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40407,as,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40408,certain,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40409,eating,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40410,habits,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40411,",",O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40412,were,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40413,studied,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40414,in,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40415,482,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40416,Israeli,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40417,children,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40418,(,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40419,251,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40420,boys,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40421,and,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40422,231,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40423,girls,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40424,),O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40425,",",O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40426,thirteen,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40427,to,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40428,fourteen,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40429,years,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40430,old,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40431,.,O,1385.0,"We observed a significant inverse association between nut consumption and overall mortality ( HR Opinions about good nutrition , causes of obesity and its prevention , as well as certain eating habits , were studied in 482 Israeli children ( 251 boys and 231 girls ) , thirteen to fourteen years old ."
40590,The,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40591,belief,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40592,in,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40593,the,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40594,fattening,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40595,value,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40596,of,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40597,potatoes,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40598,",",O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40599,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40600,",",O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40601,and,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40602,nuts,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40603,was,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40604,shared,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40605,by,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40606,a,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40607,higher,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40608,percentage,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40609,of,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40610,overweight,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40611,than,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40612,of,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40613,under-,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40614,and,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40615,normal,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40616,-,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40617,weight,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40618,children,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40619,.,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40697,The,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40698,effects,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40699,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40700,the,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40701,type,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40702,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40703,dietary,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40704,fat,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40705,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40706,180,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40707,g,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40708,/,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40709,kg,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40710,diet,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40711,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40712,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40713,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40714,calcium,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40715,phosphate,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40716,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40717,CaHPO4,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40718,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40719,supplementation,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40720,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40721,25,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40722,vs.,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40723,225,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40724,mmol,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40725,/,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40726,kg,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40727,diet,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40728,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40729,on,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40730,luminal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40731,solubility,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40732,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40733,fatty,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40734,acids,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40735,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40736,bile,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40737,acids,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40738,",",O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40739,cytotoxicity,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40740,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40741,fecal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40742,water,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40743,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40744,intestinal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40745,epitheliolysis,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40746,were,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40747,studied,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40748,in,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40749,rats,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40750,.,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
41136,In,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41137,40,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41138,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41139,42,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41140,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41141,y,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41142,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41143,old,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41144,men,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41145,",",O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41146,mean,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41147,tHcy,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41148,was,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41149,10.1,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41150,mumol,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41151,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41152,L,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41153,for,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41154,nonusers,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41155,and,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41156,12.0,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41157,mumol,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41158,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41159,L,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41160,for,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41161,drinkers,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41162,of,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41163,>,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41164,or,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41165,=,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41166,9,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41167,cups,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41168,of,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41169,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41170,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41171,d.,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41172,Corresponding,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41173,tHcy,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41174,concentrations,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41175,in,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41176,40,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41177,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41178,42,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41179,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41180,y,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41181,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41182,old,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41183,women,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41184,were,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41185,8.2,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41186,and,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41187,10.5,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41188,mumol,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41189,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41190,L,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41191,",",O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41192,respectively,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41193,.,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41726,Cox,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41727,proportional,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41728,hazards,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41729,regression,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41730,was,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41731,used,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41732,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41733,calculate,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41734,hazard,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41735,ratios,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41736,for,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41737,incident,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41738,diabetes,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41739,according,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41740,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41741,categories,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41742,of,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41743,total,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41744,flavonoids,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41745,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41746,anthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41747,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41748,flavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41749,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41750,flavanones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41751,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41752,flavonols,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41753,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41754,flavan-3,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41755,-,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41756,ol,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41757,monomers,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41758,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41759,isoflavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41760,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41761,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41762,proanthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41763,.,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41958,This,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41959,study,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41960,investigated,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41961,the,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41962,correlation,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41963,of,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41964,dietary,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41965,patterns,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41966,with,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41967,components,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41968,of,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41969,dyslipidemia,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41970,and,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41971,fasting,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41972,plasma,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41973,glucose,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41974,(,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41975,FPG,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41976,),O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41977,among,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41978,young,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41979,and,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41980,middle,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41981,-,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41982,aged,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41983,adults,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41984,(,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41985,aged,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41986,between,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41987,20,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41988,and,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41989,50,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41990,years,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41991,),O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41992,with,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41993,dyslipidemia,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41994,and,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41995,abnormal,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41996,FPG,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41997,in,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41998,Taiwan,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
41999,.,O,1439.0,This study investigated the correlation of dietary patterns with components of dyslipidemia and fasting plasma glucose ( FPG ) among young and middle - aged adults ( aged between 20 and 50 years ) with dyslipidemia and abnormal FPG in Taiwan .
42050,Elevated,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42051,FPG,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42052,level,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42053,was,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42054,defined,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42055,according,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42056,to,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42057,the,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42058,American,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42059,Diabetes,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42060,Association,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42061,.,O,1443.0,Elevated FPG level was defined according to the American Diabetes Association .
42522,We,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42523,selected,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42524,354,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42525,cases,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42526,of,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42527,pathologically,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42528,confirmed,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42529,gastric,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42530,adenocarcinoma,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42531,from,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42532,15,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42533,hospitals,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42534,",",O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42535,representative,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42536,of,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42537,nearly,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42538,all,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42539,those,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42540,in,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42541,the,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42542,study,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42543,areas,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42544,.,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42545,A,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42546,control,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42547,for,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42548,each,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42549,case,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42550,",",O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42551,matched,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42552,by,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42553,age,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42554,",",O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42555,sex,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42556,and,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42557,area,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42558,of,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42559,residence,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42560,",",O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42561,was,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42562,selected,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42563,from,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42564,the,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42565,same,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42566,hospital,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42567,as,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42568,the,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42569,case,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42570,.,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42690,With,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42691,reference,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42692,to,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42693,past,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42694,diet,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42695,",",O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42696,a,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42697,possible,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42698,protective,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42699,effect,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42700,was,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42701,observed,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42702,for,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42703,daily,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42704,consumption,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42705,of,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42706,fresh,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42707,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42708,and,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42709,green,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42710,vegetables,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42711,.,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42777,Whilst,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42778,dietary,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42779,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42780,have,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42781,been,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42782,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42783,subject,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42784,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42785,breast,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42786,cancer,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42787,risk,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42788,-,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42789,reduction,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42790,",",O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42791,this,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42792,review,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42793,will,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42794,focus,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42795,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42796,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42797,clinical,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42798,effects,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42799,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42800,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42801,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42802,reducing,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42803,recurrence,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42804,.,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42805,Overall,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42806,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42807,we,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42808,recommend,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42809,breast,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42810,cancer,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42811,patients,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42812,consume,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42813,a,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42814,diet,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42815,naturally,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42816,high,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42817,in,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42818,flavonol,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42819,polyphenols,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42820,including,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42821,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42822,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42823,vegetables,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42824,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42825,onion,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42826,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42827,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42828,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42829,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42830,and,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42831,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42832,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42833,apples,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42834,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42835,citrus,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42836,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42837,.,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
43138,On,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43139,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43140,basis,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43141,of,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43142,these,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43143,results,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43144,",",O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43145,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43146,bioactivity,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43147,index,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43148,(,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43149,BI,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43150,),O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43151,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43152,dietary,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43153,cancer,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43154,prevention,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43155,is,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43156,proposed,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43157,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43158,provide,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43159,a,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43160,simple,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43161,reference,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43162,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43163,consumers,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43164,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43165,choose,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43166,vegetables,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43167,in,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43168,accordance,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43169,with,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43170,their,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43171,beneficial,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43172,activities,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43173,.,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43396,Background,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43397,Arsenic,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43398,-,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43399,related,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43400,cardiovascular,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43401,effects,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43402,at,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43403,exposure,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43404,levels,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43405,below,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43406,the,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43407,US,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43408,Environmental,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43409,Protection,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43410,Agency,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43411,'s,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43412,standard,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43413,of,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43414,10,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43415, ,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43416,μg,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43417,/,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43418,L,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43419,are,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43420,unclear,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43421,.,O,1490.0,Background Arsenic - related cardiovascular effects at exposure levels below the US Environmental Protection Agency 's standard of 10   μg / L are unclear .
43438,We,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43439,investigated,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43440,associations,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43441,of,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43442,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43443,intake,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43444,",",O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43445,a,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43446,marker,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43447,of,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43448,arsenic,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43449,exposure,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43450,",",O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43451,with,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43452,subclinical,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43453,cardiovascular,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43454,disease,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43455,(,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43456,CVD,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43457,),O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43458,markers,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43459,in,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43460,a,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43461,multiethnic,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43462,population,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43463,.,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43693,Associations,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43694,with,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43695,urinary,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43696,arsenic,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43697,were,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43698,similar,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43699,to,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43700,those,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43701,for,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43702,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43703,intake,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43704,.,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43881,Of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43882,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43883,tree,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43884,nuts,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43885,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43886,walnuts,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43887,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43888,pecans,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43889,and,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43890,chestnuts,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43891,have,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43892,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43893,highest,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43894,contents,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43895,of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43896,antioxidants,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43897,.,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43898,Walnuts,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43899,contain,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43900,more,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43901,than,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43902,20,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43903,mmol,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43904,antioxidants,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43905,per,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43906,100,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43907,g,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43908,",",O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43909,mostly,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43910,in,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43911,the,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43912,walnut,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43913,pellicles,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43914,.,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43929,These,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43930,data,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43931,are,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43932,in,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43933,accordance,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43934,with,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43935,our,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43936,present,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43937,extended,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43938,analysis,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43939,of,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43940,an,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43941,earlier,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43942,report,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43943,on,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43944,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43945,intake,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43946,and,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43947,death,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43948,attributed,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43949,to,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43950,various,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43951,diseases,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43952,in,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43953,the,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43954,Iowa,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43955,Women,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43956,'s,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43957,Health,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43958,Study,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43959,.,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
44216,We,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44217,conclude,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44218,that,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44219,several,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44220,nutrition,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44221,-,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44222,related,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44223,processes,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44224,jointly,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44225,contribute,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44226,to,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44227,prostate,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44228,carcinogenesis,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44229,.,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44230,60,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44231,migraine,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44232,patients,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44233,completed,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44234,elimination,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44235,diets,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44236,after,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44237,a,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44238,5,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44239,-,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44240,day,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44241,period,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44242,of,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44243,withdrawal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44244,from,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44245,their,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44246,normal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44247,diet,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44248,.,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44400,Both,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44401,immunological,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44402,and,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44403,non,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44404,-,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44405,immunological,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44406,mechanisms,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44407,may,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44408,play,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44409,a,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44410,part,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44411,in,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44412,the,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44413,pathogenesis,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44414,of,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44415,migraine,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44416,caused,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44417,by,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44418,food,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44419,intolerance,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44420,.,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44475,A,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44476,positive,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44477,immediate,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44478,skin,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44479,prick,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44480,test,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44481,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44482,SPT,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44483,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44484,for,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44485,paprika,B-http://purl.bioontology.org/ontology/SNOMEDCT/227408005,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44486,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44487,dry,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44488,powder,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44489,of,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44490,Capsicum,B-http://purl.bioontology.org/ontology/SNOMEDCT/421556008,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44491,annuum,I-http://purl.bioontology.org/ontology/SNOMEDCT/421556008,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44492,[,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44493,Solanaceae,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44494,],O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44495,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44496,",",O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44497,coriander,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44498,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44499,Coriandrum,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44500,sativum,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44501,[,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44502,umbelliferous,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44503,],O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44504,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44505,",",O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44506,and,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44507,mace,B-http://purl.bioontology.org/ontology/SNOMEDCT/227404007,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44508,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44509,shell,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44510,of,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44511,nutmeg,B-http://purl.bioontology.org/ontology/SNOMEDCT/735046009,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44512,",",O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44513,Myristica,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44514,fragrans,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44515,[,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44516,Myristicaceae,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44517,],O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44518,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44519,at,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44520,a,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44521,concentration,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44522,of,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44523,10,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44524,%,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44525,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44526,w,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44527,/,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44528,v,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44529,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44530,was,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44531,obtained,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44532,.,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44758,We,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44759,speculated,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44760,that,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44761,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44762,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44763,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44764,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44765,or,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44766,bacon,B-http://purl.bioontology.org/ontology/SNOMEDCT/226928005,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44767,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44768,increase,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44769,and,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44770,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44771,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44772,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44773,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44774,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44775,decrease,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44776,colon,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44777,carcinogenesis,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44778,in,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44779,rats,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44780,.,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
45253,Results,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45254,showed,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45255,that,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45256,the,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45257,beverage,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45258,has,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45259,lower,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45260,lactose,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45261,and,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45262,higher,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45263,Ca,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45264,than,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45265,untreated,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45266,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45267,and,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45268,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45269,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45270,kefir,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45271,.,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45357,We,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45358,carried,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45359,out,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45360,a,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45361,population,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45362,-,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45363,based,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45364,case,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45365,-,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45366,control,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45367,study,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45368,involving,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45369,380,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45370,cases,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45371,of,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45372,melanoma,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45373,and,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45374,719,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45375,age-,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45376,and,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45377,sex,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45378,-,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45379,matched,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45380,controls,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
45381,.,O,1569.0,We carried out a population - based case - control study involving 380 cases of melanoma and 719 age- and sex - matched controls .
46070,Regular,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46071,consumption,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46072,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46073,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46074,and,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46075,vegetables,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46076,is,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46077,associated,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46078,with,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46079,reduced,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46080,risks,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46081,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46082,cancer,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46083,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46084,cardiovascular,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46085,disease,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46086,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46087,stroke,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46088,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46089,Alzheimer,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46090,disease,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46091,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46092,cataracts,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46093,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46094,and,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46095,some,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46096,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46097,the,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46098,functional,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46099,declines,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46100,associated,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46101,with,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46102,aging,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46103,.,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46373,In,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46374,particular,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46375,",",O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46376,rates,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46377,of,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46378,breast,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46379,and,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46380,prostate,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46381,cancers,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46382,remain,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46383,high,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46384,among,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46385,Adventist,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46386,populations,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46387,despite,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46388,an,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46389,overall,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46390,healthy,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46391,lifestyle,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46392,and,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46393,long,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46394,life,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46395,expectancy,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46396,.,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46934,Vegetarian,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46935,diets,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46936,may,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46937,contain,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46938,high,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46939,amounts,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46940,of,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46941,oxalate,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46942,when,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46943,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46944,grain,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46945,wheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46946,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46947,wheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46948,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46949,are,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46950,ingested,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46951,.,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
47149,Similarly,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47150,consumption,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47151,of,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47152,milky,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47153,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47154,produced,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47155,no,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47156,change,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47157,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47158,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47159,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47160,9.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47161,a.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47162,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47163,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47164,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47165,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47166,the,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47167,50,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47168,%,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47169,increase,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47170,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47171,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47172,noted,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47173,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47174,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47175,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47176,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47177,15.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47178,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47179,was,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47180,not,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47181,statistically,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47182,significant,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47183,.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47394,Phytochemicals,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47395,are,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47396,present,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47397,in,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47398,fruits,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47399,",",O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47400,vegetables,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47401,and,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47402,various,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47403,plants,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47404,",",O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47405,and,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47406,constitute,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47407,nonessential,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47408,nutrients,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47409,such,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47410,as,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47411,vitamins,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47412,or,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47413,minerals,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47414,",",O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47415,many,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47416,of,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47417,them,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47418,being,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47419,consumed,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47420,in,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47421,a,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47422,popular,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47423,way,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47424,or,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47425,used,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47426,as,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47427,herbal,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47428,remedies,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47429,or,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47430,dietary,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47431,supplements,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47432,.,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47433,In,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47434,this,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47435,narrative,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47436,review,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47437,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47438,we,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47439,present,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47440,evidence,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47441,on,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47442,traditional,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47443,endemic,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47444,Mexican,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47445,foods,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47446,such,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47447,as,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47448,cacao,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47449,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47450,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47451,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47452,common,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47453,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47454,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47455,prickle,B-http://purl.bioontology.org/ontology/SNOMEDCT/735050002,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47456,pear,I-http://purl.bioontology.org/ontology/SNOMEDCT/735050002,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47457,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47458,chili,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47459,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47460,avocado,B-http://purl.bioontology.org/ontology/SNOMEDCT/735249009,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47461,and,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47462,salba,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47463,-,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47464,chia,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47465,as,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47466,functional,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47467,agents,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47468,to,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47469,improve,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47470,the,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47471,metabolic,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47472,status,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47473,in,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47474,risk,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47475,phenotypes,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47476,.,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
48348,Our,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48349,findings,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48350,suggest,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48351,that,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48352,more,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48353,than,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48354,one,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48355,-,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48356,third,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48357,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48358,the,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48359,high,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48360,incidence,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48361,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48362,oesophageal,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48363,cancer,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48364,in,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48365,northwest,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48366,France,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48367,could,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48368,be,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48369,explained,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48370,by,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48371,the,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48372,local,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48373,excess,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48374,in,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48375,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48376,consumption,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48377,",",O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48378,whereas,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48379,geographical,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48380,variations,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48381,in,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48382,consumption,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48383,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48384,dietary,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48385,protective,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48386,factors,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48387,could,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48388,explain,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48389,no,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48390,more,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48391,than,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48392,10,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48393,%,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48394,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48395,it,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48396,.,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48436,Reducing,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48437,the,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48438,amount,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48439,of,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48440,sodium,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48441,in,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48442,food,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48443,products,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48444,is,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48445,necessary,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48446,in,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48447,decreasing,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48448,the,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48449,prevalence,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48450,of,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48451,hypertension,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48452,",",O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48453,heart,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48454,attack,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48455,",",O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48456,and,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48457,stroke,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48458,.,O,1674.0,"Reducing the amount of sodium in food products is necessary in decreasing the prevalence of hypertension , heart attack , and stroke ."
48459,There,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48460,is,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48461,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48462,lack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48463,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48464,information,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48465,on,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48466,sodium,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48467,reduction,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48468,in,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48469,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48470,chips,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48471,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48472,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48473,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48474,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48475,which,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48476,comprise,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48477,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48478,large,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48479,percentage,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48480,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48481,salty,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48482,snack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48483,sales,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48484,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48485,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48486,the,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48487,use,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48488,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48489,flavor,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48490,enhancers,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48491,to,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48492,maintain,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48493,consumer,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48494,acceptability,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48495,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48496,these,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48497,products,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48498,.,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48655,These,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48656,findings,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48657,imply,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48658,acceptance,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48659,of,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48660,sodium,B-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48661,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48662,reduced,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48663,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48664,chips,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48665,and,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48666,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48667,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48668,is,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48669,possible,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48670,by,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48671,focusing,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48672,on,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48673,these,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48674,identified,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48675,drivers,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48676,of,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48677,liking,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48678,.,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
49273,A,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49274,longitudinal,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49275,study,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49276,was,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49277,conducted,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49278,to,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49279,assess,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49280,to,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49281,what,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49282,extent,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49283,intramammary,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49284,infection,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49285,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49286,IMI,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49287,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49288,with,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49289,non,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49290,-,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49291,aureus,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49292,staphylococci,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49293,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49294,NAS,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49295,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49296,within,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49297,the,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49298,first,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49299,4,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49300,d,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49301,after,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49302,calving,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49303,in,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49304,dairy,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49305,heifers,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49306,affects,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49307,quarter,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49308,milk,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49309,yield,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49310,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49311,qMY,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49312,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49313,and,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49314,quarter,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49315,milk,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49316,somatic,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49317,cell,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49318,count,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49319,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49320,qSCC,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49321,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49322,during,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49323,the,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49324,first,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49325,4,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49326,mo,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49327,of,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49328,lactation,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49329,.,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49330,In,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49331,total,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49332,",",O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49333,324,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49334,quarters,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49335,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49336,82,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49337,Holstein,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49338,Friesian,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49339,heifers,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49340,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49341,3,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49342,commercial,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49343,dairy,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49344,herds,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49345,equipped,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49346,with,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49347,an,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49348,automatic,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49349,milking,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49350,system,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49351,were,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49352,included,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49353,and,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49354,followed,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49355,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49356,calving,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49357,up,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49358,to,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49359,4,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49360,mo,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49361,in,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49362,lactation,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49363,.,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49441,Overall,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49442,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49443,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49444,IMI,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49445,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49446,early,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49447,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49448,caused,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49449,only,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49450,a,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49451,slight,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49452,but,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49453,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49454,increase,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49455,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49456,qSCC,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49457,compared,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49458,with,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49459,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49460,from,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49461,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49462,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49463,during,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49464,the,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49465,first,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49466,4,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49467,mo,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49468,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49469,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49470,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49471,whereas,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49472,no,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49473,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49474,difference,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49475,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49476,daily,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49477,qMY,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49478,was,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49479,present,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49480,between,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49481,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49482,-,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49483,infected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49484,and,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49485,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49486,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49487,.,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49882,The,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49883,objective,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49884,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49885,this,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49886,study,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49887,was,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49888,to,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49889,evaluate,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49890,the,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49891,effects,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49892,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49893,fat,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49894,free,I-http://purl.bioontology.org/ontology/SNOMEDCT/762952008;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49895,peanut,I-http://purl.bioontology.org/ontology/SNOMEDCT/762952008;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49896,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/762952008;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49897,(,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49898,FFPF,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49899,),O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49900,",",O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49901,peanuts,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49902,",",O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49903,and,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49904,peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49905,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49906,on,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49907,cardiovascular,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49908,disease,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49909,(,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49910,CVD,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49911,),O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49912,risk,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49913,factors,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49914,and,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49915,the,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49916,development,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49917,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49918,atherosclerosis,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49919,in,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49920,male,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49921,Syrian,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49922,golden,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49923,hamsters,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49924,.,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
50247,In,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50248,addition,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50249,",",O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50250,many,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50251,clinical,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50252,observational,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50253,studies,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50254,have,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50255,demonstrated,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50256,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50257,absence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50258,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50259,a,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50260,relationship,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50261,between,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50262,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50263,frequency,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50264,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50265,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50266,soup,I-http://purl.bioontology.org/ontology/SNOMEDCT/227354002;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50267,intake,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50268,and,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50269,blood,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50270,pressure,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50271,levels,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50272,or,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50273,hypertension,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50274,incidence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50275,.,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50296,However,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50297,",",O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50298,in,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50299,basic,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50300,studies,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50301,",",O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50302,it,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50303,was,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50304,found,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50305,that,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50306,the,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50307,ingredients,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50308,of,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50309,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50310,attenuate,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50311,sympathetic,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50312,nerve,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50313,activity,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50314,",",O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50315,resulting,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50316,in,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50317,lowered,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50318,blood,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50319,pressure,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50320,and,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50321,heart,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50322,rate,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50323,.,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50931,Extracts,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50932,from,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50933,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50934,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50935,ratio=3.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50936,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50937,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50938,calcot,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50939,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50940,ratio=4.8,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50941,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50942,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50943,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50944,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50945,ratio=4.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50946,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50947,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50948,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50949,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50950,ratio=2.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50951,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50952,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50953,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50954,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50955,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50956,ratio=3.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50957,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50958,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50959,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50960,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50961,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50962,ratio=3.6,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50963,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50964,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50965,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50966,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50967,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50968,ratio=4.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50969,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50970,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50971,and,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50972,purple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50973,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50974,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50975,ratio=3.7,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50976,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50977,were,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50978,confirmed,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50979,to,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50980,contain,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50981,MIs,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50982,in,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50983,the,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50984,AREPE,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50985,cell,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50986,line,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50987,.,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50988,These,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50989,results,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50990,are,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50991,very,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50992,similar,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50993,to,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50994,those,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50995,described,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50996,for,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50997,vegetables,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50998,consumed,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50999,in,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51000,the,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51001,United,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51002,States,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51003,",",O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51004,with,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51005,the,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51006,exception,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51007,of,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51008,calcot,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51009,",",O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51010,which,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51011,is,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51012,common,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51013,in,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51014,Catalonia,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51015,but,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51016,is,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51017,not,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51018,grown,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51019,or,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51020,consumed,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51021,widely,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51022,in,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51023,the,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51024,United,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51025,States,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51026,.,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51348,Wheat,O,1762.0,Wheat ( Triticum spp .
51349,(,O,1762.0,Wheat ( Triticum spp .
51350,Triticum,O,1762.0,Wheat ( Triticum spp .
51351,spp,O,1762.0,Wheat ( Triticum spp .
51352,.,O,1762.0,Wheat ( Triticum spp .
51536,These,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51537,analyses,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51538,provide,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51539,molecular,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51540,evidence,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51541,for,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51542,the,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51543,absence,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51544,of,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51545,toxic,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51546,gliadin,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51547,-,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51548,like,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51549,peptides,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51550,in,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51551,sorghum,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51552,",",O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51553,confirming,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51554,that,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51555,sorghum,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51556,can,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51557,be,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51558,definitively,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51559,considered,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51560,safe,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51561,for,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51562,consumption,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51563,by,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51564,people,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51565,with,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51566,celiac,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51567,disease,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51568,.,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51911,This,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51912,policy,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51913,was,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51914,expected,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51915,to,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51916,result,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51917,in,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51918,a,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51919,mean,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51920,additional,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51921,intake,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51922,of,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51923,approximately,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51924,400,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51925,microg,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51926,FA,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51927,/,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51928,d.,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51929,We,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51930,assessed,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51931,the,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51932,effectiveness,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51933,of,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51934,the,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51935,FA,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51936,flour,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51937,fortification,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51938,program,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51939,on,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51940,bread,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51941,folate,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51942,content,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51943,and,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51944,on,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51945,blood,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51946,folate,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51947,concentration,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51948,in,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51949,women,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51950,of,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51951,childbearing,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51952,age,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51953,in,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51954,Santiago,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51955,",",O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51956,Chile,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
51957,.,O,1780.0,"This policy was expected to result in a mean additional intake of approximately 400 microg FA / d. We assessed the effectiveness of the FA flour fortification program on bread folate content and on blood folate concentration in women of childbearing age in Santiago , Chile ."
52095,The,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52096,mean,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52097,FA,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52098,content,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52099,of,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52100,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52101,was,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52102,2020,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52103,+,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52104,/-,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52105,940,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52106,micro,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52107,g,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52108,/,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52109,kg,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52110,.,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52221,The,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52222,30,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52223,papers,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52224,examine,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52225,populations,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52226,in,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52227,12,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52228,countries,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52229,and,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52230,provide,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52231,data,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52232,on,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52233,consumption,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52234,of,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52235,both,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52236,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52237,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52238,green,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52239,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52240,.,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52574,An,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52575,increase,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52576,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52577,5,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52578,U,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52579,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52580,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52581,dietary,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52582,score,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52583,was,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52584,associated,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52585,with,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52586,a,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52587,change,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52588,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52589,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52590,BMI,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52591,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52592,0.43,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52593,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52594,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52595,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52596,0.030,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52597,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52598,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52599,0.68,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52600,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52601,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52602,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52603,0.007,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52604,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52605,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52606,after,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52607,controlling,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52608,for,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52609,potential,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52610,confounders,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52611,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52612,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52613,men,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52614,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52615,women,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52616,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52617,respectively,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52618,.,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52701,These,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52702,data,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52703,suggest,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52704,that,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52705,the,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52706,traditional,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52707,Mediterranean,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52708,dietary,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52709,pattern,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52710,is,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52711,inversely,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52712,associated,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52713,with,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52714,BMI,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52715,and,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52716,obesity,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52717,.,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52759,Seven,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52760,culinary,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52761,spices,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52762,including,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52763,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52764,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52765,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52766,cayenne,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52767,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52768,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52769,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52770,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52771,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52772,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52773,Mediterranean,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52774,oregano,B-http://purl.bioontology.org/ontology/SNOMEDCT/227407000,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52775,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52776,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52777,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52778,and,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52779,turmeric,B-http://purl.bioontology.org/ontology/SNOMEDCT/227414003,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52780,were,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52781,extracted,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52782,with,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52783,boiling,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52784,water,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52785,.,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
53059,The,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53060,objective,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53061,of,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53062,the,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53063,present,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53064,study,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53065,was,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53066,to,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53067,investigate,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53068,how,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53069,glycaemic,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53070,and,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53071,insulinaemic,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53072,responses,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53073,to,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53074,a,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53075,mashed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53076,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53077,meal,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53078,changed,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53079,when,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53080,a,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53081,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53082,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53083,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53084,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53085,(,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53086,rapeseed,B-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53087,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53088,),O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53089,",",O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53090,a,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53091,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/228064004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53092,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/228064004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53093,protein,I-http://purl.bioontology.org/ontology/SNOMEDCT/228064004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53094,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/228064004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53095,(,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53096,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53097,breast,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53098,),O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53099,and/or,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53100,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53101,were,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53102,added,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53103,to,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53104,the,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53105,meal,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53106,.,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53107,Healthy,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53108,subjects,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53109,(,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53110,n,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53111,11,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53112,),O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53113,ingested,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53114,the,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53115,test,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53116,meals,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53117,once,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53118,and,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53119,the,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53120,reference,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53121,food,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53122,(,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53123,glucose,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53124,solution,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53125,),O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53126,twice,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53127,in,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53128,a,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53129,random,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53130,order,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53131,at,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53132,1,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53133,-,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53134,week,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53135,intervals,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53136,.,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53171,The,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53172,glycaemic,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53173,index,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53174,(,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53175,GI,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53176,),O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53177,of,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53178,pure,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53179,mashed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53180,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53181,was,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53182,108,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53183,",",O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53184,whereas,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53185,combined,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53186,with,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53187,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53188,breast,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53189,",",O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53190,rapeseed,B-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53191,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53192,and,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53193,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53194,",",O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53195,it,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53196,was,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53197,only,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53198,54,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53199,.,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53611,Thus,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53612,",",O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53613,a,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53614,skilled,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53615,nutritionist,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53616,should,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53617,be,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53618,an,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53619,integral,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53620,part,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53621,of,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53622,the,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53623,multidisciplinary,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53624,management,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53625,of,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53626,GEP,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53627,-,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53628,NET,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53629,patients,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53630,.,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53694,These,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53695,very,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53696,-,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53697,low,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53698,-,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53699,carbohydrate,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53700,diets,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53701,",",O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53702,with,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53703,fat,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53704,comprising,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53705,>,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53706,70,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53707,%,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53708,of,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53709,calories,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53710,",",O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53711,have,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53712,been,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53713,dismissed,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53714,as,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53715,fads,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53716,.,O,1849.0,"These very - low - carbohydrate diets , with fat comprising > 70 % of calories , have been dismissed as fads ."
53750,In,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53751,addition,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53752,to,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53753,the,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53754,reductions,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53755,in,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53756,blood,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53757,glucose,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53758,and,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53759,insulin,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53760,achievable,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53761,through,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53762,carbohydrate,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53763,restriction,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53764,",",O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53765,chronic,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53766,ketosis,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53767,might,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53768,confer,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53769,unique,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53770,metabolic,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53771,benefits,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53772,of,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53773,relevance,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53774,to,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53775,cancer,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53776,",",O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53777,neurodegenerative,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53778,conditions,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53779,",",O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53780,and,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53781,other,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53782,diseases,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53783,associated,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53784,with,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53785,insulin,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53786,resistance,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
53787,.,O,1852.0,"In addition to the reductions in blood glucose and insulin achievable through carbohydrate restriction , chronic ketosis might confer unique metabolic benefits of relevance to cancer , neurodegenerative conditions , and other diseases associated with insulin resistance ."
54083,Hazard,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54084,ratios,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54085,for,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54086,dietary,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54087,factors,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54088,were,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54089,calculated,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54090,by,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54091,Cox,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54092,'s,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54093,proportional,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54094,hazards,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54095,model,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54096,.,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54200,It,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54201,was,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54202,suggested,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54203,that,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54204,urothelial,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54205,cancer,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54206,death,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54207,could,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54208,be,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54209,potentially,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54210,preventable,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54211,by,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54212,smoking,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54213,cessation,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54214,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54215,regular,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54216,intake,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54217,of,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54218,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54219,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54220,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54221,.,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54487,Results,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54488,showed,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54489,the,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54490,existence,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54491,of,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54492,common,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54493,antigenic,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54494,epitopes,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54495,in,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54496,pistachio,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54497,and,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54498,Artemisia,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54499,pollen,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54500,for,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54501,this,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54502,patient,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54503,.,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54504,We,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54505,concluded,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54506,that,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54507,mugwort,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54508,hay,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54509,fever,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54510,can,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54511,be,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54512,associated,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54513,with,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54514,the,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54515,Compositae,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54516,family,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54517,of,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54518,foods,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54519,",",O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54520,but,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54521,that,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54522,it,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54523,is,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54524,not,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54525,normally,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54526,associated,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54527,with,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54528,other,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54529,foods,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54530,.,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54692,Among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54693,women,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54694,and,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54695,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54696,to,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54697,a,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54698,lesser,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54699,extent,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54700,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54701,among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54702,men,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54703,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54704,inverse,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54705,associations,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54706,were,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54707,stronger,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54708,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54709,distal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54710,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54711,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54712,than,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54713,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54714,proximal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54715,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54716,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54717,.,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
55116,Significant,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55117,evidence,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55118,from,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55119,epidemiological,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55120,investigations,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55121,showed,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55122,that,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55123,dietary,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55124,polyphenols,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55125,might,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55126,manage,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55127,and,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55128,prevent,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55129,type,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55130,2,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55131,diabetes,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55132,(,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55133,T2D,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55134,),O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55135,.,O,1905.0,Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes ( T2D ) .
55835,These,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55836,data,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55837,indicate,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55838,that,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55839,changes,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55840,in,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55841,the,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55842,gut,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55843,microbiota,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55844,of,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55845,mice,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55846,fed,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55847,Yukihikari,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55848,could,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55849,be,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55850,advantageous,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55851,in,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55852,the,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55853,prevention,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55854,of,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55855,food,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55856,allergy,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55857,.,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
56355,There,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56356,is,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56357,a,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56358,need,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56359,to,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56360,reduce,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56361,the,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56362,fat,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56363,content,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56364,in,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56365,fried,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56366,foods,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56367,because,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56368,of,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56369,increasing,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56370,health,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56371,concerns,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56372,from,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56373,consumers,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
56374,.,O,1945.0,There is a need to reduce the fat content in fried foods because of increasing health concerns from consumers .
57223,"""",O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57224,The,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57225,course,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57226,addressed,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57227,nutrition,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57228,practices,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57229,associated,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57230,with,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57231,the,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57232,reduction,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57233,of,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57234,risk,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57235,for,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57236,coronary,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57237,heart,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57238,disease,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57239,",",O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57240,cancer,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57241,",",O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57242,osteoporosis,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57243,",",O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57244,and,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57245,obesity,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57246,.,O,1977.0,""" The course addressed nutrition practices associated with the reduction of risk for coronary heart disease , cancer , osteoporosis , and obesity ."
57334,One,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57335,hundred,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57336,forty,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57337,-,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57338,two,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57339,of,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57340,195,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57341,participants,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57342,(,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57343,73,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57344,%,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57345,),O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57346,completed,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57347,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57348,course,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57349,and,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57350,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57351,evaluation,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57352,.,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57394,They,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57395,decreased,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57396,the,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57397,number,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57398,of,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57399,times,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57400,they,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57401,selected,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57402,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57403,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57404,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57405,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57406,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57407,regular,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57408,red,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57409,meats,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57410,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57411,foods,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57412,from,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57413,the,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57414,saturated,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57415,fatty,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57416,acid,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57417,group,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57418,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57419,desserts,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57420,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57421,sodium,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57422,-,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57423,rich,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57424,products,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57425,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57426,and,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57427,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57428,/,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57429,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57430,(,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57431,p,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57432,less,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57433,than,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57434,.05,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57435,),O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57436,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57437,and,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57438,they,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57439,increased,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57440,selection,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57441,of,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57442,low,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57443,-,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57444,fat,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57445,dairy,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57446,products,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57447,(,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57448,p,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57449,less,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57450,than,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57451,.05,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57452,),O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57453,.,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57615,The,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57616,Saharawi,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57617,diet,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57618,was,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57619,found,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57620,to,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57621,mainly,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57622,include,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57623,cereals,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57624,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57625,oils,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57626,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57627,sugars,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57628,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57629,vegetables,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57630,(,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57631,especially,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57632,onions,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57633,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57634,tomatoes,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57635,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57636,and,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57637,carrots,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57638,),O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57639,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57640,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57641,",",O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57642,and,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57643,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
57644,.,O,1995.0,"The Saharawi diet was found to mainly include cereals , oils , sugars , vegetables ( especially onions , tomatoes , and carrots ) , tea , and meat ."
58189,RWT,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58190,was,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58191,the,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58192,only,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58193,meal,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58194,that,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58195,showed,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58196,significantly,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58197,lower,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58198,glucose,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58199,response,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58200,when,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58201,compared,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58202,with,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58203,the,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58204,control,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58205,(,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58206,P<0·05,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58207,),O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58208,.,O,2006.0,RWT was the only meal that showed significantly lower glucose response when compared with the control ( P<0·05 ) .
58273,Therefore,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58274,",",O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58275,the,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58276,ingestion,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58277,of,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58278,soya,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58279,beancurd,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58280,with,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58281,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58282,may,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58283,have,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58284,a,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58285,direct,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58286,impact,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58287,on,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58288,reducing,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58289,the,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58290,risk,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58291,in,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58292,Asians,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58293,transiting,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58294,from,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58295,being,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58296,pre,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58297,-,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58298,diabetics,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58299,to,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58300,diabetics,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58301,.,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58385,We,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58386,used,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58387,data,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58388,from,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58389,the,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58390,Mexican,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58391,Teachers,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58392,',O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58393,Cohort,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58394,including,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58395,64,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58396,934,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58397,disease,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58398,-,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58399,free,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58400,women,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58401,aged,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58402,≥25,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58403,years,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58404,at,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58405,baseline,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58406,.,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58602,Addressing,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58603,intake,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58604,of,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58605,liquid,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58606,UPF,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58607,and,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58608,processed,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58609,meats,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58610,may,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58611,help,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58612,in,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58613,managing,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58614,hypertension,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58615,in,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58616,LMIC,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58617,.,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58640,Milk,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58641,proteins,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58642,are,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58643,currently,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58644,the,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58645,main,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58646,source,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58647,of,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58648,a,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58649,range,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58650,of,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58651,biologically,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58652,active,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58653,peptides,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58654,.,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
59517,In,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59518,addition,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59519,",",O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59520,olives,B-http://purl.bioontology.org/ontology/SNOMEDCT/227436000,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59521,(,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59522,Olea,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59523,europaea,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59524,L.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59525,),O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59526,and,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59527,olive,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59528,oils,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59529,provide,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59530,a,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59531,rich,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59532,source,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59533,of,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59534,natural,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59535,antioxidants,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59536,.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59772,A,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59773,substantially,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59774,increased,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59775,risk,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59776,for,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59777,heavy,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59778,drinkers,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59779,and,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59780,a,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59781,slightly,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59782,reduced,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59783,risk,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59784,for,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59785,lighter,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59786,drinkers,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59787,results,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59788,in,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59789,the,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59790,J,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59791,-,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59792,shaped,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59793,alcohol,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59794,-,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59795,mortality,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59796,curve,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
59797,.,O,2068.0,A substantially increased risk for heavy drinkers and a slightly reduced risk for lighter drinkers results in the J - shaped alcohol - mortality curve .
60022,The,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60023,consumption,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60024,of,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60025,animal,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60026,products,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60027,exposes,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60028,humans,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60029,to,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60030,saturated,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60031,fat,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60032,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60033,cholesterol,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60034,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60035,lactose,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60036,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60037,estrogens,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60038,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60039,and,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60040,pathogenic,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60041,microorganisms,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60042,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60043,while,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60044,displacing,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60045,fiber,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60046,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60047,complex,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60048,carbohydrates,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60049,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60050,antioxidants,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60051,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60052,and,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60053,other,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60054,components,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60055,needed,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60056,for,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60057,health,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60058,.,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60120,When,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60121,omnivorous,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60122,individuals,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60123,change,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60124,to,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60125,a,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60126,plant,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60127,-,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60128,based,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60129,diet,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60130,",",O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60131,diet,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60132,quality,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60133,as,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60134,measured,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60135,by,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60136,the,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60137,Alternate,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60138,Healthy,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60139,Eating,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60140,Index,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60141,improves,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60142,",",O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60143,and,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60144,the,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60145,risk,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60146,of,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60147,these,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60148,health,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60149,problems,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60150,diminishes,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60151,.,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60269,Information,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60270,on,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60271,demographic,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60272,and,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60273,lifestyle,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60274,factors,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60275,was,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60276,collected,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60277,using,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60278,mailed,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60279,questionnaires,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60280,between,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60281,2002,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60282,and,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60283,2003,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60284,.,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60349,Hazard,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60350,ratio,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60351,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60352,HR,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60353,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60354,estimates,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60355,for,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60356,consuming,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60357,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60358,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60359,drink,B-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60360,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60361,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60362,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60363,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60364,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60365,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60366,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60367,drink,B-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60368,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60369,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60370,but,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60371,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60372,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60373,drink,B-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60374,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60375,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60376,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60377,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60378,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60379,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60380,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60381,drink,B-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60382,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60383,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60384,were,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60385,0.89,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60386,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60387,95,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60388,%,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60389,confidence,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60390,interval,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60391,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60392,0.74,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60393,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60394,1.07,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60395,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60396,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60397,0.99,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60398,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60399,0.83,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60400,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60401,1.17,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60402,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60403,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60404,0.88,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60405,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60406,0.70,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60407,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60408,1.12,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60409,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60410,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60411,respectively,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60412,.,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60652,There,O,2103.0,There was no significant difference between genders .
60653,was,O,2103.0,There was no significant difference between genders .
60654,no,O,2103.0,There was no significant difference between genders .
60655,significant,O,2103.0,There was no significant difference between genders .
60656,difference,O,2103.0,There was no significant difference between genders .
60657,between,O,2103.0,There was no significant difference between genders .
60658,genders,O,2103.0,There was no significant difference between genders .
60659,.,O,2103.0,There was no significant difference between genders .
60739,Silymarin,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60740,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60741,a,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60742,natural,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60743,acknowledged,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60744,hepatoprotector,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60745,used,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60746,in,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60747,humans,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60748,to,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60749,treat,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60750,liver,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60751,diseases,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60752,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60753,has,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60754,been,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60755,tested,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60756,in,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60757,dairy,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60758,cows,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60759,during,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60760,peripartum,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60761,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60762,a,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60763,period,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60764,during,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60765,which,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60766,animals,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60767,are,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60768,subject,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60769,to,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60770,subclinical,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60771,fatty,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60772,liver,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60773,.,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
61418,Results,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61419,from,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61420,high,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61421,quality,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61422,obesity,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61423,studies,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61424,did,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61425,not,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61426,suggest,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61427,a,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61428,positive,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61429,association,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61430,between,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61431,body,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61432,mass,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61433,index,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61434,and,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61435,sugar,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61436,intake,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61437,.,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61554,Regarding,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61555,dental,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61556,caries,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61557,",",O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61558,combinations,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61559,of,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61560,sugar,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61561,amount,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61562,/,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61563,frequency,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61564,",",O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61565,fluoride,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61566,exposure,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61567,",",O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61568,and,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61569,food,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61570,adhesiveness,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61571,were,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61572,more,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61573,reliable,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61574,predictors,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61575,of,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61576,caries,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61577,risk,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61578,than,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61579,the,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61580,amount,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61581,of,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61582,sugar,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61583,alone,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61584,.,O,2137.0,"Regarding dental caries , combinations of sugar amount / frequency , fluoride exposure , and food adhesiveness were more reliable predictors of caries risk than the amount of sugar alone ."
61603,Ginger,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61604,(,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61605,Zingiber,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61606,officinale,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61607,Roscoe,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61608,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61609,Zingiberacae,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61610,),O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61611,is,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61612,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61613,medicinal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61614,plant,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61615,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61616,has,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61617,been,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61618,widely,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61619,used,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61620,in,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61621,Chinese,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61622,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61623,Ayurvedic,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61624,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61625,Tibb,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61626,-,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61627,Unani,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61628,herbal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61629,medicines,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61630,all,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61631,over,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61632,the,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61633,world,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61634,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61635,since,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61636,antiquity,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61637,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61638,for,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61639,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61640,wide,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61641,array,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61642,of,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61643,unrelated,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61644,ailments,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61645,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61646,include,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61647,arthritis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61648,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61649,rheumatism,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61650,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61651,sprains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61652,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61653,muscular,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61654,aches,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61655,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61656,pains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61657,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61658,sore,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61659,throats,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61660,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61661,cramps,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61662,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61663,constipation,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61664,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61665,indigestion,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61666,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61667,vomiting,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61668,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61669,hypertension,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61670,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61671,dementia,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61672,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61673,fever,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61674,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61675,infectious,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61676,diseases,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61677,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61678,helminthiasis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61679,.,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61854,Breast,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61855,cancer,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61856,is,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61857,the,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61858,most,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61859,common,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61860,cancer,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61861,among,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61862,females,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61863,worldwide,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61864,.,O,2146.0,Breast cancer is the most common cancer among females worldwide .
62026,Previously,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62027,",",O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62028,a,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62029,lower,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62030,risk,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62031,of,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62032,colorectal,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62033,cancer,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62034,was,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62035,observed,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62036,with,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62037,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62038,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62039,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62040,consumption,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62041,in,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62042,the,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62043,European,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62044,Prospective,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62045,Investigation,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62046,into,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62047,Cancer,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62048,and,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62049,Nutrition,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62050,within,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62051,a,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62052,follow,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62053,-,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62054,up,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62055,period,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62056,of,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62057,9,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62058,years,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62059,which,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62060,was,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62061,not,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62062,fully,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62063,supported,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62064,by,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62065,a,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62066,recent,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62067,meta,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62068,-,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62069,analysis,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62070,.,O,2151.0,"Previously , a lower risk of colorectal cancer was observed with fruit and vegetable consumption in the European Prospective Investigation into Cancer and Nutrition within a follow - up period of 9 years which was not fully supported by a recent meta - analysis ."
62649,By,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62650,contrast,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62651,",",O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62652,heating,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62653,of,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62654,semipurified,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62655,protein,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62656,extracts,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62657,from,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62658,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62659,tuber,I-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62660,and,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62661,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62662,for,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62663,30,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62664,min,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62665,at,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62666,100,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62667,degrees,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62668,C,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62669,did,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62670,not,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62671,deplete,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62672,the,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62673,immunoreactivity,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62674,of,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62675,the,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62676,major,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62677,allergens,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62678,",",O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62679,indicating,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62680,that,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62681,this,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62682,is,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62683,an,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62684,inappropriate,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62685,test,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62686,for,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62687,identifying,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62688,labile,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62689,food,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62690,allergens,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62691,.,O,2175.0,"By contrast , heating of semipurified protein extracts from celery tuber and apple for 30 min at 100 degrees C did not deplete the immunoreactivity of the major allergens , indicating that this is an inappropriate test for identifying labile food allergens ."
62692,Due,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62693,to,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62694,their,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62695,high,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62696,endogenous,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62697,enzyme,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62698,activities,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62699,",",O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62700,apples,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62701,and,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62702,other,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62703,fruits,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62704,require,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62705,special,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62706,extraction,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62707,procedures,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62708,applying,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62709,either,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62710,low,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62711,temperature,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62712,or,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62713,enzyme,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62714,inhibitors,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62715,.,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62716,Variation,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62717,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62718,extraction,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62719,conditions,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62720,had,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62721,little,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62722,effect,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62723,on,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62724,the,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62725,composition,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62726,and,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62727,activity,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62728,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62729,extracts,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62730,from,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62731,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62732,.,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62946,To,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62947,that,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62948,end,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62949,",",O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62950,response,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62951,surface,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62952,methodology,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62953,(,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62954,RSM,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62955,),O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62956,was,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62957,used,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62958,to,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62959,determine,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62960,optimal,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62961,levels,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62962,of,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62963,carob,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62964,germ,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62965,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62966,",",O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62967,H₂O,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62968,",",O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62969,and,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62970,HPMC,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
62971,.,O,2185.0,"To that end , response surface methodology ( RSM ) was used to determine optimal levels of carob germ flour , H₂O , and HPMC ."
63264,During,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63265,"2,193,751",O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63266,person,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63267,years,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63268,of,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63269,follow,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63270,-,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63271,up,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63272,",",O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63273,103,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63274,participants,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63275,were,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63276,diagnosed,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63277,with,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63278,ESCC,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63279,and,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63280,213,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63281,participants,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63282,with,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63283,EAC,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63284,.,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63461,High,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63462,GI,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63463,food,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63464,can,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63465,be,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63466,detrimental,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63467,to,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63468,diabetics,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63469,since,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63470,they,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63471,can,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63472,rapidly,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63473,increase,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63474,the,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63475,glucose,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63476,level,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63477,in,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63478,blood,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63479,during,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63480,digestion,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63481,.,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63578,Response,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63579,surface,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63580,methodology,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63581,(,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63582,RSM,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63583,),O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63584,was,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63585,used,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63586,to,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63587,optimize,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63588,the,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63589,cooking,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63590,conditions,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63591,.,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
64096,Epidemiologic,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64097,evidence,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64098,of,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64099,a,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64100,protective,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64101,role,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64102,for,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64103,fruits,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64104,and,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64105,vegetables,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64106,in,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64107,cancer,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64108,prevention,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64109,is,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64110,substantial,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64111,.,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64852,Results,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64853,of,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64854,experiments,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64855,indicated,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64856,that,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64857,the,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64858,application,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64859,of,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64860,both,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64861,organic,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64862,wastes,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64863,significantly,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64864,decreased,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64865,heavy,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64866,metal,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64867,uptake,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64868,by,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64869,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64870,plants,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
64871,.,O,2257.0,Results of experiments indicated that the application of both organic wastes significantly decreased heavy metal uptake by tomato plants .
65231,France,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65232,had,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65233,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65234,highest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65235,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65236,intake,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65237,and,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65238,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65239,highest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65240,total,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65241,alcohol,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65242,intake,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65243,",",O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65244,and,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65245,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65246,second,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65247,lowest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65248,CHD,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65249,mortality,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65250,rate,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65251,.,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65329,We,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65330,conclude,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65331,that,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65332,ethanol,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65333,",",O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65334,particularly,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65335,wine,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65336,ethanol,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65337,",",O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65338,is,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65339,inversely,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65340,related,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65341,to,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65342,CHD,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65343,but,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65344,not,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65345,to,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65346,longevity,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65347,in,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65348,populations,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65349,.,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65579,In,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65580,addition,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65581,the,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65582,effect,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65583,of,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65584,cooking,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65585,and,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65586,proteolytic,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65587,digestion,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65588,on,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65589,the,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65590,corn,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65591,allergens,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65592,was,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65593,investigated,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65594,.,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65715,For,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65716,alcoholic,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65717,beverages,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65718,separately,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65719,",",O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65720,it,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65721,was,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65722,0.68,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65723,for,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65724,the,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65725,highest,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65726,tertile,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65727,of,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65728,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65729,",",O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65730,1.12,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65731,for,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65732,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65733,and,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65734,0.86,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65735,for,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65736,liquor,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65737,.,O,2291.0,"For alcoholic beverages separately , it was 0.68 for the highest tertile of beer , 1.12 for wine and 0.86 for liquor ."
65738,The,O,2292.0,The decreasing trend was significant for beer intake .
65739,decreasing,O,2292.0,The decreasing trend was significant for beer intake .
65740,trend,O,2292.0,The decreasing trend was significant for beer intake .
65741,was,O,2292.0,The decreasing trend was significant for beer intake .
65742,significant,O,2292.0,The decreasing trend was significant for beer intake .
65743,for,O,2292.0,The decreasing trend was significant for beer intake .
65744,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2292.0,The decreasing trend was significant for beer intake .
65745,intake,O,2292.0,The decreasing trend was significant for beer intake .
65746,.,O,2292.0,The decreasing trend was significant for beer intake .
65763,Whereas,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65764,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65765,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65766,cola,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65767,intake,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65768,was,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65769,not,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65770,associated,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65771,with,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65772,prostate,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65773,cancer,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65774,",",O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65775,a,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65776,decrease,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65777,in,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65778,risk,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65779,was,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65780,observed,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65781,with,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65782,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65783,intake,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65784,of,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65785,more,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65786,than,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65787,500,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65788,g,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65789,per,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65790,day,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65791,(,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65792,OR,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65793,0.70,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65794,),O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65795,.,O,2294.0,"Whereas coffee and cola intake was not associated with prostate cancer , a decrease in risk was observed with tea intake of more than 500 g per day ( OR 0.70 ) ."
65860,Here,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65861,",",O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65862,we,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65863,show,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65864,that,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65865,the,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65866,genetically,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65867,modified,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65868,soybean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65869,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65870,Plenish,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65871,",",O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65872,which,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65873,came,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65874,on,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65875,the,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65876,U.S.,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65877,market,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65878,in,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65879,2014,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65880,and,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65881,is,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65882,low,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65883,in,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65884,linoleic,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65885,acid,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65886,",",O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65887,induces,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65888,less,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65889,obesity,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65890,than,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65891,conventional,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65892,soybean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65893,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65894,in,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65895,C57BL/6,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65896,male,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65897,mice,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65898,.,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
66011,These,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66012,results,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66013,implicate,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66014,a,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66015,new,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66016,class,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66017,of,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66018,compounds,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66019,in,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66020,diet,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66021,-,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66022,induced,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66023,obesity,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66024,-,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66025,C18,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66026,epoxide,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66027,and,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66028,diol,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66029,oxylipins,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66030,.,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66156,Cerebral,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66157,ischemia,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66158,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66159,reperfusion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66160,(,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66161,I,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66162,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66163,R,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66164,),O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66165,injury,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66166,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66167,expression,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66168,of,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66169,adhesion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66170,molecules,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66171,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66172,pro-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66173,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66174,anti,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66175,-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66176,inflammatory,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66177,cytokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66178,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66179,chemokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66180,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66181,microglial,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66182,activation,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66183,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66184,neutrophil,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66185,infiltration,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66186,were,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66187,evaluated,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66188,.,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66302,Epidemiological,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66303,studies,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66304,have,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66305,noted,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66306,a,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66307,consistent,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66308,association,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66309,between,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66310,the,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66311,consumption,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66312,of,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66313,diets,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66314,rich,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66315,in,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66316,fruits,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66317,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66318,vegetables,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66319,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66320,a,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66321,lower,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66322,risk,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66323,for,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66324,chronic,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66325,diseases,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66326,including,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66327,cancer,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66328,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66329,cardiovascular,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66330,disease,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66331,.,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66394,Antioxidants,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66395,help,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66396,lower,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66397,risk,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66398,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66399,cardiovascular,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66400,events,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66401,by,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66402,inhibition,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66403,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66404,LDL,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66405,-,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66406,cholesterol,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66407,oxidation,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66408,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66409,promotion,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66410,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66411,plaque,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66412,stability,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66413,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66414,improved,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66415,vascular,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66416,endothelial,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66417,function,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66418,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66419,and,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66420,decreased,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66421,tendency,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66422,for,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66423,thrombosis,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66424,.,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66473,Preliminary,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66474,animal,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66475,studies,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66476,have,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66477,indicated,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66478,that,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66479,diets,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66480,rich,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66481,in,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66482,strawberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66483,may,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66484,also,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66485,have,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66486,the,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66487,potential,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66488,to,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66489,provide,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66490,benefits,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66491,to,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66492,the,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66493,aging,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66494,brain,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66495,.,O,2321.0,Preliminary animal studies have indicated that diets rich in strawberries may also have the potential to provide benefits to the aging brain .
66573,In,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66574,recent,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66575,decades,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66576,",",O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66577,researchers,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66578,have,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66579,found,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66580,novel,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66581,bioactive,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66582,phytocompounds,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66583,able,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66584,to,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66585,counteract,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66586,the,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66587,effects,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66588,of,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66589,physical,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66590,and,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66591,chemical,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66592,mutagens,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66593,.,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66658,In,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66659,addition,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66660,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66661,an,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66662,analysis,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66663,of,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66664,some,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66665,phytochemicals,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66666,extracted,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66667,from,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66668,those,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66669,vegetables,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66670,and,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66671,the,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66672,analysis,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66673,of,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66674,a,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66675,resin,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66676,(,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66677,"propolis),whose",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66678,antigenotoxic,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66679,power,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66680,has,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66681,been,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66682,demonstrated,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66683,in,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66684,various,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66685,tests,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66686,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66687,including,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66688,the,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66689,Ames,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66690,assay,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66691,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66692,sister,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66693,chromatid,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66694,exchange,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66695,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66696,chromosomal,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66697,aberrations,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66698,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66699,micronucleus,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66700,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66701,and,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66702,comet,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66703,assay,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66704,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66705,was,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66706,also,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66707,performed,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66708,.,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
67417,Among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67418,men,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67419,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67420,the,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67421,risk,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67422,of,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67423,stomach,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67424,cancer,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67425,was,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67426,significantly,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67427,elevated,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67428,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67429,current,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67430,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67431,(,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67432,OR,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67433,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67434,1.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67435,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67436,95,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67437,%,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67438,CI,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67439,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67440,1.1,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67441,-,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67442,2.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67443,),O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67444,but,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67445,not,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67446,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67447,former,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67448,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67449,.,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67758,One,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67759,of,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67760,the,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67761,greatest,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67762,challenges,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67763,is,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67764,to,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67765,reduce,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67766,malnutrition,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67767,worldwide,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67768,while,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67769,promoting,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67770,sustainable,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67771,agricultural,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67772,and,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67773,food,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67774,systems,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67775,.,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67963,Fermentation,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67964,is,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67965,one,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67966,of,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67967,the,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67968,most,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67969,antique,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67970,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67971,economical,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67972,methods,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67973,of,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67974,producing,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67975,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67976,preserving,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67977,foods,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67978,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67979,can,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67980,be,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67981,easily,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67982,employed,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67983,for,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67984,cereal,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67985,processing,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67986,.,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
68201,This,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68202,article,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68203,provides,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68204,a,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68205,concise,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68206,account,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68207,of,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68208,wheat,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68209,gluten,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68210,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68211,focusing,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68212,on,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68213,properties,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68214,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68215,and,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68216,features,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68217,which,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68218,are,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68219,relevant,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68220,to,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68221,its,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68222,role,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68223,in,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68224,triggering,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68225,coeliac,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68226,disease,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68227,and,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68228,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68229,to,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68230,a,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68231,lesser,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68232,extent,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68233,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68234,other,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68235,gluten,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68236,-,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68237,related,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68238,disorders,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68239,.,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68997,Moreover,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
68998,",",O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
68999,the,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69000,study,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69001,highlights,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69002,that,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69003,policy,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69004,responses,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69005,to,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69006,improve,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69007,population,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69008,diets,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69009,may,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69010,need,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69011,to,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69012,be,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69013,tailored,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69014,to,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69015,target,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69016,different,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69017,types,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69018,of,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69019,foods,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69020,for,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69021,different,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69022,population,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69023,groups,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69024,.,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
70132,Further,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70133,refining,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70134,",",O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70135,such,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70136,as,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70137,deodorization,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70138,",",O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70139,results,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70140,in,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70141,significant,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70142,loss,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70143,in,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70144,PS,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70145,",",O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70146,but,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70147,hydrogenation,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70148,after,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70149,refining,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70150,has,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70151,a,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70152,minimal,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70153,effect,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70154,on,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70155,PS,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70156,loss,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70157,.,O,2446.0,"Further refining , such as deodorization , results in significant loss in PS , but hydrogenation after refining has a minimal effect on PS loss ."
70712,Consumption,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70713,of,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70714,reduced,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70715,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70716,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70717,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70718,was,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70719,associated,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70720,with,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70721,reduced,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70722,relative,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70723,risk,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70724,.,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
71483,Two,O,2487.0,Two distinct dietary patterns were identified .
71484,distinct,O,2487.0,Two distinct dietary patterns were identified .
71485,dietary,O,2487.0,Two distinct dietary patterns were identified .
71486,patterns,O,2487.0,Two distinct dietary patterns were identified .
71487,were,O,2487.0,Two distinct dietary patterns were identified .
71488,identified,O,2487.0,Two distinct dietary patterns were identified .
71489,.,O,2487.0,Two distinct dietary patterns were identified .
71575,Compared,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71576,with,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71577,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71578,study,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71579,participants,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71580,in,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71581,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71582,first,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71583,tertile,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71584,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71585,T1,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71586,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71587,lowest,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71588,consumption,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71589,),O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71590,of,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71591,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71592,prudent,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71593,pattern,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71594,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71595,participants,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71596,in,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71597,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71598,third,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71599,tertile,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71600,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71601,T3,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71602,),O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71603,had,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71604,a,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71605,lower,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71606,prevalence,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71607,of,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71608,low,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71609,BMD,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71610,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71611,prevalence,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71612,ratio,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71613,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71614,PR)=0·52,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71615,;,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71616,95,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71617,%,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71618,CI,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71619,0·33,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71620,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71621,0·83,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71622,),O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71623,after,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71624,adjusting,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71625,for,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71626,socio,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71627,-,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71628,demographic,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71629,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71630,lifestyle,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71631,and,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71632,behavioural,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71633,characteristics,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71634,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71635,chronic,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71636,conditions,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71637,and,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71638,energy,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71639,intake,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71640,.,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71733,Twenty,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71734,-,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71735,four,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71736,mid,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71737,-,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71738,lactating,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71739,Sarda,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71740,dairy,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71741,ewes,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71742,were,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71743,allotted,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71744,to,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71745,3,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71746,homogeneous,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71747,experimental,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71748,groups,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71749,(,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71750,8,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71751,animals,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71752,per,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71753,group,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71754,divided,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71755,into,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71756,4,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71757,pens,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71758,),O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71759,.,O,2494.0,Twenty - four mid - lactating Sarda dairy ewes were allotted to 3 homogeneous experimental groups ( 8 animals per group divided into 4 pens ) .
71843,The,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71844,study,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71845,lasted,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71846,8,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71847,wk,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71848,",",O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71849,with,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71850,3,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71851,wk,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71852,of,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71853,adaptation,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71854,and,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71855,5,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71856,wk,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71857,for,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71858,the,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71859,experimental,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71860,period,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71861,.,O,2499.0,"The study lasted 8 wk , with 3 wk of adaptation and 5 wk for the experimental period ."
71971,In,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71972,conclusion,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71973,",",O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71974,CH,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71975,can,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71976,be,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71977,substituted,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71978,for,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71979,soybean,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71980,hulls,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71981,in,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71982,the,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71983,diet,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71984,of,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71985,dairy,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71986,sheep,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71987,without,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71988,adverse,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71989,effects,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71990,on,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71991,milk,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71992,production,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71993,or,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71994,apparent,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71995,negative,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71996,effects,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71997,on,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71998,animal,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71999,health,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
72000,conditions,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
72001,.,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
72049,Aqueous,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72050,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72051,methanol,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72052,extracts,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72053,of,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72054,dry,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72055,sage,B-http://purl.bioontology.org/ontology/SNOMEDCT/227411006,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72056,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72057,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72058,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72059,basil,B-http://purl.bioontology.org/ontology/SNOMEDCT/735106000,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72060,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72061,parsley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735048005,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72062,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72063,chili,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72064,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72065,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72066,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72067,onion,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72068,were,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72069,analyzed,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72070,to,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72071,investigate,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72072,their,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72073,anti,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72074,-,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72075,oxidant,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72076,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72077,anti,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72078,-,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72079,glycant,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72080,activities,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72081,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72082,in,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72083,vitro,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72084,inhibitory,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72085,potential,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72086,against,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72087,enzymes,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72088,involved,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72089,in,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72090,glycemic,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72091,regulation,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72092,.,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72238,We,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72239,investigated,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72240,associations,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72241,between,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72242,dietary,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72243,patterns,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72244,and,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72245,QoL,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72246,changes,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72247,in,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72248,colorectal,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72249,cancer,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72250,(,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72251,CRC,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72252,),O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72253,patients,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72254,.,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72255,The,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72256,study,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72257,included,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72258,192,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72259,CRC,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72260,patients,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72261,with,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72262,available,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72263,EORTC,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72264,QLQ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72265,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72266,C30,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72267,data,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72268,before,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72269,and,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72270,12,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72271, ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72272,months,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72273,post,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72274,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72275,surgery,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72276,and,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72277,food,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72278,frequency,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72279,questionnaire,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72280,data,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72281,at,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72282,12,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72283, ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72284,months,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72285,post,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72286,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72287,surgery,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72288,.,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
73023,Within,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73024,a,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73025,sample,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73026,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73027,obese,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73028,adults,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73029,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73030,consumption,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73031,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73032,dairy,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73033,products,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73034,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73035,dairy,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73036,protein,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73037,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73038,and,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73039,calcium,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73040,was,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73041,associated,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73042,with,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73043,more,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73044,favourable,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73045,body,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73046,composition,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73047,.,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73772,The,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73773,insulin,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73774,rise,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73775,was,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73776,statistically,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73777,significantly,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73778,greater,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73779,than,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73780,would,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73781,be,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73782,predicted,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73783,from,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73784,the,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73785,glucose,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73786,response,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73787,for,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73788,oatmeal,B-http://purl.bioontology.org/ontology/SNOMEDCT/226725004,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73789,",",O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73790,lentils,B-http://purl.bioontology.org/ontology/SNOMEDCT/227350006,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73791,",",O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73792,kidney,B-http://purl.bioontology.org/ontology/SNOMEDCT/227362005,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73793,beans,I-http://purl.bioontology.org/ontology/SNOMEDCT/227362005,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73794,",",O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73795,and,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73796,high,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73797,-,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73798,amylose,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73799,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73800,muffins,I-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73801,.,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
74221,Poor,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74222,dietary,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74223,behaviors,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74224,in,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74225,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74226,periconceptional,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74227,period,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74228,could,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74229,be,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74230,altered,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74231,to,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74232,promote,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74233,behavior,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74234,change,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74235,in,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74236,dietary,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74237,intake,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74238,to,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74239,improve,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74240,perinatal,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74241,outcomes,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74242,and,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74243,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74244,long,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74245,-,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74246,term,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74247,health,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74248,of,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74249,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74250,child,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74251,.,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74445,Of,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74446,326,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74447,atopic,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74448,children,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74449,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74450,10,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74451,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74452,3,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74453,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74454,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74455,presented,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74456,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74457,skin,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74458,test,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74459,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74460,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74461,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74462,but,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74463,only,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74464,five,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74465,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74466,1.5,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74467,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74468,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74469,also,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74470,had,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74471,a,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74472,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74473,clinical,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74474,history,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74475,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74476,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74477,exposure,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74478,.,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74560,Associated,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74561,fruit,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74562,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74563,specific,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74564,IgE,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74565,(,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74566,SPT,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74567,and/or,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74568,RAST,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74569,),O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74570,were,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74571,found,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74572,in,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74573,all,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74574,latex,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74575,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74576,symptomatic,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74577,children,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74578,and,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74579,in,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74580,2/5,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74581,latex,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74582,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74583,asymptomatic,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74584,children,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74585,.,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74601,Only,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74602,one,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74603,patient,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74604,with,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74605,clinical,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74606,allergy,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74607,to,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74608,latex,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74609,and,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74610,positive,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74611,skin,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74612,tests,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74613,to,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74614,fruits,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74615,had,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74616,a,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74617,history,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74618,of,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74619,clinical,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74620,symptoms,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74621,after,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74622,ingestion,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74623,of,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74624,kiwi,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74625,and,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74626,orange,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74627,.,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74827,This,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74828,paper,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74829,presents,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74830,estimates,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74831,of,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74832,folic,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74833,acid,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74834,intake,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74835,in,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74836,the,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74837,target,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74838,population,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74839,and,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74840,other,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74841,subgroups,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74842,of,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74843,the,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74844,Australian,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74845,population,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74846,following,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74847,implementation,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74848,of,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74849,the,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74850,mandatory,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74851,folic,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74852,acid,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74853,fortification,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74854,standard,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74855,.,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
75062,The,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75063,MRP,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75064,were,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75065,obtained,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75066,from,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75067,milk,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75068,protein,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75069,",",O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75070,whey,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75071,protein,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75072,concentrates,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75073,and,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75074,sodium,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75075,caseinate,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75076,",",O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75077,using,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75078,2,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75079,types,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75080,of,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75081,sugars,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75082,",",O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75083,lactose,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75084,and,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75085,glucose,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75086,",",O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75087,by,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75088,heating,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75089,the,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75090,mixture,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75091,at,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75092,55,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75093,°,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75094,C,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75095,for,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75096,7d,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75097,in,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75098,a,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75099,sodium,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75100,phosphate,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75101,buffer,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75102,(,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75103,pH,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75104,7.4,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75105,),O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75106,.,O,2609.0,"The MRP were obtained from milk protein , whey protein concentrates and sodium caseinate , using 2 types of sugars , lactose and glucose , by heating the mixture at 55 ° C for 7d in a sodium phosphate buffer ( pH 7.4 ) ."
75206,As,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75207,a,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75208,result,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75209,",",O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75210,modification,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75211,and,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75212,their,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75213,localization,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75214,in,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75215,AA,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75216,sequence,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75217,of,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75218,MRP,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75219,was,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75220,identified,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75221,.,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75258,In,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75259,particular,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75260,",",O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75261,glucose,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75262,-,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75263,sodium,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75264,caseinate,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75265,MRP,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75266,showed,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75267,the,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75268,highest,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75269,biological,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75270,activities,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75271,among,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75272,all,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75273,MRP,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75274,.,O,2616.0,"In particular , glucose - sodium caseinate MRP showed the highest biological activities among all MRP ."
75488,The,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75489,laboratory,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75490,work,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75491,-,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75492,up,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75493,disclosed,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75494,metabolic,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75495,alkalosis,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75496,",",O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75497,hypokalemia,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75498,",",O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75499,hypochloremia,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75500,",",O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75501,and,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75502,a,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75503,reduced,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75504,urinary,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75505,chloride,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75506,excretion,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75507,.,O,2624.0,"The laboratory work - up disclosed metabolic alkalosis , hypokalemia , hypochloremia , and a reduced urinary chloride excretion ."
75763,Nevertheless,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75764,",",O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75765,we,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75766,suggest,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75767,dietary,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75768,guidelines,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75769,for,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75770,prevention,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75771,of,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75772,CHD,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75773,in,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75774,Spain,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75775,.,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75975,This,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75976,diet,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75977,is,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75978,low,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75979,in,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75980,saturated,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75981,fat,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75982,(,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75983,<,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75984,or,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75985,=,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75986,7,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75987,-,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75988,8,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75989,%,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75990,of,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75991,energy,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75992,),O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75993,",",O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75994,with,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75995,total,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75996,fat,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75997,ranging,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75998,from,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
75999,<,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76000,25,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76001,%,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76002,to,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76003,>,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76004,35,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76005,%,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76006,of,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76007,energy,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76008,throughout,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76009,the,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76010,region,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76011,.,O,2640.0,"This diet is low in saturated fat ( < or = 7 - 8 % of energy ) , with total fat ranging from < 25 % to > 35 % of energy throughout the region ."
76554,Studies,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76555,investigating,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76556,the,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76557,relation,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76558,of,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76559,diet,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76560,to,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76561,breast,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76562,cancer,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76563,have,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76564,produced,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76565,conflicting,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76566,results,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76567,.,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76624,By,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76625,December,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76626,31,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76627,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76628,2001,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76629,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76630,238,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76631,cases,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76632,had,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76633,occurred,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76634,in,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76635,which,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76636,HER-2,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76637,status,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76638,was,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76639,known,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76640,.,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
77329,Consumption,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77330,of,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77331,such,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77332,contaminated,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77333,water,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77334,",",O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77335,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77336,",",O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77337,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000;http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77338,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000;http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77339,poultry,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000;http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77340,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000;http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77341,results,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77342,in,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77343,reproductive,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77344,disorders,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77345,such,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77346,as,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77347,fertility,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77348,loss,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77349,in,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77350,men,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77351,and,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77352,increase,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77353,risk,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77354,of,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77355,different,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77356,types,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77357,of,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77358,cancers,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77359,in,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77360,humans,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77361,.,O,2685.0,"Consumption of such contaminated water , milk , meat and poultry products results in reproductive disorders such as fertility loss in men and increase risk of different types of cancers in humans ."
77362,Therefore,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77363,",",O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77364,assessment,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77365,of,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77366,impact,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77367,of,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77368,environmental,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77369,contamination,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77370,by,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77371,these,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77372,drugs,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77373,on,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77374,living,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77375,system,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77376,is,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77377,of,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77378,paramount,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77379,importance,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77380,.,O,2686.0,"Therefore , assessment of impact of environmental contamination by these drugs on living system is of paramount importance ."
77437,In,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77438,an,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77439,international,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77440,comparison,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77441,of,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77442,recent,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77443,mortality,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77444,statistics,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77445,among,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77446,G7,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77447,countries,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77448,",",O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77449,Japan,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77450,had,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77451,the,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77452,longest,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77453,average,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77454,life,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77455,expectancy,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77456,",",O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77457,primarily,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77458,due,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77459,to,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77460,remarkably,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77461,low,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77462,mortality,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77463,rates,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77464,from,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77465,ischemic,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77466,heart,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77467,disease,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77468,and,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77469,cancer,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77470,(,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77471,particularly,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77472,breast,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77473,and,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77474,prostate,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77475,),O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77476,.,O,2689.0,"In an international comparison of recent mortality statistics among G7 countries , Japan had the longest average life expectancy , primarily due to remarkably low mortality rates from ischemic heart disease and cancer ( particularly breast and prostate ) ."
77964,These,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77965,data,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77966,did,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77967,not,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77968,show,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77969,a,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77970,significant,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77971,association,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77972,between,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77973,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77974,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77975,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77976,consumption,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77977,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77978,EC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77979,",",O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77980,EAC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77981,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77982,ESCC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77983,",",O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77984,although,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77985,a,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77986,decreased,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77987,risk,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77988,of,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77989,ESCC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77990,among,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77991,men,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77992,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77993,current,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77994,smokers,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77995,is,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77996,suggested,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77997,",",O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77998,but,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77999,need,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78000,to,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78001,be,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78002,confirmed,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78003,in,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78004,further,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78005,prospective,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78006,studies,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78007,including,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78008,more,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78009,cases,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78010,.,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78011,Ovarian,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78012,cancer,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78013,is,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78014,commonly,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78015,a,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78016,fatal,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78017,disease,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78018,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78019,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78020,despite,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78021,advances,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78022,in,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78023,screening,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78024,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78025,treatment,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78026,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78027,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78028,lack,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78029,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78030,understanding,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78031,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78032,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78033,underlying,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78034,etiology,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78035,has,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78036,limited,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78037,prevention,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78038,strategies,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78039,.,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78480,The,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78481,present,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78482,study,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78483,is,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78484,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78485,first,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78486,to,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78487,show,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78488,a,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78489,negative,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78490,association,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78491,between,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78492,risk,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78493,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78494,TNBC,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78495,and,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78496,a,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78497,healthy,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78498,dietary,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78499,pattern,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78500,in,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78501,women,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78502,with,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78503,dense,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78504,breasts,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78505,and,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78506,suggests,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78507,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78508,importance,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78509,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78510,diet,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78511,in,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78512,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78513,prevention,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78514,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78515,TNBC,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78516,.,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78670,Among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78671,men,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78672,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78673,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78674,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78675,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78676,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78677,month,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78678,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78679,six,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78680,cups,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78681,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78682,week,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78683,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78684,among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78685,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78686,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78687,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78688,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78689,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78690,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78691,d,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78692,or,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78693,more,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78694,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78695,the,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78696,associated,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78697,hazard,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78698,ratios,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78699,were,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78700,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78701,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78702,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78703,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78704,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78705,0.50,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78706,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78707,0.97,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78708,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78709,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78710,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78711,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78712,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78713,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78714,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78715,0.49,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78716,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78717,0.98,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78718,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78719,compared,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78720,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78721,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78722,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78723,drank,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78724,little,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78725,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78726,no,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78727,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78728,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78729,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78730,a,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78731,P,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78732,value,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78733,for,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78734,trend,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78735,of,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78736,0.32,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78737,.,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
79868,The,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79869,intake,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79870,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79871,400,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79872,-,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79873,600,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79874,g,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79875,/,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79876,d,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79877,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79878,fruits,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79879,and,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79880,vegetables,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79881,is,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79882,associated,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79883,with,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79884,reduced,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79885,incidence,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79886,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79887,many,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79888,common,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79889,forms,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79890,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79891,cancer,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79892,.,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79930,Red,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79931,foods,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79932,contain,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79933,lycopene,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79934,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79935,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79936,pigment,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79937,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79938,tomatoes,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79939,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79940,which,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79941,is,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79942,localized,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79943,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79944,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79945,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79946,gland,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79947,and,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79948,may,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79949,be,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79950,involved,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79951,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79952,maintaining,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79953,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79954,health,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79955,.,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
80792,The,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80793,prevailing,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80794,view,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80795,holds,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80796,that,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80797,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80798,integrity,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80799,of,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80800,plant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80801,cell,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80802,wall,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80803,structure,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80804,is,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80805,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80806,primary,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80807,determinant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80808,of,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80809,energy,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80810,and,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80811,nutrient,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80812,extraction,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80813,from,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80814,plant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80815,cells,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80816,as,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80817,they,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80818,pass,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80819,through,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80820,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80821,gastrointestinal,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80822,(,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80823,GI,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80824,),O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80825,tract,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80826,.,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
81001,Furthermore,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81002,",",O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81003,the,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81004,cell,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81005,walls,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81006,of,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81007,walnuts,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81008,tend,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81009,to,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81010,rupture,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81011,rather,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81012,than,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81013,separate,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81014,and,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81015,as,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81016,walnut,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81017,tissue,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81018,passes,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81019,through,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81020,the,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81021,GI,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81022,tract,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81023,",",O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81024,lipids,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81025,tend,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81026,to,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81027,coalesce,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81028,reducing,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81029,digestion,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81030,efficiency,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81031,.,O,2806.0,"Furthermore , the cell walls of walnuts tend to rupture rather than separate and as walnut tissue passes through the GI tract , lipids tend to coalesce reducing digestion efficiency ."
81083,However,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81084,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81085,mechanisms,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81086,including,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81087,low,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81088,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81089,density,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81090,lipoproteins,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81091,oxidation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81092,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81093,inhibition,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81094,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81095,platelet,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81096,aggregation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81097,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81098,modification,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81099,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81100,eicosanoid,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81101,metabolism,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81102,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81103,and,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81104,endothelium,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81105,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81106,dependent,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81107,relaxation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81108,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81109,blood,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81110,vessels,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81111,are,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81112,recognized,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81113,as,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81114,contributory,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81115,.,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81966,A,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81967,vegetarian,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81968,diet,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81969,is,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81970,defined,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81971,as,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81972,one,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81973,that,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81974,does,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81975,not,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81976,include,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81977,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81978,(,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81979,including,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81980,fowl,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81981,),O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81982,or,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81983,seafood,B-http://purl.bioontology.org/ontology/SNOMEDCT/44027008,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81984,",",O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81985,or,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81986,products,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81987,containing,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81988,those,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81989,foods,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81990,.,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81991,This,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81992,article,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81993,reviews,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81994,the,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81995,current,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81996,data,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81997,related,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81998,to,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81999,key,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82000,nutrients,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82001,for,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82002,vegetarians,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82003,including,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82004,protein,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82005,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82006,n-3,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82007,fatty,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82008,acids,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82009,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82010,iron,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82011,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82012,zinc,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82013,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82014,iodine,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82015,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82016,calcium,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82017,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82018,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82019,vitamins,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82020,D,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82021,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82022,B-12,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82023,.,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82205,In,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82206,addition,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82207,to,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82208,assessing,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82209,dietary,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82210,adequacy,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82211,",",O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82212,food,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82213,and,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82214,nutrition,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82215,professionals,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82216,can,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82217,also,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82218,play,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82219,key,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82220,roles,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82221,in,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82222,educating,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82223,vegetarians,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82224,about,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82225,sources,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82226,of,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82227,specific,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82228,nutrients,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82229,",",O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82230,food,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82231,purchase,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82232,and,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82233,preparation,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82234,",",O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82235,and,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82236,dietary,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82237,modifications,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82238,to,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82239,meet,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82240,their,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82241,needs,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82242,.,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82344,Quantification,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82345,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82346,the,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82347,intracellular,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82348,proton,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82349,concentration,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82350,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82351,human,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82352,gastric,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82353,tumor,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82354,cells,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82355,(,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82356,HGT-1,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82357,),O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82358,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82359,a,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82360,well,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82361,-,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82362,established,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82363,indicator,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82364,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82365,proton,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82366,secretion,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82367,and,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82368,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82369,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82370,turn,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82371,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82372,stomach,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82373,acid,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82374,formation,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82375,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82376,vivo,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82377,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82378,confirmed,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82379,the,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82380,stronger,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82381,effect,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82382,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82383,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82384,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82385,as,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82386,compared,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82387,to,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82388,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82389,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82390,.,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82926,Test,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82927,meals,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82928,(,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82929,100,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82930,micrograms,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82931,Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82932,),O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82933,labeled,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82934,with,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82935,59Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82936,were,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82937,fed,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82938,after,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82939,5,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82940,d,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82941,and,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82942,59Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82943,absorption,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82944,determined,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82945,by,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82946,whole,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82947,-,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82948,body,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82949,counting,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82950,.,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82969,Nonheme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82970,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82971,was,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82972,better,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82973,absorbed,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82974,than,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82975,heme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82976,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82977,regardless,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82978,of,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82979,other,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82980,dietary,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82981,factors,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82982,.,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
83092,The,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83093,monitoring,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83094,of,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83095,heavy,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83096,metals,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83097,in,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83098,industrialized,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83099,areas,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83100,to,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83101,study,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83102,their,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83103,association,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83104,with,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83105,different,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83106,occupational,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83107,and,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83108,environmental,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83109,factors,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83110,is,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83111,carried,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83112,out,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83113,in,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83114,different,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83115,ways,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83116,.,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83521,Ethyl,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83522,acetate,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83523,extract,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83524,showed,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83525,higher,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83526,activity,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83527,compared,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83528,with,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83529,other,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83530,extracts,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83531,.,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
84088,The,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84089,diet,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84090,of,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84091,young,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84092,children,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84093,is,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84094,an,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84095,important,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84096,determinant,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84097,of,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84098,long,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84099,-,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84100,term,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84101,health,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84102,effects,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84103,",",O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84104,such,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84105,as,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84106,overweight,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84107,and,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84108,obesity,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84109,.,O,2915.0,"The diet of young children is an important determinant of long - term health effects , such as overweight and obesity ."
84415,Intervention,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84416,periods,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84417,were,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84418,preceded,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84419,by,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84420,2,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84421,-,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84422,week,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84423,depletion,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84424,phases,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84425,.,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
85012,These,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85013,changes,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85014,have,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85015,occurred,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85016,along,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85017,with,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85018,dietary,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85019,shifts,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85020,in,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85021,the,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85022,population,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85023,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85024,from,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85025,a,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85026,diet,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85027,predominantly,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85028,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85029,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85030,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85031,small,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85032,portions,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85033,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85034,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85035,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85036,vegetables,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85037,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85038,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85039,fish,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85040,to,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85041,one,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85042,with,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85043,larger,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85044,portions,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85045,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85046,all,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85047,foods,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85048,but,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85049,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85050,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85051,eggs,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85052,.,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85693,Subsequent,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85694,16th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85695,to,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85696,early,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85697,20th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85698,century,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85699,manuscripts,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85700,produced,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85701,in,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85702,Europe,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85703,and,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85704,New,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85705,Spain,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85706,revealed,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85707,>,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85708,100,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85709,medicinal,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85710,uses,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85711,for,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85712,cacao,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85713,/,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85714,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85715,.,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85873,The,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85874,Mushroom,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85875,Council,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85876,convened,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85877,the,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85878,Mushrooms,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85879,and,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85880,Health,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85881,Summit,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85882,in,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85883,Washington,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85884,",",O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85885,DC,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85886,",",O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85887,on,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85888,9,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85889,-,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85890,10,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85891,September,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85892,2013,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85893,.,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
86111,Also,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86112,",",O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86113,early,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86114,sensory,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86115,research,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86116,suggests,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86117,that,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86118,mushrooms,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86119,blended,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86120,with,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86121,meats,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86122,and,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86123,lower,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86124,sodium,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86125,dishes,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86126,are,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86127,well,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86128,liked,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86129,and,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86130,may,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86131,help,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86132,to,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86133,reduce,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86134,intakes,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86135,of,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86136,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86137,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86138,and,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86139,salt,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86140,without,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86141,compromising,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86142,taste,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86143,.,O,2983.0,"Also , early sensory research suggests that mushrooms blended with meats and lower sodium dishes are well liked and may help to reduce intakes of red meat and salt without compromising taste ."
86386,The,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86387,glucose,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86388,response,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86389,was,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86390,diminished,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86391,following,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86392,ingestion,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86393,of,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86394,the,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86395,meals,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86396,containing,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86397,protein,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86398,with,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86399,the,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86400,exception,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86401,of,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86402,the,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86403,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86404,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86405,meals,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
86406,.,O,2992.0,The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals .
87362,Fatty,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87363,acid,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87364,concentrations,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87365,were,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87366,similar,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87367,to,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87368,those,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87369,found,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87370,for,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87371,the,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87372,other,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87373,meals,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87374,.,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87558,Relative,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87559,to,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87560,baseline,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87561,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87562,the,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87563,proportion,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87564,of,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87565,calories,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87566,from,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87567,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87568,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87569,soup,B-http://purl.bioontology.org/ontology/SNOMEDCT/227566009,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87570,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87571,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87572,ONS,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87573,significantly,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87574,increased,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87575,at,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87576,post,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87577,-,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87578,treatment,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87579,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87580,while,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87581,grain,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87582,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87583,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87584,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87585,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87586,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87587,baked,B-http://purl.bioontology.org/ontology/SNOMEDCT/227682004,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87588,dessert,I-http://purl.bioontology.org/ontology/SNOMEDCT/227682004,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87589,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87590,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87591,oil,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87592,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87593,sugar,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87594,decreased,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87595,(,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87596,P,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87597,<,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87598,0.03,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87599,),O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87600,.,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
88308,In,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88309,this,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88310,study,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88311,the,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88312,dietary,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88313,intakes,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88314,of,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88315,young,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88316,pregnant,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88317,women,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88318,attending,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88319,a,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88320,Maternal,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88321,and,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88322,Infant,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88323,Care,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88324,Program,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88325,at,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88326,Tuskegee,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88327,Institute,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88328,were,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88329,evaluated,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88330,for,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88331,selected,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88332,vitamins,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88333,and,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88334,minerals,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88335,.,O,3059.0,In this study the dietary intakes of young pregnant women attending a Maternal and Infant Care Program at Tuskegee Institute were evaluated for selected vitamins and minerals .
88350,The,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88351,toxemia,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88352,group,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88353,generally,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88354,consumed,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88355,lesser,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88356,amounts,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88357,of,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88358,vitamins,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88359,and,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88360,minerals,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88361,than,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88362,the,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88363,controls,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88364,.,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88495,Acetate,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88496,might,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88497,also,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88498,have,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88499,an,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88500,effect,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88501,on,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88502,protein,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88503,synthesis,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88504,via,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88505,the,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88506,AMP,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88507,-,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88508,activated,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88509,kinase,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88510,signaling,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88511,pathway,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88512,",",O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88513,because,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88514,it,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88515,is,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88516,the,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88517,main,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88518,energy,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88519,source,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88520,for,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88521,the,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88522,mammary,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88523,secretory,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88524,cell,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88525,.,O,3068.0,"Acetate might also have an effect on protein synthesis via the AMP - activated kinase signaling pathway , because it is the main energy source for the mammary secretory cell ."
88644,Treatments,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88645,were,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88646,acetate,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88647,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88648,A,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88649,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88650,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88651,glucose,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88652,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88653,G,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88654,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88655,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88656,each,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88657,at,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88658,5,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88659,%,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88660,of,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88661,ad,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88662,libitum,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88663,ME,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88664,intake,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88665,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88666,casein,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88667,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88668,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88669,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88670,at,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88671,15,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88672,%,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88673,of,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88674,ad,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88675,libitum,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88676,MP,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88677,intake,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88678,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88679,A,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88680,+,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88681,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88682,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88683,G,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88684,+,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88685,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88686,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88687,or,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88688,a,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88689,saline,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88690,solution,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88691,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88692,negative,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88693,control,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88694,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88695,.,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88783,Infusion,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88784,of,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88785,casein,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88786,and,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88787,glucose,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88788,together,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88789,further,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88790,increased,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88791,milk,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88792,protein,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88793,yield,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88794,in,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88795,an,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88796,additive,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88797,fashion,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88798,",",O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88799,and,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88800,47,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88801,%,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88802,of,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88803,the,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88804,infused,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88805,casein,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88806,was,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88807,recovered,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88808,in,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88809,milk,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88810,protein,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88811,.,O,3076.0,"Infusion of casein and glucose together further increased milk protein yield in an additive fashion , and 47 % of the infused casein was recovered in milk protein ."
88812,Acetate,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88813,infused,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88814,alone,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88815,had,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88816,no,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88817,effect,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88818,on,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88819,milk,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88820,protein,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88821,yield,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88822,but,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88823,increased,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88824,milk,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88825,fat,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88826,yield,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88827,numerically,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88828,",",O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88829,suggesting,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88830,that,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88831,the,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88832,greater,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88833,amount,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88834,of,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88835,acetate,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88836,taken,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88837,up,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88838,by,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88839,the,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88840,mammary,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88841,gland,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88842,was,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88843,used,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88844,for,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88845,milk,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88846,fat,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88847,synthesis,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88848,.,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
89996,Bitterness,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89997,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89998,however,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89999,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90000,is,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90001,an,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90002,integral,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90003,part,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90004,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90005,the,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90006,complex,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90007,flavor,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90008,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90009,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90010,.,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90160,Untrained,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90161,chocolate,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90162,ice,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90163,cream,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90164,consumers,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90165,participated,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90166,in,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90167,a,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90168,large,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90169,-,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90170,scale,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90171,sensory,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90172,test,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90173,by,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90174,indicating,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90175,their,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90176,preferences,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90177,for,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90178,blinded,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90179,pairs,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90180,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90181,unspiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90182,and,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90183,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90184,samples,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90185,",",O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90186,where,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90187,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90188,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90189,sample,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90190,had,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90191,increasing,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90192,levels,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90193,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90194,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90195,added,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90196,bitterant,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90197,.,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90391,Based,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90392,on,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90393,available,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90394,data,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90395,",",O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90396,it,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90397,appears,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90398,that,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90399,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90400,",",O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90401,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90402,",",O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90403,and,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90404,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90405,are,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90406,inversely,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90407,associated,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90408,with,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90409,cardiovascular,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90410,disease,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90411,risk,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90412,.,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90546,The,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90547,samples,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90548,were,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90549,prepared,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90550,using,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90551,3,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90552,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90553,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90554,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90555,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90556,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90557,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90558,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90559,starch,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90560,",",O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90561,with,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90562,10,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90563,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90564,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90565,30,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90566,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90567,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90568,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90569,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90570,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90571,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90572,sugar,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90573,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90574,trehalose,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90575,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90576,allose,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90577,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90578,added,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90579,and,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90580,10,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90581,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90582,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90583,30,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90584,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90585,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90586,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90587,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90588,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90589,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90590,oil,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90591,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90592,canola,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90593,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90594,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90595,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90596,.,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90597,The,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90598,droplet,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90599,size,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90600,of,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90601,the,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90602,film,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90603,suspension,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90604,increased,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90605,with,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90606,increasing,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90607,oil,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90608,concentration,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90609,both,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90610,in,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90611,trehalose,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90612,and,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90613,allose,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90614,",",O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90615,which,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90616,blended,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90617,with,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90618,oil,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90619,.,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
91572,Low,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91573,energy,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91574,reporters,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91575,had,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91576,a,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91577,healthier,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91578,diet,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91579,than,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91580,the,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91581,rest,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91582,with,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91583,the,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91584,weighed,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91585,record,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91586,.,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91621,Intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91622,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91623,vitamin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91624,C,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91625,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91626,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91627,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91628,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91629,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91630,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91631,folate,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91632,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91633,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91634,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91635,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91636,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91637,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91638,riboflavin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91639,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91640,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91641,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91642,0.03,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91643,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91644,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91645,thiamine,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91646,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91647,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91648,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91649,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91650,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91651,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91652,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91653,magnesium,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91654,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91655,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91656,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91657,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91658,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91659,per,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91660,megajoule,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91661,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91662,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91663,quartile,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91664,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91665,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91666,fat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91667,intake,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91668,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91669,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91670,a,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91671,%,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91672,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91673,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91674,energy,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91675,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91676,decreased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91677,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91678,reflecting,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91679,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91680,intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91681,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91682,cereals,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91683,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91684,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91685,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91686,0.002,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91687,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91688,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91689,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91690,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91691,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91692,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91693,0.01,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91694,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91695,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91696,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91697,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91698,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91699,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91700,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91701,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91702,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91703,pure,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91704,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91705,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91706,not,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91707,minced,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91708,or,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91709,meat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91710,products,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91711,;,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91712,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91713,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91714,0.047,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91715,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91716,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91717,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91718,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91719,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91720,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91721,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91722,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91723,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91724,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91725,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91726,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91727,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91728,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91729,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91730,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91731,0.005,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91732,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91733,.,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91950,Further,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91951,indicators,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91952,of,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91953,inflammation,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91954,were,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91955,recently,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91956,investigated,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91957,either,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91958,to,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91959,satisfy,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91960,the,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91961,high,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91962,specificity,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91963,necessary,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91964,for,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91965,automatic,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91966,separation,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91967,of,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91968,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91969,or,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91970,to,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91971,create,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91972,reliable,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91973,alarm,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91974,lists,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91975,.,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
92142,In,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92143,Traditional,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92144,Persian,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92145,Medicine,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92146,(,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92147,TPM,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92148,),O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92149,there,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92150,is,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92151,a,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92152,major,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92153,focus,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92154,on,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92155,contribution,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92156,of,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92157,special,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92158,diet,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92159,and,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92160,foods,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92161,to,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92162,cancer,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92163,management,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92164,.,O,3195.0,In Traditional Persian Medicine ( TPM ) there is a major focus on contribution of special diet and foods to cancer management .
92618,While,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92619,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92620,evidence,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92621,suggests,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92622,that,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92623,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92624,consumption,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92625,is,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92626,beneficial,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92627,for,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92628,obese,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92629,individuals,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92630,",",O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92631,randomized,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92632,-,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92633,controlled,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92634,trials,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92635,are,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92636,needed,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92637,to,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92638,further,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92639,support,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92640,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92641,hypothesis,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92642,.,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92720,Accumulating,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92721,evidence,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92722,shows,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92723,that,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92724,consuming,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92725,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92726,or,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92727,dairy,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92728,products,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92729,may,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92730,contribute,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92731,to,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92732,the,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92733,risk,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92734,of,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92735,prostate,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92736,and,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92737,ovarian,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92738,cancers,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92739,",",O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92740,autoimmune,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92741,diseases,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92742,",",O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92743,and,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92744,some,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92745,childhood,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92746,ailments,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92747,.,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
93766,IgE,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93767,reactivity,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93768,for,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93769,raw,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93770,carrot,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93771,immunoblot,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93772,was,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93773,completely,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93774,inhibited,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93775,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93776,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93777,and,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93778,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93779,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93780,",",O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93781,but,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93782,not,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93783,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93784,olive,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93785,or,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93786,grass,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93787,pollens,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93788,.,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
94244,Removal,O,3271.0,Removal of cholesterol from the diet halted this progression .
94245,of,O,3271.0,Removal of cholesterol from the diet halted this progression .
94246,cholesterol,O,3271.0,Removal of cholesterol from the diet halted this progression .
94247,from,O,3271.0,Removal of cholesterol from the diet halted this progression .
94248,the,O,3271.0,Removal of cholesterol from the diet halted this progression .
94249,diet,O,3271.0,Removal of cholesterol from the diet halted this progression .
94250,halted,O,3271.0,Removal of cholesterol from the diet halted this progression .
94251,this,O,3271.0,Removal of cholesterol from the diet halted this progression .
94252,progression,O,3271.0,Removal of cholesterol from the diet halted this progression .
94253,.,O,3271.0,Removal of cholesterol from the diet halted this progression .
94661,In,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94662,both,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94663,groups,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94664,",",O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94665,patients,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94666,measured,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94667,their,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94668,plasma,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94669,TG,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94670,before,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94671,and,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94672,3,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94673,hours,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94674,after,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94675,each,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94676,meal,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94677,by,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94678,Accutrend,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94679,GCT,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94680,(,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94681,ROCHE,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94682,",",O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94683,Mannheim,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94684,",",O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94685,Germany,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94686,),O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94687,.,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95868,Since,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95869,avoidance,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95870,of,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95871,dietary,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95872,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95873,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95874,the,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95875,only,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95876,option,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95877,for,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95878,celiac,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95879,patients,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95880,",",O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95881,a,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95882,sensitive,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95883,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95884,detection,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95885,and,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95886,quantitation,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95887,method,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95888,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95889,warranted,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95890,.,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
96008,ELISA,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96009,results,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96010,showed,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96011,considerable,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96012,variation,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96013,in,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96014,gluten,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96015,recoveries,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96016,from,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96017,both,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96018,intact,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96019,and,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96020,PT,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96021,-,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96022,digested,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96023,gluten,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96024,fractions,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96025,among,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96026,different,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96027,kits,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96028,.,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96225,Uranium,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96226,maximum,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96227,average,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96228,concentration,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96229,in,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96230,the,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96231,edible,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96232,vegetables,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96233,parts,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96234,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96235,mg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96236,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96237,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96238,fresh,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96239,weight,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96240,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96241,ranged,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96242,in,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96243,the,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96244,following,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96245,order,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96246,:,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96247,lettuce,B-http://purl.bioontology.org/ontology/SNOMEDCT/735042006,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96248,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96249,234,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96250,microg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96251,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96252,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96253,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96254,>,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96255,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/256318007;http://purl.bioontology.org/ontology/SNOMEDCT/256354006,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96256,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256318007;http://purl.bioontology.org/ontology/SNOMEDCT/256354006,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96257,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96258,30,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96259,microg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96260,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96261,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96262,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96263,>,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96264,potatoes,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96265,without,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96266,peel,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96267,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96268,4,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96269,microg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96270,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96271,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96272,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96273,.,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96399,Conversely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96400,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96401,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96402,glucoregulatory,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96403,qualities,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96404,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96405,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96406,proteins,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96407,in,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96408,animal,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96409,-,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96410,based,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96411,foods,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96412,are,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96413,extremely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96414,divergent,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96415,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96416,with,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96417,a,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96418,higher,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96419,intake,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96420,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96421,certain,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96422,animal,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96423,-,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96424,based,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96425,protein,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96426,foods,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96427,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96428,negative,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96429,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96430,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96431,and,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96432,others,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96433,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96434,neutral,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96435,or,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96436,positive,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96437,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96438,on,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96439,type,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96440,2,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96441,diabetes,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96442,risk,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96443,.,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
97038,There,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97039,is,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97040,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97041,lack,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97042,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97043,sufficient,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97044,evidence,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97045,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97046,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97047,protective,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97048,relationship,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97049,between,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97050,FD,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97051,or,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97052,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97053,consumption,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97054,and,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97055,metabolic,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97056,syndrome,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97057,.,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97345,Although,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97346,lectins,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97347,seem,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97348,to,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97349,have,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97350,great,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97351,potential,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97352,as,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97353,anticancer,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97354,agents,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97355,",",O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97356,further,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97357,research,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97358,is,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97359,still,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97360,needed,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97361,and,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97362,should,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97363,include,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97364,a,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97365,genomic,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97366,and,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97367,proteomic,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97368,approach,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97369,.,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97370,Limited,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97371,data,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97372,exist,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97373,regarding,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97374,nutrient,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97375,intakes,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97376,and,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97377,overall,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97378,dietary,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97379,quality,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97380,in,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97381,Canadian,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97382,Arctic,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97383,populations,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97384,.,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97726,Blueberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97727,",",I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97728,strawberry,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97729,",",I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97730,blackberry,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97731,",",I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97732,grape,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97733,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97734,plum,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97735,juices,I-http://purl.bioontology.org/ontology/SNOMEDCT/102261002;http://purl.bioontology.org/ontology/SNOMEDCT/227418000;http://purl.bioontology.org/ontology/SNOMEDCT/735051003,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97736,or,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97737,extracts,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97738,have,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97739,been,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97740,successfully,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97741,tested,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97742,in,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97743,cognitively,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97744,impaired,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97745,rodents,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97746,.,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97771,The,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97772,benefits,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97773,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97774,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97775,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97776,are,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97777,thought,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97778,to,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97779,be,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97780,a,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97781,result,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97782,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97783,its,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97784,polyphenol,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97785,content,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97786,.,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
98185,Women,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98186,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98187,both,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98188,ethnic,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98189,groups,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98190,were,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98191,found,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98192,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98193,avoid,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98194,saturated,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98195,fat,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98196,and,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98197,cholesterol,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98198,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98199,a,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98200,greater,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98201,degree,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98202,than,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98203,men,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98204,",",O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98205,scoring,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98206,higher,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98207,on,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98208,five,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98209,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98210,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98211,six,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98212,components,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98213,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98214,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98215,scale,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98216,.,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98480,In,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98481,contrast,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98482,",",O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98483,consumption,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98484,of,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98485,three,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98486,or,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98487,more,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98488,cups,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98489,of,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98490,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98491,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98492,per,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98493,day,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98494,had,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98495,a,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98496,significant,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98497,positive,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98498,association,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98499,with,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98500,UADT,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98501,cancer,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98502,(,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98503,OR,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98504,1.39,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98505,",",O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98506,95,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98507,%,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98508,CI,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98509,1.13,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98510,-,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98511,1.70,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98512,),O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98513,.,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98693,Breast,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98694,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98695,",",O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98696,infant,B-http://purl.bioontology.org/ontology/SNOMEDCT/412413001,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98697,formula,I-http://purl.bioontology.org/ontology/SNOMEDCT/412413001,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98698,",",O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98699,and,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98700,cow,B-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98701,'s,I-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98702,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98703,were,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98704,the,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98705,top,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98706,sources,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98707,of,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98708,energy,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98709,and,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98710,nutrients,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98711,",",O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98712,especially,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98713,in,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98714,younger,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98715,groups,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98716,.,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98717,Among,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98718,infants,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98719,aged,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98720,6,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98721,-,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98722,11.9,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98723,months,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98724,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98725,the,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98726,top,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98727,food,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98728,sources,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98729,of,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98730,energy,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98731,included,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98732,soups,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98733,and,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98734,stews,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98735,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98736,cookies,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98737,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98738,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98739,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98740,tortillas,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98741,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98742,eggs,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98743,and,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98744,egg,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98745,dishes,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98746,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98747,and,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98748,traditional,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98749,beverages,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98750,.,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98986,Sixteen,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98987,male,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98988,Holstein,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98989,-,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98990,Friesian,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98991,calves,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98992,(,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98993,120±2.8,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98994,kg,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98995,of,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98996,BW,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98997,),O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98998,were,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98999,assigned,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99000,to,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99001,either,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99002,a,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99003,high,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99004,-,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99005,lactose,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99006,(,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99007,HL,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99008,),O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99009,or,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99010,a,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99011,high,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99012,-,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99013,fat,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99014,(,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99015,HF,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99016,),O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99017,MR,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99018,for,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99019,13,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99020,consecutive,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99021,weeks,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99022,.,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99102,Long,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99103,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99104,term,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99105,exposure,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99106,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99107,calves,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99108,to,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99109,HF,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99110,or,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99111,HL,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99112,MR,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99113,did,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99114,not,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99115,affect,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99116,whole,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99117,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99118,body,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99119,insulin,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99120,sensitivity,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99121,(,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99122,averaging,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99123,4.2±0.5×10,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99124,During,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99125,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99126,periparturient,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99127,phase,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99128,",",O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99129,cows,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99130,are,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99131,typically,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99132,in,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99133,an,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99134,inflammation,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99135,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99136,like,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99137,condition,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99138,",",O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99139,and,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99140,it,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99141,has,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99142,been,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99143,suggested,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99144,that,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99145,inflammation,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99146,associated,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99147,with,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99148,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99149,development,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99150,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99151,stress,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99152,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99153,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99154,endoplasmic,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99155,reticulum,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99156,(,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99157,ER,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99158,),O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99159,in,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99160,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99161,liver,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99162,contributes,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99163,to,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99164,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99165,development,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99166,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99167,fatty,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99168,liver,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99169,syndrome,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99170,and,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99171,ketosis,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99172,.,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99213,Two,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99214,groups,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99215,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99216,cows,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99217,received,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99218,either,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99219,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99220,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99221,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99222,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99223,as,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99224,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99225,control,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99226,diet,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99227,or,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99228,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99229,same,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99230,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99231,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99232,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99233,supplemented,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99234,with,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99235,1,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99236,%,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99237,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99238,GSGME,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99239,over,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99240,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99241,period,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99242,from,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99243,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99244,3,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99245,prepartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99246,to,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99247,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99248,9,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99249,postpartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99250,.,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99837,The,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99838,daily,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99839,intake,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99840,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99841,i,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99842,-,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99843,As,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99844,ranged,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99845,from,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99846,0.61,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99847,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99848,0.78,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99849,μg,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99850,kg⁻¹,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99851,body,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99852,weight,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99853,(,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99854,bw,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99855,),O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99856,in,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99857,children,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99858,up,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99859,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99860,5,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99861,y,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99862,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99863,age,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99864,;,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99865,these,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99866,values,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99867,were,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99868,below,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99869,the,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99870,maximum,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99871,value,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99872,established,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99873,by,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99874,the,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99875,EFSA,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99876,Panel,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99877,(,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99878,8.0,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99879,μg,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99880,kg⁻¹,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99881,bw,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99882,per,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99883,day,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99884,),O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99885,",",O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99886,but,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99887,it,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99888,should,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99889,be,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99890,considered,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99891,typical,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99892,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99893,populations,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99894,with,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99895,a,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99896,high,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99897,exposure,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99898,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99899,this,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99900,pollutant,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99901,.,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
100287,This,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100288,study,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100289,aims,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100290,to,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100291,review,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100292,scientific,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100293,evidence,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100294,from,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100295,all,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100296,studies,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100297,",",O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100298,published,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100299,from,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100300,1996,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100301,to,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100302,March,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100303,2010,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100304,that,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100305,examined,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100306,the,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100307,protective,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100308,effects,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100309,of,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100310,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100311,on,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100312,colorectal,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100313,cancer,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100314,and,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100315,other,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100316,types,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100317,of,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100318,cancer,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100319,.,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100465,In,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100466,2011,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100467,",",O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100468,the,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100469,first,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100470,iteration,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100471,of,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100472,our,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100473,allergen,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100474,threshold,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100475,database,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100476,(,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100477,ATDB,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100478,),O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100479,was,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100480,established,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100481,based,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100482,on,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100483,individual,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100484,NOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100485,and,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100486,LOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100487,from,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100488,oral,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100489,food,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100490,challenge,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100491,in,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100492,roughly,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100493,1750,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100494,allergic,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100495,individuals,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100496,.,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100518,Systematic,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100519,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100520,collection,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100521,has,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100522,continued,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100523,(,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100524,2011,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100525,-,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100526,2018,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100527,),O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100528,and,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100529,the,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100530,dataset,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100531,now,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100532,contains,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100533,over,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100534,3400,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100535,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100536,points,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100537,.,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100878,Whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100879,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100880,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100881,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100882,as,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100883,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100884,substitution,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100885,for,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100886,any,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100887,other,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100888,subgroup,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100889,was,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100890,associated,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100891,with,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100892,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100893,lower,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100894,rate,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100895,of,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100896,ischaemic,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100897,stroke,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100898,(,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100899,HR,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100900,between,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100901,0·33,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100902,and,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100903,0·36,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100904,/,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100905,serving,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100906,per,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100907,d,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100908,),O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100909,.,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
101699,The,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101700,remaining,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101701,30,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101702,%,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101703,of,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101704,calcium,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101705,was,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101706,provided,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101707,by,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101708,grains,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101709,and,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101710,grain,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101711,products,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101712,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101713,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101714,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101715,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101716,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101717,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101718,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101719,vegetables,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101720,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101721,fruits,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101722,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101723,eggs,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101724,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101725,legumes,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101726,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101727,nuts,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101728,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101729,and,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101730,seeds,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101731,.,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101732,Chocolate,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101733,elicits,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101734,unique,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101735,brain,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101736,activity,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101737,compared,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101738,to,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101739,other,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101740,foods,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101741,",",O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101742,activating,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101743,similar,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101744,brain,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101745,regions,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101746,and,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101747,neurobiological,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101748,substrates,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101749,with,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101750,potentially,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101751,similar,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101752,psychoactive,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101753,effects,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101754,as,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101755,substances,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101756,of,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101757,abuse,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101758,.,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101968,We,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101969,did,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101970,not,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101971,find,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101972,a,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101973,correlation,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101974,between,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101975,BES,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101976,scores,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101977,and,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101978,the,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101979,total,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101980,amount,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101981,of,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101982,chocolate,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101983,consumed,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101984,or,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101985,self,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101986,-,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101987,reported,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101988,scores,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101989,on,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101990,the,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101991,PEQ,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101992,.,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
102568,High,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102569,salt,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102570,intake,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102571,is,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102572,a,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102573,major,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102574,risk,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102575,factor,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102576,of,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102577,hypertension,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102578,and,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102579,cardiovascular,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102580,disease,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102581,.,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102963,We,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102964,also,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102965,identified,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102966,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102967,mid,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102968,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102969,dorsal,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102970,insula,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102971,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102972,well,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102973,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102974,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102975,primary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102976,and,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102977,secondary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102978,somatosensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102979,cortex,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102980,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102981,regions,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102982,previously,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102983,assumed,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102984,to,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102985,integrate,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102986,oral,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102987,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102988,sensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102989,inputs,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102990,.,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102991,These,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102992,findings,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102993,suggest,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102994,that,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102995,fat,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102996,perception,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102997,involves,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102998,a,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102999,specific,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103000,set,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103001,of,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103002,brain,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103003,regions,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103004,that,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103005,were,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103006,previously,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103007,reported,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103008,to,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103009,underpin,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103010,gustatory,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103011,processing,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103012,and,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103013,oral,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103014,-,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103015,sensory,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103016,integration,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103017,processes,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103018,.,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103056,We,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103057,investigated,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103058,associations,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103059,between,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103060,intakes,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103061,of,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103062,11,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103063,nutrients,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103064,(,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103065,thiamine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103066,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103067,riboflavin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103068,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103069,niacin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103070,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103071,pantothenic,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103072,acid,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103073,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103074,vitamin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103075,B6,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103076,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103077,biotin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103078,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103079,folate,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103080,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103081,vitamin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103082,B12,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103083,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103084,methionine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103085,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103086,choline,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103087,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103088,and,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103089,betaine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103090,),O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103091,and,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103092,gastric,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103093,cancer,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103094,risk,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103095,.,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103140,Dietary,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103141,intakes,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103142,of,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103143,nutrients,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103144,were,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103145,estimated,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103146,at,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103147,baseline,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103148,(,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103149,1990,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103150,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103151,1994,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103152,),O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103153,using,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103154,a,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103155,121,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103156,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103157,item,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103158,food,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103159,frequency,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103160,questionnaire,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103161,.,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103907,Conjugated,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103908,linoleic,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103909,acid,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103910,(,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103911,CLA,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103912,),O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103913,is,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103914,a,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103915,collective,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103916,term,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103917,for,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103918,positional,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103919,and,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103920,geometric,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103921,isomers,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103922,of,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103923,octadecadienoic,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103924,acid,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103925,in,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103926,which,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103927,the,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103928,double,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103929,bonds,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103930,are,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103931,conjugated,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103932,",",O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103933,i.e.,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103934,contiguous,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103935,.,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
104016,Two,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104017,isomers,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104018,predominate,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104019,in,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104020,the,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104021,synthetic,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104022,preparation,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104023,",",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104024,"c9,t11",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104025,and,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104026,"t10,c12",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104027,.,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104304,Quarantine,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104305,did,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104306,not,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104307,significantly,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104308,modify,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104309,smoking,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104310,habit,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104311,nor,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104312,body,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104313,mass,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104314,index,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104315,.,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
118875,A,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118876,diet,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118877,based,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118878,on,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118879,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118880,and,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118881,beans,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118882,may,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118883,have,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118884,a,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118885,protective,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118886,role,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118887,against,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118888,weight,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118889,gain,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118890,in,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118891,women,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118892,.,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118917,However,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118918,",",O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118919,thorough,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118920,reviews,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118921,on,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118922,the,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118923,efficacy,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118924,of,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118925,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118926,on,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118927,brain,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118928,processes,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118929,in,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118930,young,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118931,adults,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118932,do,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118933,not,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118934,exist,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118935,precisely,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118936,due,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118937,to,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118938,the,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118939,limited,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118940,number,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118941,of,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118942,studies,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118943,in,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118944,the,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118945,matter,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118946,.,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
119038,Findings,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119039,from,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119040,individual,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119041,studies,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119042,confirm,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119043,that,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119044,acute,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119045,and,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119046,chronic,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119047,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119048,intake,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119049,have,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119050,a,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119051,positive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119052,effect,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119053,on,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119054,several,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119055,cognitive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119056,outcomes,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119057,.,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119508,The,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119509,aim,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119510,was,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119511,to,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119512,compare,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119513,the,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119514,effect,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119515,on,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119516,atherogenesis,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119517,of,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119518,dietary,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119519,monounsaturated,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119520,and,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119521,saturated,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119522,fatty,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119523,acids,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119524,in,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119525,cholesterol,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119526,-,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119527,clamped,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119528,rabbits,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119529,.,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119561,The,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119562,amount,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119563,of,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119564,fat,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119565,fed,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119566,daily,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119567,was,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119568,10,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119569,g,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119570,per,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119571,rabbit,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119572,in,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119573,Expts,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119574,A,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119575,(,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119576,n,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119577,23,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119578,),O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119579,",",O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119580,C,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119581,(,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119582,n,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119583,36,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119584,),O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119585,",",O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119586,and,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119587,D,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119588,(,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119589,n,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119590,58,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119591,),O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119592,and,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119593,5,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119594,g,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119595,per,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119596,rabbit,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119597,in,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119598,Expt,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119599,B,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119600,(,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119601,n,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119602,24,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119603,),O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119604,.,O,4168.0,"The amount of fat fed daily was 10 g per rabbit in Expts A ( n 23 ) , C ( n 36 ) , and D ( n 58 ) and 5 g per rabbit in Expt B ( n 24 ) ."
119838,Cases,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119839,(,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119840,N,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119841,=,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119842,148,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119843,),O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119844,were,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119845,married,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119846,men,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119847,ages,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119848,20,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119849,through,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119850,74,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119851,years,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119852,diagnosed,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119853,with,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119854,pancreatic,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119855,cancer,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119856,from,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119857,July,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119858,1982,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119859,through,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119860,June,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119861,1986,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119862,.,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
120008,After,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120009,adjustment,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120010,for,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120011,demographic,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120012,and,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120013,dietary,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120014,characteristics,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120015,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120016,there,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120017,was,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120018,no,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120019,association,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120020,between,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120021,pancreatic,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120022,cancer,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120023,risk,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120024,and,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120025,the,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120026,intake,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120027,of,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120028,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120029,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120030,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120031,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120032,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120033,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120034,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120035,hard,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120036,liquor,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120037,or,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120038,all,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120039,alcohol,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120040,combined,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120041,;,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120042,a,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120043,slight,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120044,reduction,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120045,in,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120046,risk,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120047,was,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120048,seen,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120049,among,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120050,those,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120051,consuming,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120052,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120053,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120054,daily,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120055,.,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120664,Results,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120665,indicated,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120666,that,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120667,Western,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120668,style,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120669,diet,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120670,such,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120671,as,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120672,expenditure,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120673,of,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120674,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120675,",",O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120676,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120677,and,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120678,egg,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120679,and,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120680,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120681,had,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120682,negative,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120683,association,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120684,with,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120685,SMR,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120686,.,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120980,There,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120981,was,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120982,a,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120983,positive,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120984,relationship,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120985,between,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120986,gastric,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120987,-,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120988,cancer,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120989,risk,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120990,and,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120991,the,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120992,age,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120993,at,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120994,which,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120995,the,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120996,interviewees,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120997,started,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120998,using,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120999,refrigerators,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
121000,.,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
121128,Milk,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121129,sEV,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121130,were,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121131,isolated,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121132,from,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121133,three,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121134,BLV,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121135,-,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121136,infected,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121137,and,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121138,three,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121139,uninfected,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121140,cattle,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121141,.,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121618,Further,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121619,observational,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121620,prospective,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121621,research,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121622,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121623,well,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121624,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121625,designed,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121626,randomised,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121627,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121628,controlled,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121629,studies,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121630,are,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121631,needed,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121632,to,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121633,confirm,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121634,this,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121635,cross,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121636,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121637,sectional,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121638,relationship,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121639,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121640,to,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121641,comprehend,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121642,the,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121643,role,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121644,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121645,mechanisms,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121646,that,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121647,different,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121648,types,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121649,of,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121650,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121651,may,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121652,play,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121653,in,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121654,insulin,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121655,resistance,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121656,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121657,cardiometabolic,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121658,disorders,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121659,.,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
122222,Ethanol,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122223,significantly,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122224,reduced,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122225,AFSA,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122226,by,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122227,60,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122228,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122229,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122230,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122231,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122232,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122233,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122234,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122235,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122236,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122237,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122238,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122239,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122240,or,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122241,62,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122242,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122243,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122244,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122245,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122246,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122247,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122248,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122249,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122250,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122251,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122252,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122253,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122254,.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122869,Diet,O,4280.0,Diet was assessed via three 24 h records .
122870,was,O,4280.0,Diet was assessed via three 24 h records .
122871,assessed,O,4280.0,Diet was assessed via three 24 h records .
122872,via,O,4280.0,Diet was assessed via three 24 h records .
122873,three,O,4280.0,Diet was assessed via three 24 h records .
122874,24,O,4280.0,Diet was assessed via three 24 h records .
122875,h,O,4280.0,Diet was assessed via three 24 h records .
122876,records,O,4280.0,Diet was assessed via three 24 h records .
122877,.,O,4280.0,Diet was assessed via three 24 h records .
123390,These,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123391,results,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123392,suggest,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123393,diets,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123394,high,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123395,in,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123396,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123397,or,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123398,RS,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123399,could,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123400,influence,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123401,cancer,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123402,initiation,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123403,or,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123404,progression,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123405,by,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123406,changes,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123407,in,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123408,circulating,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123409,levels,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123410,of,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123411,hormones,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123412,and,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123413,other,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123414,factors,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123415,.,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123416,Enzyme,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123417,-,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123418,linked,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123419,immunosorbent,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123420,assay,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123421,(,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123422,ELISA,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123423,),O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123424,is,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123425,a,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123426,commonly,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123427,used,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123428,method,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123429,for,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123430,the,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123431,detection,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123432,of,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123433,trace,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123434,amounts,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123435,of,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123436,potentially,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123437,allergenic,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123438,protein,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123439,residues,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123440,in,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123441,foods,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123442,.,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123564,When,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123565,vinegar,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123566,was,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123567,spiked,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123568,with,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123569,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123570,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/51905005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123571,at,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123572,pH,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123573,3,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123574,",",O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123575,3.5,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123576,",",O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123577,and,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123578,4,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123579,",",O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123580,detectability,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123581,of,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123582,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123583,was,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123584,lowest,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123585,at,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123586,pH,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123587,3,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123588,.,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123926,In,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123927,conclusion,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123928,",",O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123929,the,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123930,present,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123931,study,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123932,confirms,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123933,the,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123934,presence,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123935,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123936,a,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123937,moderate,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123938,adverse,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123939,effect,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123940,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123941,high,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123942,intake,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123943,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123944,foods,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123945,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123946,animal,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123947,origin,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123948,",",O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123949,chiefly,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123950,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123951,",",O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123952,while,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123953,it,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123954,suggests,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123955,that,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123956,a,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123957,diet,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123958,rich,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123959,in,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123960,fresh,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123961,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123962,and,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123963,vegetables,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123964,does,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123965,not,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123966,convey,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123967,a,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123968,protection,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123969,.,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
124382,We,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124383,have,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124384,recently,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124385,reported,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124386,that,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124387,patients,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124388,with,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124389,fibromyalgia,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124390,(,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124391,FM,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124392,),O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124393,may,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124394,be,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124395,at,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124396,increased,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124397,risk,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124398,for,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124399,cardiovascular,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124400,disease,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124401,.,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124942,Excessive,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124943,alcohol,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124944,intake,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124945,also,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124946,contributes,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124947,significantly,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124948,to,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124949,the,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124950,CLD,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124951,burden,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124952,in,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124953,the,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124954,form,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124955,of,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124956,alcoholic,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124957,liver,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124958,disease,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124959,(,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124960,ALD,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124961,),O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
124962,.,O,4358.0,Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease ( ALD ) .
125615,To,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125616,study,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125617,the,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125618,association,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125619,between,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125620,fruits,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125621,and,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125622,vegetables,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125623,and,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125624,risk,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125625,of,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125626,RCC,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125627,in,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125628,a,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125629,population,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125630,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125631,based,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125632,prospective,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125633,cohort,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125634,study,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125635,of,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125636,Swedish,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125637,women,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125638,",",O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125639,we,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125640,collected,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125641,dietary,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125642,information,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125643,from,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125644,"61,000",O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125645,women,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125646,age,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125647,40,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125648,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125649,76,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125650,years,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125651,by,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125652,a,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125653,food,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125654,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125655,frequency,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125656,questionnaire,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125657,.,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125728,When,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125729,fruits,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125730,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125731,vegetables,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125732,were,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125733,examined,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125734,separately,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125735,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125736,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125737,who,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125738,consumed,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125739,more,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125740,than,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125741,75,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125742,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125743,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125744,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125745,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125746,fruits,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125747,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125748,vegetables,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125749,had,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125750,multivariate,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125751,relative,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125752,risk,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125753,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125754,0.59,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125755,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125756,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125757,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125758,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125759,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125760,0.27,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125761,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125762,1.25,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125763,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125764,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125765,0.60,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125766,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125767,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125768,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125769,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125770,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125771,0.31,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125772,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125773,1.17,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125774,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125775,respectively,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125776,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125777,compared,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125778,to,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125779,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125780,consuming,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125781,11,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125782,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125783,less,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125784,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125785,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125786,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125787,.,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125788,Within,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125789,the,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125790,group,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125791,of,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125792,fruits,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125793,",",O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125794,the,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125795,strongest,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125796,inverse,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125797,association,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125798,was,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125799,observed,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125800,for,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125801,banana,B-http://purl.bioontology.org/ontology/SNOMEDCT/256307007,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125802,(,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125803,p,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125804,=,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125805,0.07,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125806,by,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125807,Wald,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125808,test,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125809,),O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125810,.,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
126025,We,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126026,identified,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126027,a,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126028,modest,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126029,inverse,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126030,association,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126031,of,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126032,water,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126033,intake,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126034,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126035,odds,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126036,ratio,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126037,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126038,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126039,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126040,0.70,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126041,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126042,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126043,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126044,confidence,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126045,interval,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126046,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126047,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126048,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126049,0.48,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126050,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126051,1.02,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126052,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126053,and,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126054,total,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126055,fluid,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126056,intake,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126057,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126058,high,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126059,vs.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126060,low,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126061,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126062,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126063,0.70,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126064,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126065,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126066,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126067,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126068,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126069,0.46,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126070,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126071,1.06,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126072,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126073,with,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126074,risk,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126075,of,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126076,rectal,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126077,cancer,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126078,in,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126079,men,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126080,and,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126081,a,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126082,positive,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126083,association,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126084,with,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126085,juice,B-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126086,among,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126087,women,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126088,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126089,high,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126090,vs.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126091,low,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126092,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126093,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126094,1.56,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126095,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126096,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126097,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126098,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126099,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126100,1.00,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126101,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126102,2.41,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126103,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126104,.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
127075,Dietary,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127076,intake,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127077,data,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127078,were,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127079,collected,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127080,via,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127081,three,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127082,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127083,day,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127084,24,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127085,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127086,h,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127087,food,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127088,records,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127089,",",O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127090,and,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127091,sugar,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127092,intake,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127093,was,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127094,calculated,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127095,for,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127096,the,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127097,total,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127098,sugar,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127099,content,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127100,of,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127101,foods,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127102,using,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127103,our,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127104,database,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127105,compiled,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127106,from,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127107,various,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127108,sources,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127109,.,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127355,Consequently,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127356,",",O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127357,this,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127358,information,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127359,could,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127360,be,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127361,of,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127362,value,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127363,to,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127364,obesity-,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127365,and,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127366,metabolic,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127367,disease,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127368,-,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127369,prevention,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127370,strategies,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127371,.,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127852,Treatments,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127853,(,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127854,2,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127855,x,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127856,2,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127857,factorial,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127858,arrangement,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127859,),O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127860,given,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127861,orally,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127862,once,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127863,daily,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127864,for,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127865,the,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127866,first,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127867,3,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127868,d,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127869,postpartum,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127870,were,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127871,water,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127872,(,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127873,control,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127874,),O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127875,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127876,500,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127877,ml,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127878,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127879,PG,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127880,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127881,454,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127882,g,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127883,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127884,fat,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127885,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127886,or,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127887,500,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127888,ml,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127889,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127890,PG,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127891,plus,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127892,454,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127893,g,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127894,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127895,fat,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127896,.,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127897,All,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127898,treatments,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127899,were,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127900,administered,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127901,as,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127902,a,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127903,total,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127904,volume,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127905,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127906,1.9,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127907,L.,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127908,Administration,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127909,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127910,PG,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127911,decreased,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127912,concentrations,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127913,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127914,nonesterified,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127915,fatty,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127916,acids,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127917,(,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127918,NEFA,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127919,),O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127920,in,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127921,plasma,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127922,during,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127923,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127924,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127925,7,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127926,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127927,and,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127928,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127929,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127930,21,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127931,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127932,postpartum,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127933,and,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127934,tended,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127935,to,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127936,decrease,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127937,concentrations,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127938,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127939,beta,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127940,-,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127941,hydroxybutyrate,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127942,during,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127943,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127944,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127945,7,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127946,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127947,postpartum,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127948,.,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
128431,Skin,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128432,prick,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128433,tests,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128434,for,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128435,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128436,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128437,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128438,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128439,and,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128440,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128441,were,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128442,positive,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128443,in,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128444,51,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128445,(,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128446,64.6,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128447,%,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128448,),O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128449,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128450,61,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128451,(,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128452,77.2,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128453,%,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128454,),O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128455,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128456,and,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128457,71,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128458,(,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128459,89.9,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128460,%,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128461,),O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128462,patients,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128463,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128464,respectively,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128465,.,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128593,Approximately,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128594,half,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128595,of,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128596,these,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128597,patients,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128598,had,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128599,symptoms,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128600,(,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128601,especially,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128602,oral,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128603,allergy,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128604,syndrome,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128605,),O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128606,after,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128607,eating,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128608,these,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128609,products,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128610,.,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128741,This,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128742,paper,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128743,demonstrates,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128744,that,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128745,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128746,makes,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128747,a,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128748,significant,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128749,contribution,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128750,to,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128751,U.S.,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128752,per,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128753,capita,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128754,dietary,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128755,antioxidants,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128756,and,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128757,by,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128758,inference,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128759,the,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128760,European,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128761,Community,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128762,'s,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128763,.,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
129697,A,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129698,small,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129699,pilot,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129700,study,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129701,(,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129702,6,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129703,-,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129704,7,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129705,subjects,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129706,per,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129707,group,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129708,),O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129709,was,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129710,also,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129711,conducted,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129712,to,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129713,observe,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129714,whether,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129715,chronic,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129716,almond,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129717,ingestion,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129718,(,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129719,1,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129720,serving,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129721,5,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129722,d,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129723,/,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129724,wk,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129725,for,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129726,12,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129727,weeks,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129728,),O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129729,lowered,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129730,hemoglobin,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129731,A(1c,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129732,),O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129733,in,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129734,individuals,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129735,with,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129736,type,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129737,2,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129738,diabetes,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129739,mellitus,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129740,.,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129916,Current,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129917,cigarette,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129918,smokers,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129919,at,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129920,time,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129921,of,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129922,examination,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129923,had,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129924,a,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129925,3,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129926,-,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129927,fold,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129928,risk,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129929,for,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129930,upper,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129931,aerodigestive,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129932,tract,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129933,cancer,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129934,compared,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129935,with,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129936,never,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129937,-,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129938,smokers,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129939,.,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
130286,Positive,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130287,skin,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130288,test,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130289,reactions,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130290,were,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130291,seen,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130292,almost,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130293,exclusively,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130294,in,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130295,atopics,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130296,.,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130434,Oral,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130435,and,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130436,external,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130437,dosing,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130438,methods,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130439,replicating,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130440,field,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130441,exposure,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130442,were,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130443,developed,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130444,using,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130445,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130446,double,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130447,crested,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130448,cormorant,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130449,(,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130450,DCCO,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130451,),O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130452,to,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130453,test,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130454,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130455,toxicity,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130456,of,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130457,artificially,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130458,weathered,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130459,Deepwater,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130460,Horizon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130461,Mississippi,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130462,Canyon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130463,252,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130464,oil,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130465,.,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130773,We,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130774,have,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130775,mainly,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130776,focused,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130777,on,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130778,several,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130779,phytochemicals,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130780,like,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130781,resveratrol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130782,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130783,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130784,grapes,I-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130785,and,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130786,peanuts,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130787,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130788,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130789,allicin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130790,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130791,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130792,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130793,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130794,lycopene,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130795,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130796,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130797,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130798,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130799,indole-3,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130800,-,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130801,carbinol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130802,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130803,cruciferous,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130804,vegetables,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130805,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130806,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130807,vitamin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130808,C,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130809,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130810,citrus,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130811,fruits,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130812,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130813,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130814,[,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130815,6]-gingerol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130816,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130817,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130818,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130819,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130820,emodin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130821,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130822,aloe,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130823,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130824,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130825,natural,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130826,antioxidant,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130827,mixture,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130828,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130829,spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130830,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130831,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130832,beta,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130833,carotenoids,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130834,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130835,carrots,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130836,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130837,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130838,sulphoraphane,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130839,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130840,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130841,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130842,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130843,ellagic,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130844,acid,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130845,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130846,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130847,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130848,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130849,myrecitin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130850,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130851,cranberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/227421003,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130852,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130853,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130854,carnosol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130855,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130856,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130857,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130858,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130859,vanillin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130860,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130861,vanilla,B-http://purl.bioontology.org/ontology/SNOMEDCT/412070003,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130862,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130863,and,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130864,eugenol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130865,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130866,cloves,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130867,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130868,.,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
131317,Imbalance,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131318,between,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131319,the,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131320,activities,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131321,of,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131322,these,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131323,two,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131324,enzymes,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131325,is,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131326,associated,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131327,with,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131328,various,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131329,forms,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131330,of,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131331,cancer,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131332,.,O,4565.0,Imbalance between the activities of these two enzymes is associated with various forms of cancer .
131363,The,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131364,Food,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131365,and,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131366,Drug,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131367,Administration,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131368,(,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131369,FDA,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131370,),O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131371,has,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131372,already,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131373,approved,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131374,four,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131375,compounds,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131376,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131377,namely,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131378,vorinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131379,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131380,romidepsin,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131381,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131382,belinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131383,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131384,and,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131385,panobinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131386,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131387,as,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131388,HDACi,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131389,for,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131390,the,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131391,treatment,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131392,of,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131393,cancer,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131394,.,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131395,Several,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131396,other,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131397,HDACi,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131398,of,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131399,natural,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131400,and,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131401,synthetic,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131402,origin,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131403,are,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131404,under,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131405,clinical,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131406,trial,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131407,for,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131408,the,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131409,evaluation,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131410,of,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131411,efficiency,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131412,and,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131413,side,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131414,-,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131415,effects,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131416,.,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131455,Several,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131456,HDACi,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131457,of,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131458,natural,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131459,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131460,dietary,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131461,origin,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131462,are,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131463,butein,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131464,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131465,protocatechuic,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131466,aldehyde,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131467,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131468,kaempferol,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131469,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131470,grapes,B-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131471,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131472,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131473,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131474,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131475,tomatoes,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131476,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131477,potatoes,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131478,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131479,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131480,onions,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131481,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131482,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131483,resveratrol,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131484,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131485,grapes,B-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131486,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131487,red,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131488,wine,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131489,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131490,blueberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/412061001,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131491,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131492,peanuts,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131493,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131494,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131495,sinapinic,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131496,acid,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131497,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131498,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131499,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131500,vinegar,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131501,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131502,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131503,diallyl,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131504,disulfide,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131505,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131506,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131507,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131508,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131509,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131510,zerumbone,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131511,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131512,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131513,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131514,.,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
132212,Colorectal,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132213,carcinoma,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132214,(,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132215,CRC,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132216,),O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132217,is,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132218,the,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132219,second,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132220,most,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132221,common,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132222,cancer,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132223,diagnosed,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132224,in,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132225,Algeria,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132226,.,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
